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ABSTRACT 
In recent years, there has been a rise in the incidence of neonatal infections due to 
Enterobacteriaceae including Escherichia coli, Enterobacter, Klebsiella and Serratia 
spp. These are major causative agents in neonatal intensive care unit (NICU) 
infections. Neonates, especially those born with low birth weight (< 2000g), are fed 
via a nasogastric tube. Despite recent concerns over the microbiological safety of 
infant feeds, there has been no consideration that the nasogastric enteral feeding tube 
may act as a site for bacterial colonisation and act as a locus for infection. Therefore 
bacterial analysis of used feeding tubes is of importance with regard to identifying 
risk factors during neonatal enteral feeding. 
The aims of this study were to determine whether neonatal nasogastric enteral 
feeding tubes are colonised by opportunistic pathogens in the Enterobacteriaceae, 
and whether their presence was influenced by the feeding regime. 
In this research a collection 224 Enterobacteriaceae strains previously isolated from 
the enteral feeding tubes of neonates on intensive care units have been analysed. This 
study describes the use of DNA finger printing, via pulsed-field gel electrophoresis 
(PFGE), to determine if the same strains were isolated on different occasions from 
the NICUs. Therefore indicating whether certain strains have colonised the NICUs 
leading to increased exposure and risk to the neonates. 
The second project aim compared the virulence potential of Enterobacteriaceae, 
many of which were associated with feeding tubes. Twenty strains were chosen that 
represented species from the major genera isolated; E. coli, Serratia, Klebsiella and 
Enterobacter spp. Virulence to mammalian cells has been assessed using attachment 
and invasion studies of human colonic carcinoma epithelial cells (Caco-2), rat blood 
brain barrier cells (rBECE4) and human brain microvascular endothelial cells 
(HBMEC) tissue culture cells. Macrophage survival was studied using the (U937) 
cell line of human monocyte cells.  
The analysis has covered attachment and invasion of human intestinal cells, survival 
in macrophages, and invasion of rat and human brain cells. The results show that 
certain strains of E. coli k1 isolated from neonatal feeding tubes are able to persist in 
macrophages and hence be dispersed and potentially cause systemic infections.  
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 Introduction 1.1
Despite improvements in health care, still an average of 4 million babies out of 
130 million born every year die in the first 4 weeks of life (Lawn et al., 2005). The 
United Nations (UN) Millennium Development Goals (MDGs) represent the widest 
commitment in history to addressing global poverty and ill health. The fourth UN 
goal (MDG-4) commits the international community to reducing mortality in 
children aged younger than 5 years by two-thirds between 1990 and 2015 
(Haines and Cassels, 2004). Although between 1960 and 1990, the risk of dying in 
the first 5 years of life was halved, achieving MDG-4 will depend on mortality 
reductions even greater in percentage terms than those already achieved (Lawn et al., 
2005). A decade before the target date of 2015, there are predictions that the goal 
will not be met. A major challenge, which is less frequently identified in policy 
analysis, is the slow progress in reducing global neonatal mortality. Between 1980 
and 2000, child mortality after the first month of life between 2 months and 5 years 
fell by a third, whereas the neonatal mortality rate was reduced by only about 
a quarter (Travis et al., 2004). Hence, an increasing proportion of child deaths are 
now in the neonatal period. In 2000, approximately 38% of all deaths in children 
younger than age of 5 years happened in the first month of life. Deaths in the first 
week of life have shown the least progress in reduction. In 1980, only 23% of deaths 
occurred in the first week of life and by the year 2000 this had risen to an estimated 
28% (3 million deaths). To meet MDG-4, a substantial reduction in neonatal 
mortality rate in high-mortality countries is needed, and reduction deaths in the first 
week of life will be essential to achieve this target. In year 2000 in Europe, the 
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average neonatal mortality rate per 1000 live births was 11 (range 2 - 38 across 
countries), the number of deaths being 116 /1000. Three-quarters of neonatal deaths 
arose in the first week of life. The major direct causes were infections 36%, preterm 
birth 28% and birth asphyxia 23%. 60 – 80% of neonatal deaths were in low birth 
weight babies (Lawn et al., 2005). In 2008, globally, there were 8.8 million deaths in 
children less than 5 years in age, and 41% (3.6 million) of these deaths occurred in 
neonates. The most significant risk factors identified were pre-term complications, 
birth asphyxia, sepsis and pneumonia. In Europe, in 2008 there were 148,000 
neonatal deaths, 18% of these were due to preterm complications and various 
infections comprised 33% of the deaths (Lawn et al., 2005; Black et al., 2010).  
Premature neonates are vulnerable to infections from several routes. Major clinical 
risk factors include the presence of medical devices e.g. nasogastric feeding tubes, 
intravascular catheters, immaturity of their immune system, and immaturity of their 
epithelial and mucosal barriers. The gastrointestinal tract of the neonate is sterile 
at birth, yet it is rapidly colonised by bacteria afterwards (Kaufman and 
Fairchild, 2004). 
Recent reported events in the UK, highlighted by the national press, indicated that 
nosocomial infections and sepsis continue to be significant causes of mortality and 
morbidity in preterm infants on neonatal intensive care units (Black et al., 2010; 
Liu et al., 2012). Furthermore, the care environment can be a major source of 
potential pathogens. Earlier studies have shown that healthcare practice in neonatal 
units (antibiotic exposure, diet) has significant effect on the incidence of intestinal 
sepsis in premature neonate. Others have also demonstrated that the care 
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environment also plays a significant role in these nosocomial infections. Previous 
work at NTU has already demonstrated that feeding tubes, which most premature 
neonates are dependent upon, can be rapidly colonised with high levels potentially 
pathogenic organisms and act as a reservoir that may perturb the normal colonising 
process. They also showed that different feeding regimes can modify this 
colonisation pattern (Hurrell et al., 2009a and 2009b).  
A portion of neonatal illnesses are due to bacterial infection, to which the neonate is 
highly susceptible due to their immature immune status. Therefore rates of early 
exposure to bacteria must be carefully considered to evidence infections by 
opportunistic pathogens, which include members of the Enterobacteriaceae. 
 Enterobacteriaceae 1.2
Enterobacteriaceae are a family of Gram-negative bacteria that contains 44 genera 
and more than 176 species (Hong Nhung et al., 2007). The first identified member of 
the family was Serratia marcescens, which was described by Bizio in 1823, who 
found it had grown on Italian barley dish. More than half a century later, in 1880s, 
Klebsiella and Proteus were described. Initially biochemical methods were used to 
define the Enterobacteriaceae family. Currently the family has been reclassified 
according to phenotyping and genotyping methods (Janda and Abbott, 2006).  
The Enterobacteriaceae are a large and varied grouping of Gram negative rods. 
Members are relatively small, non-spore forming bacilli typically about 0.5 µm in 
width and 1 to 5 µm in length. Most are motile. Some have capsules. They grow 
under both aerobic and anaerobic conditions, and ferment various carbohydrates. 
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They are oxidase negative; some species are further defined serologically based on 
flagella protein, polysaccharide capsule and lipopolysaccharide. Several virulence 
factors including, invasion and toxins are the most studied pathogenicity factors of 
the Enterobacteriaceae.  
Most Enterobacteriaceae are opportunistic pathogens, especially Escherichia coli, 
Klebsiella spp., Serratia spp., Enterobacter spp. and Salmonella, and are associated 
with significant morbidity and mortality (Friedland et al., 2003; Adamson et al., 
2012). These organisms can cause many different kinds of infections in wounds 
(sepsis), brain (meningitis), pneumonia, and urinary tract infections especially in 
intensive care units (ICU) (Kollef et al., 1999; Ibrahim et al., 2000). Nosocomial 
infections are caused by Enterobacteriaceae such as E. coli (most common), 
Klebsiella, Proteus, Serratia and Citrobacter spp. Some of these organisms are part 
of the normal flora, such as E. coli and Enterobacter cloacae, and may cause such 
infections via selection following an empiric antimicrobial regime (Iversen and 
Forsythe, 2004a; Stoll et al., 2005). The most commonly encountered human 
pathogens of the family Enterobacteriaceae causing infections are showed in 
Table  1.1 (Liu et al., 2012; Podschun and Ullmann, 1998; Pazhani et al., 2005; 
Fraser and Arnett, 2006; Chaudhry et al., 2007; Hammerum and Heuer, 2009; 
Bisi-Johnson et al., 2011). 
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Table  1.1 The most commonly clinical important species of Enterobacteriaceae 
causing infections 
Genus Clinically important species Clinical Presentation 
Citrobacter freundii Pneumonia, meningitis, septicaemia, wound and urinary tract 
infections  
Enterobacter aerogenes, cloacae Pneumonia, septicaemia, wound and urinary tract infections  
Escherichia coli Diarrhoea, meningitis, septicaemia and urinary tract infections  
Klebsiella pneumoniae, oxytoca Pneumonia, septicaemia and urinary tract infections  
Morganella morganii Septicaemia and urinary tract infections 
Plesiomonas shigelloides Diarrhoea and septicaemia 
Providencia rettgeri, stuartii Urinary tract infections 
Salmonella enteritica Diarrhoea, typhoid fever, septicaemia, osteomyelitis and urinary 
tract infections  
Serratia marcescens, liquefaciens Pneumonia, septicaemia, wound and urinary tract infections  
Shigella sonnei, flexneri Diarrhoea  
Yersinia pestis, enterocolitica Diarrhoea, septicaemia plague and enteritis 
 Bacteria, breast milk and formula-fed  1.3
Human breast milk can be replaced with infant formula (IF) when the infant is 
unable to obtain mothers‘ milk or the amount is insufficient for normal development. 
In some cases mothers are unable to produce the milk or too little to feed her baby. 
Infant formula can also be required as a consequence of separating the child from 
their mother for health reasons, being at work, or the death of the mother 
(FAO/WHO, 2004 and 2006). Following delivery, the intestinal bacterial flora is 
usually sparse during the first few days of life, independent of feeding habits and 
environmental factors may be more important than breastfeeding (Mackie et al., 
1999; Dominguez-Bello et al., 2010). The colonisation of the neonate intestinal tract 
is initially dependent on the neonates‘ environment (Rosberg-Cody et al., 2004). The 
majority studies of infants intestinal gut flora were on faecal samples using the 
classical plating techniques with culturing on specific media. There have been 
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a limited number of studies, using cultivation and molecular techniques to follow the 
changes in the neonatal gut flora in the first weeks of life. Some of these studies have 
distinguished neonates according to birth weight, and mode of nutrition (ie. breast or 
formula-fed) (Favier et al., 2002; Fanaro et al., 2003). The environment and hospital 
staff are a major source of the colonising bacteria (Bezirtzoglou, 1997). After this 
initial colonization, the diversity of the subsequent bacterial flora community 
is influenced by the diet (Harmsen et al., 2000; Wold and Adlerberth, 2002; 
Alderberth et al., 2011). 
Diet is an important factor in composition and development of microbiota in early of 
life. The microbiota of breast-fed and formula-fed infants was found to differ 
significantly in both composition and diversity. Breast-fed babies contain the 
microbiota that is more heterogeneous than that of formula-fed babies and contain 
a higher taxonomic diversity (Schwartz et al., 2012). The bacteria isolated from 
infant formula include Enterobacter agglomerans, Hafnia alvei, K. pneumoniae, 
Citrobacter koseri, Citrobacter freundii, K. oxytoca, E. cloacae, E. coli, Serratia 
spp., Acinetobacter spp., Bacillus cereus, Clostridium difficile, Clostridium 
perfringens, Clostridium botulinum, Listeria monocytogenes, Staphylococcus aureus, 
and Salmonella (FAO/WHO, 2004 and 2006). S. aureus, B. cereus, and Salmonella 
serovars could be linked to neonate infections (Cahill et al., 2008; Forsythe, 2005). 
A published study (Bezirtzoglou, 1997) shows that breast milk often has low 
numbers of streptococci, micrococci, lactobacilli, staphylococci, diphteroids, and 
bifidobacteria. Whereas colonisation by staphylococci is more common in breast-fed 
infants, and may be occur due to contact with the mother‘s skin during feeding.  
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A study of the predominant intestinal microbes in full term infants who were 
breastfed, found bifidobacteria as most dominated and become stable during the first 
few days of life, lactobacilli and streptococci (Koenig et al., 2011; Scholtens et al., 
2012). Whereas Enterobacteriaceae (E. coli and Klebsiella spp.), Staphylococcus, 
Clostridium, Bifidobacterium, Enterococcus and Bacteroides spp. were the 
predominant flora in infant‘s formula-fed, (Harmsen et al., 2000; Rubaltelli et al., 
1998). Another study of the microbial variety during breast-feeding and weaning 
periods in two infant by Wang et al. (2004) shows that infants were colonized by 
Enterobacteriaceae, Bacteroides, Enterococcus, Streptococcus, Staphylococcus and 
Veillonella. In addition the Enterobacteriaceae and Bacteroides were more 
predominant during breast-feeding. After weaning the clostridia were increased, 
while the Enterobacteriaceae were reduced.  
Heavey and Rowland (1999) compared the intestinal microbial flora in breastfed and 
formula-fed, and reported that the bifidobacteria were more dominant on breast-fed 
infants neonates. This may be attributable to environment and improvements 
in formula feeds (Balmer et al., 1994; Rueda et al., 1998). Also human milk 
composition such as protein, nucleotides and gangliosides play a role in both the 
immune systems and growth microbes. Cabrera-Rubio et al. (2012) indicates that the 
microbiomes in milk are influence by several factors such as composition of milk.  
The study by Rueda et al. (1998) found that the counts of bifidobacteria was higher 
in formula-fed of infant, and also indicate that the colonization by bifidobacterial was 
faster when milk formula supplemented with gangliosides. While Helen and Susan 
(2012) reported that feeding infant‘s formula supplementary nucleotides are 
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attributable to a lower incidence of episodes of diarrhoea and also rose to plasma 
antibody response to some immunisations. 
A comparative study of microbial diversity in 40 infants during the first 2 years from 
birth using real-time PCR from month 7 to month 24, showed that the numbers of 
Bacteroides and Desulfovibrio spp. increased, while E. faecalis decreased. 
In addition microbial diversity increased which number of bifidobacteria in 
breast-fed babies, and the higher levels were desulfovibrio in bottle-fed children 
(Hopkins et al., 2005; Penders et al., 2005). A comparative study of predominant 
Bifidobacterium spp., E. coli and Clostridium difficile in faecal samples of 
50 breast-fed and 50 formula-fed infants, showed that C. difficile were highest in the 
formula-fed group (10
7 
CFU/g) than in breast–fed infants (103 CFU/g). The 
predominance of E. coli in the breast-fed and formula-fed was 80% and 
94% respectively at ca. 10
9
 CFU/g, while the predominance of Bifidobacterium spp. 
was similar in both groups (Penders et al., 2005). 
Twenty-nine infants with low birth weight (<1000 g) had stool samples collected on 
days 10, 20 and 30. In day 30 the major of species were Enterococcus faecalis, 
E. coli, S. epidermidis, E. cloacae, K. pneumoniae, and Staphylococcus 
haemolyticus. Members of the Lactobacillus and Bifidobacterium genera were 
identified in only one infant. The total counts and numbers of species identified 
increased in breast milk fed infants over time. During the study, two babies were fed 
by infant‘s formula, but one of those babies died. In addition those babies were 
colonized by E. coli, E. faecalis, and S. haemolyticus (Gewolb et al., 1999).  
Chapter 1: Introduction  
  10 
 
 Enterobacteriaceae infections in neonatal feeding tubes and bottles 1.4
The most important problem for new-born infants and premature infants especially 
those born with low birth weight (< 2000g) are bacterial infections. These neonates 
are fed via a nasogastric tube. Despite recent concerns over the microbiological 
safety of infant feeds, there has been little consideration that the nasogastric enteral 
feeding tube may act as a site for bacterial colonisation due to biofilm formation, and 
act as a locus for infection (Wiener et al., 1999). The nasogastric tube is usually 
between ambient (outer portion) and body temperature (inner portion), with regular 
(every 2 h) additions of nutrients from the infant feed and in-place over sufficient 
time periods for bacterial multiplication. Previously, nasogastric feeding tubes of 
adults in a nursing home have been shown to be a reservoir for E. coli and Klebsiella 
with extended spectrum β–lactamase (ESBL) (Wiener et al., 1999). 
In recent years, there has been a rise in incidence of neonatal infections due to 
Enterobacteriaceae, and they have become the predominant causative agents in 
neonatal intensive care unit (NICU) outbreaks (Kaufman and Fairchild, 2004; 
McGuire et al., 2004; Gastmeier et al., 2007). Klebsiella spp. infections outnumber 
staphylococci infections, and Serratia spp., are the third most common causative 
pathogen (Gastmeier et al., 2007). Pathogenic strains of E. coli are one of the leading 
causes of neonatal meningitis and sepsis (Stoll et al., 2005). Neonates may be 
particularly prone to Gram negative infections (i.e. Enterobacteriaceae) as their 
innate immune cells have low responses to lipopolysaccharide (part of the Gram 
negative cell wall structure) and macrophage response (Levy et al., 2004). 
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A recent study at NTU analysed the enteral feeding tubes from >125 neonates in two 
local hospital neonatal intensive care units (NICU) (Hurrell et al., 2009a and 2009b).  
 
Figure  1.1 Electron microscopy of enteral feeding tube inner wall from: 
(a) Neonate fed breast milk and ready to feed formula. Bar indicates 4 μm size marker. (b) Neonate 
fed breast milk and reconstituted PIF with added thickener. Bar indicates 4 μm size marker. (Hurrell et 
al., 2009a) 
Enterobacteriaceae were isolated in high numbers (up to 10
7
 CFU/tube) from 
biofilms growing inside the feeding tubes, and identified see Figure  1.1. Of particular 
interest was the frequent isolation of the opportunistic pathogens E. coli, K. oxytoca, 
K. pneumoniae, S. marcescens, Enterobacter cancerogenus, and E. hormaechei. In 
addition, Cronobacter sakazakii and Yersinia enterocolitica were also isolated 
Table  1.2. The presence of the Enterobacteriaceae was irrespective of the feeding 
regime. During the period of this study there were 15 infections cases in the NICUs 
due to E. coli, K. pneumoniae, K. oxytoca, S. marcescens, and E. cloacae.  
 
Chapter 1: Introduction  
  12 
 
Table  1.2 Isolation of Enterobacteriaceae from biofilms on nasogastric enteral feeding tubes of neonates  
 
Feeding regime 
(n,%) 
Number of samples 
positive for 
Enterobacteriaceae  
Enterobacteriaceae species  
E. coli E. cancerogenus E. hormaechei K. pneumoniae R. planticola R. terrigena S. liquifaciens S. marcescens 
Breast milk 
(21,16) 
11(52)
 
3(4) 8(38) 12(57) 2(10)   2(10) 7(33) 
Fortified breast 
milk (37,29) 
29 (78) 10(27) 19(51) 10(27) 21(58) 1(3) 1(3) 5(14) 5(14) 
Ready to feed 
formula (26,20) 
21(81) 7(27) 8(31) 4(15) 7(27)  3(14) 4(15) 18(69) 
Reconstituted PIF 
(8,6) 
7(88) 5(6) 3(4)    6(75) 2(25) 3(38) 
Mixed (27,21) 21(78) 1244() 13(48) 14(52) 1(4) 3(11) 3(11) 2(7) 5(19) 
Nil by mouth 
(10,8) 
8(80)  2(20) 4(40) 1(10)    8(80) 
Total 129 (%) 97 (75) 37 (29) 53 (41) 44 (34) 32 (25) 4 (3) 13 (10) 15 (12) 46 (36) 
 
Identification of Enterobacteriaceae isolated from biofilms inside neonatal enteral feeding tubes collated according to the feeding regime of the neonate (Hurrell et al., 2009a)
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Levy et al. (1989) reported on 309 formula bottles over a 1 year period and 
found 83 (27%) were contaminated. Unfortunately, the source of contamination was 
unknown; though plasmid profiles of E. cloacae isolated from feeding liquid 
remained identical for several months, which may indicate a common source. 
Plasmid profiling however is not as discriminatory as PFGE, which would be applied 
to similar studies these days. The authors reported that E. cloacae nosocomial sepsis 
isolates over a 7-year period (1979 - 1985) had plasmid profiles that matched them to 
contaminated enteral nutrition solutions. Two out of seven K. pneumoniae 
bacteraemia over a six-month period could also be related to contaminated enteral 
feeds.   
 Enterobacteriaceae found in powdered infant formula  1.5
In a study by Muytjens et al. (1988), 10% of powdered infant formula (PIF total 
160 samples), were shown to be contaminated with Cronobacter spp. Another study 
by Iversen and Forsythe (2004b) using Druggan-Forsythe-Iversen (DFI selective 
agar), examined other dry baby food for the presence of Cronobacter. They isolated 
three Cronobacter spp. from 102 PIF samples and 5 isolates from 49 samples of baby 
food. Enterobacter cloacae, an opportunistic pathogen, were isolated from a neonatal 
intensive care unit (Fernandez-Baca et al., 2001). This bacterium and 
Enterobacter agglomerans were isolated by Muytjens et al. (1988) from powdered 
infant formula.     
During production powdered infant formula is heated and spray dried which is 
expected to kill most bacteria. However, contamination may occur after the heat 
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treatment process is over. Moreover, it is likely that contamination may happen 
during reconstitution (Smeets et al., 1998). Contamination can occur via carer 
professionals (Farmer et al., 1980). Previously Waters et al. (2004) indicated that 
cross-transmission with certain Gram-negative such as S. marcescens by the hands of 
the health care team has a high probability. Likewise, Weir (2002) asserted that 
preparing PIF must be done for neonatal intensive care units (NICUs) following the 
manufacturer‘s instructions in a designated area by trained personnel under clean and 
aseptic conditions. Finally, according to the FAO/WHO (2004) the refrigerated 
reconstituted formula should not be used after 24 hours. Continuous enteral feeding 
administration, on the other hand, should not exceed more than four hours. 
In addition FAO/WHO (2004 and 2006) collated information reported that 
Enterobacteriaceae sometimes found in powdered infant formula, which was also 
reported to be associated with neonatal infections. These were divided into groups 
A and B.  Salmonella enterica and Cronobacter spp. were placed in Group A ‗Clear 
evidence of causality‘, while E. cloacae, C. koseri, Citrobacter freundii, Hafnia 
alvei, K. pneumoniae, K. oxytoca and Pantoea agglomerans were considered as 
Group B ‗Causality plausible, but not demonstrated‘(Table  1.3). 
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Table  1.3 The Enterobacteriaceae in FAO/WHO (2004 and 2006) Category B 
Organism Infection Reference 
Citrobacter freundii Urinary tract infections respiratory and meningitis Drelichman and Band, 1985 
Citrobacter koseri Neonatal sepsis and meningitis Graham and Band, 1981 
Enterobacter cloacae 
Nosocomial, including bacteraemia, lower 
respiratory tract infections, skin and soft tissue 
infections 
Fernández-Baca et al., 2001 
Escherichia coli Neonatal meningitis Harvey  et al., 1999 
Escherichia vulneris 
Wounds, osteomyelitis, urosepsis, bacteraemia, 
meningitis 
Brenner et al., 1982 
Hafnia alvei Pneumonia, meningitis, abscesses, and septicaemia. Albert et al., 1992 
Klebsiella oxytoca Neonatal bacteraemia and meningitis Tullus et al., 1992 
Klebsiella pneumoniae Pneumonia, neonatal meningitis Harvey  et al., 1999 
Pantoea agglomerans Rare systemic infections Rostenberghe et al., 2006 
Serratia spp. 
Urinary tract infections, wound infections, and 
pneumonia 
Anahory et al., 1998 
 
 Neonates’ intestinal flora 1.6
In utero and before delivery the body surfaces, the gut lumen and the intestinal tract 
must be sterile, but during birth and after birth the baby is exposed to a wide-range of 
different bacteria (Orrhage and Nord, 1999). However not all of bacteria are able to 
colonise the baby. The initial colonisation is related to the type of delivery, the type 
of nutrition (breast milk or formula feeding), environment, hospital staff, human 
contacts and inanimate objects (Guenthner et al., 1987; Bezirtzoglou, 1997; 
Heshmati et al., 2011).  
The gastrointestinal tracts of humans contain more than 500 different species of 
bacteria. Moreover each species of bacteria comprise different bacterial strains. The 
estimated number of in the gut lumen contains as many as 10
11
 bacterial cells. These 
numbers of bacteria are comparable to those growing under conditions of 
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a laboratory. Those numbers are 10 times greater than the number of the gut lumen 
cells (Guarner and Malagelada, 2003). However, the number of bacteria varies 
between gut lumen sites, such as the stomach 10
1 – 103 cells per gram and 1011-1012 
cells per
 
gram in the lower tract (Sekirov et al., 2010). The lower bacterial number in 
the upper lumen is because of factors such as acid, enzymes in saliva and bile, which 
kills most ingested bacteria. In addition, the function of motor activity, which moves 
the food towards the end of ileum, also plays a role in the bacterial colonisation of 
the lumen (Riskin et al., 2011). 
Bacterial species inside the intestinal lumen of human can be classified into three 
groups. These groups have been recognised as pathogenic bacteria, beneficial 
bacteria and potentially pathogenic bacteria. Pathogenic bacteria can effect feeding 
intolerance, produce harmful materials inflammation, infections and make serious 
problems such as meningitis and necrotising enterocolitis especially with a premature 
baby (Dash et al., 2006). Beneficial bacteria are able to inhibit the growth of 
pathogenic bacteria such as outnumber pathogenic bacteria, activate the immune 
system, digestion of component parts and fermentation of dietary fibre 
(Westerbeek et al., 2006). Potentially pathogenic bacteria have neither a positive or 
negative impact if present in high numbers for example E. coli, Enterobacter spp. 
and streptococci. Although some of potentially pathogenic possibly will become 
pathogenic, even if present in low numbers for instance Klebsiella, E coli O157:H7 
and staphylococci (Dai and Walker, 1999). In the review by Westerbeek et al. (2006) 
five studies were considered that the beneficial bacteria and the potentially 
pathogenic bacteria colonised the intestine of premature baby. In brief, the studies 
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show that the intestine of premature babies is colonised with beneficial bacteria 
during the late period. While potentially pathogenic bacteria such as Enterobacter 
spp. and E. coli were found in the faeces of premature baby high numbers during the 
whole study period. 
 Neonatal infections 1.7
New-born babies and particularly those with very low birth-weight, have a weak 
immune system (Levy et al., 2004). This allows to the opportunistic pathogen of 
bacteria and other microbes to cause morbidity and mortality. The estimated numbers 
of newborns die in developing countries; about one million newborns die from 
infections (Ganatra and Zaidi, 2010). Thus, the study of neonatal infections is very 
important for describing and recognising the epidemiology of infections 
(Ganatra and Zaidi, 2010). In addition, the rates of risk and infection to neonates 
increased with decreased in birth weight, early age, additionally prolonged 
hospitalization (Stoll et al., 2005; Klinger et al., 2010). 
A study by Liu et al. (2012) shows that the estimated mortality in children younger 
than 5 years in 2010 were seven million and six hundred-thousand from different 
countries of the world. According to the causes of mortality, this number was 
distributed into two groups. First group occurred in neonates younger in 28 days, 
which was attributed to infectious causes, preterm birth complications, 
intrapartum-related complications, and sepsis or meningitis and other older which 
were attributed to pneumonia, diarrhoea and malaria. This is summarised in 
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Table  1.4 below which shows the rates of mortality of two groups, with the high rate 
in both groups of leading killers, are pneumonia and preterm birth. 
Table  1.4 Estimated number of mortalities in children younger than 5 years in 2010 
Causes Estimated death per millions Estimated deaths (%) 
Neonates aged 0 – 27 days 
Preterm birth complications 1·078 (0·916 – 1·325) 14 
Intrapartum-related complications 0·717 (0·610 – 0·876) 9 
Sepsis or meningitis 0·393 (0·252 – 0·552) 5 
Pneumonia 0·325 (0·209 – 0·470) 4 
Congenital abnormalities 0·270 (0·207 – 0·366) 4 
Other neonatal disorders 0·181 (0·115 – 0·284) 2 
Tetanus 0·058 (0·020 – 0·276) 1 
Diarrhoea 0·050 (0·017 – 0·151) 1 
Children aged 1 – 59 months 
Other disorders 1·356 (1·112 – 1·581) 18 
Pneumonia 1·071 (0·977 – 1·176) 14 
Diarrhoea 0·751 (0·538 – 1·031) 10 
Malaria 0·564 (0·432 – 0·709) 7 
Injury 0·354 (0·274 – 0·429) 5 
Meningitis 0·180 (0·136 – 0·237) 2 
AIDS 0·159 (0·131 – 0·185) 2 
Measles 0·114 (0·092 – 0·176) 1 
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with 
time trends since 2000 (Liu et al., 2012) 
In Table  1.5 summaries of information obtained from national nosocomial infections 
surveillance (NNIS) from 1986 to 1989 by Emori and Gaynes (1993), 1989 to 1990 
by Jarvis and Martone (1992) and 1981 and 1999 by Hsueh et al. (2002) about 
pathogens causing nosocomial infections in hospitals. Their study shows that E. coli 
was the most common isolate. 
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Table  1.5 Pathogens isolated from nosocomial infections reported to the national 
nosocomial infections surveillance (NNIS) 
Pathogens isolated 
% of isolates 
1986 and 1989 1986 and 1990. 1981 and 1999 
E. coli 16 13·7 18.6 
Enterococci 12 10.7 - 
Pseudomonas aeruginosa 11 10.1 11 
Staphylococcus aureus 10 11.2 - 
Coagulase-negative staphylococci 9 9·7 - 
 
Lee et al. (2004) studied the rate of bacteramia in a neonatal intensive care unit 
(NICU). Fifty-eight out of 623 (9.31%) patients had bacteremia, with 12 deaths. 
Among the bacterial pathogens isolated in sort as follows, were coagulase-negative 
Staphylococci 29%, S. aureus 22%, and E. cloacae 17%. In the Chittagong area of 
Bangladesh, study was performed to determine the incidence of bacterial neonatal 
sepsis. The study shows that 104 isolated were collected from 1400 blood samples of 
neonatal sepsis infection. 102 out of 104 isolated species of bacteria were belonged 
to Gram-negative and 2 belonged to Gram-positive. The main Gram-negative 
bacterial isolated were K. pneumoniae 79 (75.96%), S. marcescens 19 (18.27%) and 
Pseudomonas aeruginosa 4 (3.85%). The two (1.92%) S. aureus were isolated. Most 
of the Gram-negative bacteria showed resistance to ampicillin, ceftriaxone and 
gentamicin (Hafsa et al., 2011). Gram-negative bacteria isolated from hospital-
acquired infections and bloodstream infections in NICU are leading causes of high 
rates of morbidity and mortality. This study showed that E. coli was the most 
common organism isolated (Morfin-Otero et al., 2012). 
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 Infant meningitis 1.8
Bacterial meningitis is the inflammation of the lining around the brain and spinal 
cord, which are a significant cause of mortality and morbidity worldwide 
(Chávez-Bueno and McCracken, 2005; Shmaefsky et al., 2010). Consequently, 
bacterial meningitis is one of the most serious infection diseases and causes serious 
problems in children (Mashouf et al., 2006). Infection usually occurs between the 
fourth and eight day after birth and it can be fatal within hours to days following the 
first diagnosis (Muytjens et al., 1983). The estimates of infant sepsis and meningitis 
are approximately 1 to 5 infants per 1000 live births (Unhanand et al., 1993). The 
main risk factor for meningitis could be the lack of immunity to opportunistic 
pathogens that infect premature and infant babies, other risk factors infected by 
pathogenic bacteria, close interaction with individual having invasive disease (Feikin 
and Klugman, 2002; Al-Rawazq, 2010).  
Bacterial causes of meningitis are divided by age into two groups; first group 
premature and new-borns babies up to three months. Common causes meningitis of 
these group are group B streptococci and those that normally inhabit the gut lumen 
and the intestinal tract such as E. coli (Kim et al., 2005; Zhu et al., 2010). Older 
children are affected by Neisseria meningitidis, Streptococcus pneumoniae and third 
group under five Haemophilus influenzae (Sáez-Llorens and McCracken, 2003; 
Tunkel et al., 2004). 
The most common Gram-negative organism causing neonatal meningitis is 
E. coli K1 (Janda and Abbott, 2006; Kim et al., 2005; Zhu et al., 2010; Logue et al., 
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2012; Ribes, 2013) and also can occur due to a variety of other bacterial pathogens, 
such as E. cloacae, C. koseri, Neisseria meningitidis, Serratia spp., Enterobacter 
spp. and, Cronobacter spp.; and are also responsible for considerable morbidity and 
mortality (Friedland et al., 2003; Iversen and Forsythe, 2003; Adamson et al., 2012). 
Studies of Gram- negative enteric bacillary meningitis in neonates and infants from 
1969-1989 have been reported by Unhanand et al. (1993) with ninety-eight neonates 
and infant patient identified from 1 day to 2 years. The isolated organisms were 
E. coli 53%, Enterobacter spp. 16%, Citrobacter koseri 9%, Salmonella spp. (9%), 
Proteus mirabilis 4%, Serratia marcescens 3%, Bacteroides fragilis 3%, and 
Aeromonas spp. 2%. A number of these organisms have been isolated from 
nasogastric enteral feeding tubes, and their presence was not necessarily limited to 
the ingestion of reconstituted infant formula. 
 The bacterial interaction with mammalian cells 1.9
The diversity and high mass of microbes in the gastrointestinal tract leads to an 
interaction between them and host cells. These interactions can be commonly 
beneficial or can have detrimental effects. Human epithelial lining are colonized by 
diverse range of microbes and different bacterial species use different means of 
interaction with the host epithelium. The communities of microbes on the host 
epithelium can be affected by different factors such as nutrition, antibiotic treatment, 
environmental exposure to microorganisms, and microbial colonization in the 
neonatal period (Lindhorst and Oscarson, 2009; Abraham and Medzhitov, 2011). 
Additionally, the innate defence mechanisms of the gastrointestinal tract acts to wash 
microbes from surfaces include epithelial integrity, the fast renewal of old epithelial 
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cell, rapid propulsion of infected cells, auto-phagocytosis, and innate immune 
responses (Kim et al., 2010).  
Infants, particularly premature infants are more to prone diseases due to the 
vulnerability of natural epidermal, epithelial barriers and secreted products which are 
part of the innate immune system. For instance, the outer epidermal layer in 
a full-term infant is composed of 16 layers, whereas with premature infants at first 
few weeks this is only 3 layers, which could be more prone to invasive processes 
(Evans and Rutter, 1986). Many bacterial pathogens are able to avoid these defences 
of immune systems for example bacterial pathogens secrete various components and 
toxins (Kim et al., 2010). Also pathogenic bacteria are able to create an 
antiphagocytic surface layer usually containing of polysaccharide or by expressing 
their adhesions on polymeric structures that extend out from the cell surface (Kline et 
al., 2009). 
Infections by enteropathogenic E. coli, S. enterica, Shigella flexneri, and 
Yersinia enterocolitica are determined by the ability of microbes to attach, invade, 
colonize the intestinal epithelium, intracellular persistence and transmission from cell 
to cell (Reis and Horn, 2010). These bacteria use different infection strategies; for 
instance bacteria survive attack by resident macrophages by the injection, through 
a plasmid encoded type III secretion systems. Another strategy by the bacteria is the 
ability to invade the epithelial barrier by inducing changes in the intracellular 
compartment in which they reside, such bacteria survive and grow inside 
macrophages (Reis and Horn, 2010; Sansonetti, 2002). Bacteria can interact with the 
host cell surface in two ways. Some bacteria show attachment to the smooth surface 
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of the cells without any specific membrane action and other bacteria attach to the 
host cells by surface microvilli (Greiffenberg et al., 2000). In addition, another factor 
is the outer membrane which could play a role in interaction between Gram-negative 
bacteria and their external environment (Mogensen and Otzen, 2005). 
 Adhesion 1.9.1
Following contact of the epithelial layer with bacteria, adhesion to host cells is the 
initial step in interactions between bacteria and host cells (Reis and Horn, 2010). The 
host uses several strategies to protect the body and wash microbes from surfaces. 
Such as the epithelial layer being composed of ciliated and non-ciliated cells. The 
ciliated cells create an unstable environment for adhesion by their cleaning 
mechanisms. However microbial pathogens can express factors that bind to host 
tissue cells (Wilson et al., 2002). Adhesion of bacteria to host cells is an important 
step in the pathogenesis of infection (An and Friedman, 2000; Lindhorst and 
Oscarson, 2009). The processes of microbial adherence to host cells can be via 
fimbria or polysaccharides such as capsule. Gram negative bacterial pathogens such 
as E. coli in particular use fimbriae to attach to host cells (Wilson et al., 2002).  
Bacterial diseases of the gut commonly arise from interactions between bacterial and 
the mucosa host such as adherence and invasion (Hu and Kopecko, 2008). In 1908, 
there was the first report of the adhesion of bacteria to host cells. E. coli was reported 
to agglutinate animal cells by appendages, which was later determined to be 
multimeric pili (Kline et al., 2009). Curli fimbriae play a role in the adhesion of 
E. coli to its contact hosts (Pawar et al., 2005). Many of bacterial pathogens 
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including Y. enterocolitica, Salmonella, Shigella spp. and C. jejuni develop specific 
interactions as adhesion, invasion (Hu and Kopecko, 2008). Following adhesion the 
microbial pathogens are able to start specific biochemical processes that will led to 
causes infection such as toxin secretion and host cell invasion (Wilson et al., 2002).   
 Invasion 1.9.2
The interaction between bacterial cells and host cells largely depends upon invasion 
ability. The ability of bacterial pathogens to enter deeper within the host tissues can 
result in the infection disease. Invasion by bacterial pathogens into host tissues could 
be divided into two groups: extracellular and intracellular (Wilson et al., 2002). 
Extracellular invasion happens when bacterial pathogens damage the barriers of host 
tissue, but the microbes remain outside of the host tissue. This is a strategy used by 
bacteria, which produce toxins such as haemolysin; there are three different of 
haemolysin, α-haemolysin, β-haemolysin and γ-haemolysin. Secreted α-haemolysin 
is formed in clinical isolates, such as E. coli and Serratia spp. (König et al., 1987; 
Welch, 1987; Schmidt et al., 1995). In addition, haemolysins expressed by these 
species did not only damage cells, but could also be contributing to distributing the 
microbes within host tissues (Wilson et al., 2002). While intracellular invasion 
happens when a microbe enters and survives within the cells of a host tissue. 
A number of Gram-negative pathogens have demonstrated their ability to penetrate 
host cells. Bacteria such as E. coli and Salmonella serovars have been found 
to invade intestinal cells. Moreover, some of these bacteria are able to interact with 
macrophages, while others can cross the blood brain barrier and invade brain cells. 
Some experiments have shown that Cronobacter spp. can invade Caco-2 cells 
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in vivo. A study by Kim and Loessner (2008) investigated the likelihood of invasion 
by Cronobacter spp. of human intestinal epithelial cells. The study concluded that 
this is receptor mediated, as well as actin filament and microtubule dependent. 
Cronobacter spp. strains are able to persist in human macrophage cells. 
Townsend et al. (2007a) concluded that Cronobacter strains differ in their 
persistence and replication in a human macrophage cell line. The authors also found 
that the Enterobacteriaceae were able to translocate through the blood brain barrier 
and thus lead to brain damage for the infected rat pups (Townsend et al., 2007b). 
 Intracellular lifestyles 1.9.3
Numerous bacterial pathogens have been developed to survive and replicate within 
epithelial, endothelial or macrophages cells after attachment and invasion. The 
ability to survive and replicate within phagocytic cells is becoming well 
characterised. Bacterial pathogens use strategies to avoid killing mechanisms such as 
the production of reactive oxidative and survive at low of acidic (Wilson et al., 
2002). A phagocytic cell such as macrophages is produces pro-inflammatory 
cytokines, oxygen radicals and nitric oxide to protect the body and killing pathogenic 
microbes (Burmester and Pezzutto, 2003; Urban et al., 2006). In addition 
intracellular infections can persist for years and require extensive antibiotic treatment 
(Wilson et al., 2002). A previous study by Bringer et al. (2006) of adherent invasive 
E. coli (AIEC) isolated from Crohn's disease patients showed the organism's ability 
to replicate within macrophages in large vacuoles.  
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 Bacterial toxins 1.9.4
Based on their cell wall structure, bacteria can be divided into two groups: 
Gram-positive and Gram-negative bacteria. The cell wall of bacteria can contain 
toxic components which are proteinaceous or non-proteinaceous. These are produced 
by bacteria to damage the host cell and cause disease (Wilson et al., 2002; Forsythe, 
2010). Non-proteinaceous toxins for Gram-negative bacteria are lipopolysaccharides 
(LPS) which are also known as endotoxins. Endotoxins are complex 
lipopolysaccharides in the cell wall of Gram-negative bacteria such as E. coli, 
Salmonella and Shigella (Cetin et al., 2004a; Cetin et al., 2004b). LPS is a heat 
stable endotoxin that can persists during the preparation of powdered infant formula 
milk (Townsend et al., 2007b). The author concluded that endotoxin can enhance the 
translocation of Enterobacteriaceae across the intestinal tract and blood brain barrier, 
which could increase the risk of neonatal infections. Cetin et al. (2004b) found that 
endotoxin increases Ras homolog A (RhoA) activation which leads to impairment 
enterocyte migration consequently, this could be increase in focal adhesions and 
enhanced cell adhesiveness and also inhibit tissue repair following bacterial 
infection.  
Proteinaceous toxins (exotoxins) are generally enzymes. These toxins are divided 
into two groups according to methods of delivery to eukaryotic cells; (1) secretion 
into the host cell (2) injection into the host cell cytoplasm (Finlay and Falkow, 1997a 
and 1997b). The result of bacteria producing exotoxins is extremely watery 
diarrhoea. In addition, exotoxins are specific for intestinal cells associated with 
digestive system diseases such as vomiting and diarrhoea (Forsythe, 2010). A study 
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by Chakraborty et al. (2008) of the major virulence proteins of Vibrio cholerae and 
enterotoxigenic E. coli (ETEC) are cholera toxin (CT) and labile toxin (LT) 
respectively, which were found that these virulence proteins predominantly 
responsible of effects and damaging intestinal epithelial cells in both in vitro and 
in vivo. A report by Pagotto et al. (2003) described the virulence factors of 
Cronobacter spp. They investigated the effect of Cronobacter spp. in vivo, and found 
the organism produces an enterotoxin. Another study of Cronobacter spp. concluded 
that a 66 KD enterotoxin was more active at pH 6 and was stable for 30 min at 90ºC 
(Raghav and Aggarwal, 2007). 
 Curli fimbriae 1.9.5
Numerous Gram-negative bacteria have filamentous appendices, which extend from 
the cell surface called fimbriae or pili. These extensions consist of structural proteins 
named pilins. Fimbriae or pili are distinguished into two groups: (A) Tight contact, 
which enable the pathogenic bacteria to adherence to host cells, and (B) sex contact, 
which are responsible for the attachment of donor and receiver cells in bacterial 
conjugation (Brooks et al., 2007). In Gram negative bacteria there are various pilus 
structures, such as type 1 pili, P-pili, type IV pili and S-pili (Kline et al., 2009). 
The first recognized curli fimbriae were found in 1980s on E. coli strains that caused 
bovine mastitis (Olsén et al., 1989; Barnhart and Chapman, 2006). Similar fibrous 
structures also called thin aggregative fimbriae, which were found in other 
Enterobacteriaceae such as Shigella, Citrobacter and Salmonella enteritidis 
(Olsén et al., 1998; Romeo, 2008). Curli fimbriae enable bacteria to attach proteins 
in the extracellular matrix for instance fibronectin, laminin, and plasminogen 
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(Olsén et al., 1989). Furthermore, curli can be adhesive fibers and also play a role in 
biofilm formation and cell to cell interactions (Romeo, 2008).  
Curli fimbriae expression is dependent upon environmental conditions such as low 
temperature, low nitrogen, phosphate, and iron; to slow growth (Barnhart and 
Chapman, 2006; Olsén et al., 1993; Maurer et al., 1998; Maurer et al., 1998). 
Römling et al. (1998) and Gerstel and Römling (2008) reported that curli fimbriae 
expression correlated with different environment factors of salt, nitrogen, phosphate, 
and iron. Also Barnhart and Chapman (2006) reported that most strains in the 
laboratory produced curli fimbriae under low incubation temperatures such as less 
than 30ºC.  Olsén et al. (1989) showed that in E. coli the production of curli fimbriae 
was at growth temperatures less than 37ºC. While Bian et al. (2000) grew pathogenic 
E. coli strains at 37ºC and found that 24 out of 46 were able to produce curli 
fimbriae. Most commensal isolates of E. coli and Salmonella only express curli at 
room temperature. Though a number of clinical isolates of E. coli expressed curli at 
37ºC (Kline et al., 2009). Other studies indicated that E. coli curli fimbriae can be 
expressed in a biofilm and at 37ºC (Romeo, 2008). Bian et al. (2000) investigated 
to detect curli fimbriae production. Forty-six strains of E. coli collected from 
Karolinska hospital were investigated using Congo red stain at 28ºC for 48 hours and 
37ºC for 24 hours. Results showed that 31 strains were able to produce curli fimbriae 
at 37ºC and 24 strains at 28ºC. On the other hand two strains were produced curli 
fimbriae at 37ºC but not 28ºC. It was concluded that a human E. coli sepsis isolates 
were capable of producing curli fimbriae at 37ºC. 
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Congo red indicator agar is a suitable method to recognize genes important 
expression of curli fimbriae production (Barnhart and Chapman, 2006; 
Hammar et al., 1995). Where Barnhart and Chapman (2006) reported that different 
morphotypes could be appear when bacteria growth on media supplemented with 
Congo red indicator. Four defined morphotypes are rdar (red, dry, and rough) 
indicates curli fimbriae and cellulose production, pdar (pink, dry, and rough) 
indicates cellulose only, bdar (brown, dry, and rough) indicates only curli fimbriae 
are produced, Saw (smooth and white) colonies indicates neither curli nor cellulose 
(White et al., 2006).  
The genes of curli biogenesis in E. coli are called csg (Römling et al., 1998) and are 
grouped in two divergent operons: the csgBA and the csgDEFG. They encode, 
respectively, the structural component of curli and encoding the transcriptional 
regulator csgD and the curli export machinery csgE-G (Romeo, 2008). The csgA 
operon encodes the major subunit protein of the fibre outside of the cell 
(Hammar et al., 1995) whereas csgB nucleates the structural subunit into a fibre 
(Barnhart and Chapman, 2006). Nenninger et al., (2011) shows the major and minor 
curli fimbriae subunits are encoded by the genes csgA and csgB, whereas the 
extracellular localization and assembly of curli subunits into fibres are genes csgE, 
csgF and csgG. In addition, they found that the outer membrane lipoprotein csgG 
aids the secretion and stability of csgA and csgB. Biofilm formation, invasion and 
virulence factors of bacteria were linked with the activity of the csgD gene 
(Uhlich et al., 2002). The over expression of csgD can overcome temperature 
dependent control of curli encoding csgBA operon (Gualdi et al., 2008). 
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The expression of curli fibers and csgA were reported to induce cytokines production 
in response to E. coli in human sepsis (Bian et al., 2000). In Salmonella spp. 
a homologous gene has been identified and called agf (thin aggregative fibres) and is 
grouped in two operons encoding agfBA and agfDEFG (Römling et al., 1998; 
Barnhart and Chapman, 2006).  
 Study objectives 1.10
The project aims (a) to consider possible reasons why certain Enterobacteriaceae are 
more frequently associated with neonatal enteral feeding tubes (b) determine the 
potential virulence of such Enterobacteriaceae organisms and (c) assign isolates 
from neonatal enteral feeding tubes into ‗high risk‘ and ‗low risk‘ categories. 
 Strain selection and DNA profiling 1.10.1
Initial studies will review our culture collection of enteral feeding tube isolates, and 
additional clinical isolates provided by Dr Shiu (Queen‘s Medical Centre, 
Nottingham).  The range of genera will include E. coli, Klebsiella spp., Serratia spp. 
and Enterobacter spp.  It is plausible that during the previous study, the same strains 
were either isolated from the same neonate on more than one occasion, or even from 
different neonates. Therefore DNA fingerprinting via pulsed field gel electrophoresis 
(PFGE) will be used to identify if the same strains were isolated on different 
occasions from the NICUs. In addition, multi-locus sequence typing (MLST) of 
E. coli will be used as a highly discriminatory choice for typing and detecting 
epidemiologically important strains.  
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  Physiological and virulence tests 1.10.2
Representative strains from the four genera listed above will be selected according to 
PFGE groups, will be subject to a range of physiological and virulence related tests. 
The physiological studies will include determining biofilm formation on enteral 
feeding tubes, curli fimbriae, haemolysis, acid resistance, motility, the presence of 
extended spectrum β-lactamases (ESBL). Capsule production will be determined by 
colony morphology on milk formula agar plates. The susceptibilities of 
Enterobacteriaceae isolates to antimicrobial agents will be determined by the 
breakpoint method on antibiotic supplemented Iso-Sensitest agar according to the 
British Society for Antimicrobial Chemotherapy protocol. 
 Virulence related traits. 1.10.3
A range of virulence traits will be determined which are relevant to an enteroinvasive 
bacterial pathogen.  These will include attachment and invasion of human intestinal 
cell line Caco-2, and brain cells humans and rats, as well as survival in macrophages, 
and detection of various virulence factor (VF) genes.  
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 Safety considerations 2.1
Experiments described in this study were started after consideration of health and 
safety codes practice for microbiology level two containment laboratories of 
Nottingham Trent University, under the supervision of Professor Stephen Forsythe. 
All procedures and preparation of materials were assessed and completed on the 
appropriate COSHH forms. Category 2 organisms and all materials were disposed of 
according to recommended procedures. 
 Bacterial strains 2.2
Two hundred and twenty four strains of Enterobacteriaceae were used for the initial 
part of this study; Table  2.1 - Table  2.4. These were E. coli (n = 30), Serratia spp. 
(n = 60), Enterobacter spp. (n = 50) and Klebsiella spp. (n = 84). All of these strains 
had been isolated from enteral feeding tubes on neonatal intensive care units 
at Nottingham City Hospital (n = 174) and Queen‘s Medical Centre (n = 50). These 
strains were studied at the beginning of the project with PFGE to determine if they 
were clonal variants, and distinguishable. For the second part of the study, twenty 
three strains were chosen for virulence factors determination.  
It should be noted that later towards the end of the research period an additional 
collection of thirty-eight E. coli strains from neonatal enteral feeding tubes from 
Jordan were obtained for preliminary profiling; Table  2.5. 
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Table  2.1 E. coli strains used in this study 
Species Strain number Source Date of isolation Neonate 
E. coli 
 
780 
 
 
 
 
 
 
 
 
 
 
 
NCH 
 
16/01/2007 4 
796 30/01/2007 17 
786 17/02/2007 37 
904 
24/04/2007 
55 
905 55 
910 
03/05/2007 
64 
912 64 
913 65 
917 65 
923 
08/05/2007 
67 
924 67 
926 
 
01/05/2007 
 
61 
927 61 
929 62 
933 62 
934 63 
937 
08/05/2007 
68 
939 69 
943 70 
944 70 
947 71 
949 71 
1008 06/06/2007 99 
1009 
12/06/2007 
101 
1010 102 
1015 104 
1016 104 
1047  
QMC 
 
 
22/10/2007 
 
116 
1050 116 
1051 116 
E. coli isolated from enteral feeding tubes on neonatal intensive care units at Nottingham City 
Hospital and Queen‘s Medical Centre. NCH: Nottingham City Hospital (n = 27), QMC: Queen‘s 
Medical Centre (n = 3) 
Table  2.2 Serratia spp. strains used in this study 
Species Strain number Source Date of isolation Neonate 
Serratia marcescens 
 
791 
NCH 
 
23/01/2007 
13 
793 14 
804 30/01/2007 19 
805 06/02/2007 23 
809 07/02/2007 25 
811 
06/02/2007 
26 
812 26 
813 26 
821  
17/02/2007 
 
37 
822 37 
823 31 
837  
28/02/2007 
 
39 
838 39 
840 39 
844 
02/04/2007 
45 
846 45 
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Serratia marcescens 
 
849 
NCH 
 
10/04/2007 
 
48 
852 48 
853 
17/04/2007 
49 
854 49 
898 
15/05/2007 
73 
899 76 
903 24/04/2007 58 
911 03/05/2007 64 
918 
08/05/2007 
66 
919 66 
920 66 
921 66 
925 
01/05/2007 
61 
935 63 
936 
08/05/2007 
68 
940 69 
941 69 
942 69 
945 71 
946 71 
951 09/05/2007 72 
952 
22/05/2007 
 
79 
953 79 
954 80 
955 80 
958 82 
959 82 
961 83 
962 85 
963 85 
964 85 
965 86 
967 86 
970 87 
973 88 
974 88 
975 88 
Serratia liquifaciens 
 
1030 
QMC 
 
16/10/2007 108 
1036 
22/10/2007 
111 
1041 113 
1045 16/10/2007 115 
1055 22/10/2007 118 
1076 16/10/2007 119 
1080 12/11/2007 126 
Serratia spp. isolated from enteral feeding tubes on neonatal intensive care units at Nottingham City 
Hospital and Queen‘s Medical Centre, UK. NCH: Nottingham City Hospital (n = 53), QMC: Queen‘s 
Medical Centre (n = 7). 
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Table  2.3 Enterobacter spp. strains used in this study 
Species Strain number Source Date of isolation Neonate 
Enterobacter horm. steigerwaltii 790 
NCH 
 
16/01/2007 4 
Enterobacter hormaechei 
 
795 
 
30/01/2007 
 
17 
797 17 
798 18 
799 18 
800 19 
801 20 
802 21 
803 22 
806 06/02/2007 24 
856 
 
17/04/2007 
 
50 
859 51 
860 52 
861 52 
862 52 
863 52 
Enterobacter horm. steigerwaltii 960 23/05/2007 83 
Enterobacter cloacae 
 
979 
 
16/02/2007 
 
36 
980 36 
981 36 
983 36 
986 36 
987 36 
993 36 
997 36 
1027 
QMC 
 
 
16/10/2007 
 
108 
1028 108 
1032 110 
1033 110 
1034 110 
1035 110 
1037 112 
1038  
22/10/2007 
 
113 
1039 113 
1040 113 
1044  
16/10/2007 
 
115 
1052 117 
1053 117 
1066 
12/11/2007 
126 
1067 126 
1068 
19/11/2007 
128 
1069 128 
1074 
16/10/2007 
117 
1075 117 
Enterobacter cancerogenus 1077 31/10/2007 120 
Enterobacter cloacae 
 
1081 
12/11/2007 
126 
1084 126 
1088  
19/11/2007 
 
128 
1089 128 
1094 128 
Enterobacter spp. isolated from enteral feeding tubes on neonatal intensive care units at Nottingham 
City Hospital and Queen‘s Medical Centre, UK. NCH: Nottingham City Hospital (n = 25), QMC: 
Queen‘s Medical Centre (n = 25). 
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Table  2.4 Klebsiella spp. strains used in this study 
Species Strain number Source Date of isolation Neonate 
Klebsiella pneumoniae 778 
NCH 
16/01/2007 
1 
Klebsiella oxytoca 
779 2 
781 17/01/2007 6 
782 16/01/2007 7 
783 16/01/2007 8 
784 
 
23/01/2007 
 
9 
Klebsiella pneumoniae 
785 9 
787 10 
788 11 
Klebsiella oxytoca 789 12 
Klebsiella pneumoniae 
792 13 
794 14 
Klebsiella oxytoca 
 
807  
06/02/2007 
 
24 
808 24 
810 26 
814 
11/02/2007 
27 
815 27 
816 27 
817 27 
818 13/02/2007 28 
824 16/02/2007 36 
825 
17/02/2007 
37 
826 37 
827 
20/02/2007 
33 
828 33 
829 33 
830 33 
831 33 
832 
16/02/2007 
36 
833 36 
834 20/02/2007 35 
Klebsiella pneumoniae 
839 
28/02/2007 
39 
841 39 
Klebsiella oxytoca 
 
842 20/03/2007 42 
845 
02/04/2007 
45 
847 45 
848  
10/04/2007 
 
48 
850 48 
851 48 
907  
24/04/2007 
 
58 
908 58 
909 58 
957 
 
22/05/2007 
 
81 
966 86 
969 87 
972 87 
Klebsiella pneumoniae 
976 
30/05/2007 
89 
977 89 
Klebsiella oxytoca 
 
982 
16/02/2007 
36 
985 36 
988 36 
989 36 
990 
17/02/2007 
37 
991 37 
992 
16/02/2007 
36 
994 36 
996 36 
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Klebsiella oxytoca 998 
NCH 
16/02/2007 36 
Klebsiella pneumoniae 
999 
 
05/06/2007 
 
94 
1000 95 
1001 96 
1002 95 
1003 96 
1004 94 
1005 95 
 
Klebsiella pneumoniae 
 
1006 94 
1012  
12/06/2007 
 
103 
1013 103 
1014 103 
Klebsiella oxytoca 1042 
QMC 
 
 
22/10/2007 
 
114 
Klebsiella pneumoniae 
1046 116 
1048 116 
1049 116 
Klebsiella oxytoca 
 
1054 118 
1056 118 
1058  
16/10/2007 
 
119 
1059 119 
1071 108 
1078 
31/10/2007 
120 
1079 121 
Klebsiella pneumoniae 
1090 
 
19/11/2007 
 
129 
1091 129 
1092 129 
1093 129 
Klebsiella spp. isolated from enteral feeding tubes on neonatal intensive care units at Nottingham City 
Hospital and Queen‘s Medical Centre, UK. NCH: Nottingham City Hospital (n = 69), QMC: Queen‘s 
Medical Centre (n = 15). 
Table  2.5 E. coli strains used in this study isolated from enteral feeding tubes on 
neonatal intensive care units at Jordan Hospital 
Species Strain number Date of isolate Neonate Comment 
E. coli 
83 
11/12/2011 
22 
Free liquid 
84 22 
87 10/12/2011 36 Biofilm 
104 
12/12/2011 
19 
Free liquid 
105 19 
106 19 
Biofilm 
107 
15/12/2011 
13 
110 13 
Free liquid 115 13 
116 13 
117 13 
Biofilm 
118 13 
119 13 
Free liquid 
123 24 
126 24 Biofilm 
127 10 
Free liquid 131 15 
132 15 
133 15 
Biofilm 
134 15 
139 7 
140 7 
141 7 Free liquid 
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157 
20/12/2011 
5 
Biofilm 
 
158 5 
 
160 5 Free liquid 
 
162 12 Biofilm 
 
164 12 Free liquid 
 
165 18 
Biofilm 
 
166 18 
E. coli 167 18 
Free liquid 
 
168 18 
 
171 11 
Biofilm 
 
172 11 
 
173 27 
Free liquid 
 
174 27 
 
175 27 
Biofilm 
 
176 27 
JH: Jordan Hospital (n=38) 
 Bacterial storage and culture  2.3
All strains of Enterobacteriaceae were stored for a long term at -80°C and -20°C in 
20% glycerol broth. When required, cells were recovered from frozen stock and 
subcultured on Tryptone Soya Agar (TSA) and incubated under aerobic conditions at 
37°C for 24 h. All culture strains were stored for short periods at 10°C as 
appropriate. 
 Primers used for amplification and sequencing 2.4
All the primers used in this study were purchased from Sigma-Aldrich (UK) and 
shown in Table  2.6 and Table  2.8 below.  
Table  2.6 Primers used for the seven selected house keeping genes used in E. coli 
MLST profiling 
Oligo Tm (ºC) Sequence 5‘ to 3‘ P.S (bp) Comment 
adk f 
adk r 
54 
ATTCTGCTTGGCGCTCCGGG 
CCGTCAACTTTCGCGTATTT 
583 Adenylate kinase 
fumC f 
fumC r 
54 
TCACAGGTCGCCAGCGCTTC 
GTACGCAGCGAAAAAGATTC 
806 Fumarate hydratase 
gyrB f 
gyrB r 
60 
TCGGCGACACGGATGACGGC 
ATCAGGCCTTCACGCGCATC 
911 
 
DNA gyrase 
icd f 
icd r 
 
54 
ATGGAAAGTAAAGTAGTTGTTCCGGCACA 
GGACGCAGCAGGATCTGTT 
 
878 
Isocitrate/isopropylma
late dehydrogenase 
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mdh f 
mdh r 
60 
ATGAAAGTCGCAGTCCTCGGCGCTGCTGGCG
G 
TTAACGAACTCCTGCCCCAGAGCGATATCTTT
CTT 
932 
Malate 
dehydrogenase 
purA f 
purA r 
54 
CGCGCTGATGAAAGAGATGA 
CATACGGTAAGCCACGCAGA 
816 
Adenylosuccinate 
dehydrogenase 
recA f 
recA r 
58 
CGCATTCGCTTTACCCTGACC 
TCGTCGAAATCTACGGACCGGA 
780 
ATP/GTP binding 
motif 
P.S (bp) = Product size (base pairs). Tm = the melting temperature of the oligonucleotide (Wirth et al., 
2006) 
Table  2.7 Primers used for screen for different β-lactamase genes 
Oligo Tm (ºC) Sequence 5‘ to 3‘ P.S (bp) β-lactamase 
shv f 
shv r 
57 
CTTTATCGGCCCTCACTCAA 
AGGTGCTCATCATGGGAAAG 
237 SHV 
tem f 
tem r 
63 
CGCCGCATACACTATTCTCAGAATGA 
ACGCTCACCGGCTCCAGATTTAT 
445 TEM 
ctx-m f 
ctx-m r 
68 
ATGTGCAGYACCAGTAARGTKATGGC 
TGGGTRAARTARGTSACCAGAAYCAGCGG 
593 CTX-m 
oxa f 
oxa r 
54 
ACACAATACATATCAACTTCGC 
AGTGTGTTTAGAATGGTGATC 
813 OXA 
P.S (bp) = Product size (base pairs). Tm = the melting temperature of the oligonucleotide (Fang et al., 
2008) 
Table  2.8 Primer used for the detection of virulence factor genes  
ADHESINS 
Oligo Tm (ºC) Sequence 5‘ to 3‘ P.S (bp) Comment 
PapA f 
PapA r 
68 
ATGGCAGTGGTGTCTTTTGGTG 
CGTCCCACCATACGTGCTCTTC 
720 
 
 
Pyelonephritis 
associated pili. 
 
PapC f 
PapC r 
64 
GTGGCAGTATGAGTAATGACCGTTA 
ATATCCTTTCTGCAGGGATGCAATA 
200 
PapEF f 
PapEF r 
65 
GCAACAGCAACGCTGGTTGCATCAT 
AGAGAGAGCCACTCTTATACGGACA 
336 
pG f 
pG r 
60 
CTGTAATTACGGAAGTGATTTCTG 
ACTATCCGGCTCCGGATAAACCAT 
1070 
 
Flanking regions 
pG1"r* 66 TCCAGAAATAGCTCATGTAACCCG 1190 
AlleleI-f 
AlleleI-r 
69 
TCGTGCTCAGGTCCGGAATTT 
TGGCATCCCCCAACATTATCG 
461 
 
Internal region 
AlleleI'-f 
AlleleI'-r 
64 
CTACTATAGTTCATGCTCAGGTC 
CTGACATCCTCCAACATTATCGA 
474 
Internal region specific 
to canine isolate 
AlleleII-f 
AlleleII-r 
70 
GGGATGAGCGGGCCTTTGAT 
CGGGCCCCCAAGTAACTCG 
190 
Internal regions 
AlleleIII-f 
AlleleIII-r 
70 
GGCCTGCAATGGATTTACCTGG 
CCACCAAATGACCATGCCAGAC 
258 
sfa1 
sfa2 
69 
CTCCGGAGAACTGGGTGCATCTTAC 
CGGAGGAGTAATTACAAACCTGGCA 
410 sfa/foc operon 
SfaS f 
SfaS r 
59 
GTGGATACGACGATTACTGTG 
CCGCCAGCATTCCCTGTATTC 
240 S fimbriae 
FocG f 
FocG r 
68 
CAGCACAGGCAGTGGATACGA 
GAATGTCGCCTGCCCATTGCT 
360 F1C fimbriae 
Afa f 
Afa r 
74 
GGCAGAGGGCCGGCAACAGGC 
CCCGTAACGCGCCAGCATCTC 
559 Dr family 
bmaE-f 
bmaE-r 
68 
ATGGCGCTAACTTGCCATGCTG 
AGGGGGACATATAGCCCCCTTC 
507 
M blood group antigen 
specific M fimbriae 
gafD-f 
gafD-r 
66 
TGTTGGACCGTCTCAGGGCTC 
CTCCCGGAACTCGCTGTTACT 
952 
Glucosaminyl-specific 
G fimbriae 
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nfaE-f 
nfaE-r 
62 
GCTTACTGATTCTGGGATGGA 
CGGTGGCCGAGTCATATGCCA 
559 Non fimbrial adhesin-1 
FimH f 
FimH r 71 
TGCAGAACGGATAAGCCGTGG 
GCAGTCACCTGCCCTCCGGTA 508 
Mannose-specific 
adhesin subunit of type 
1 fimbriae 
TOXINS 
hly f 
hly r 
66 
AACAAGGATAAGCACTGTTCTGGCT 
ACCATATAAGCGGTCATTCCCGTCA 
1177 Haemolysin A 
cnf1 
cnf2 
65 
AAGATGGAGTTTCCTATGCAGGAG 
CATTCAGAGTCCTGCCCTCATTATT 
498 
Cytotoxic necrotizing 
factor-1 
cdt-a1 
cdt-a2 
62 
AAATCACCAAGAATCATCCAGTTA 
AAATCTCCTGCAATCATCCAGTTTA 
430 
Cytolethal distending 
toxin cdt-s1 
cdt-s2 
61 
GAAAGTAAATGGAATATAAATGTCCG 
GAAAATAAATGGAACACACATGTCCG 
SIDEROPHORES 
FyuA f 
FyuA r 
66 
TGATTAACCCCGCGACGGGAA 
CGCAGTAGGCACGATGTTGTA 
880 
Yersinia bactin 
AerJ f 
AerJ r 
71 
GGCTGGACATCATGGGAACTGG 
CGTCGGGAACGGGTAGAATCG 
300 
Aerobactin 
POLYSACCHARIDE COATINGS 
kpsII f 
kpsII r 
65 
GCGCATTTGCTGATACTGTTG 
CATCCAGACGATAAGCATGAGCA 
272 
All group II capsules 
KpsIII f 
KpsIII r 
63 
TCCTCTTGCTACTATTCCCCCT 
AGGCGTATCCATCCCTCCTAAC 
392 
All group III capsules 
K1-f 61 TAGCAAACGTTCTATTGGTGC 153 Only K1 capsule region 
K5-f 59 CAGTATCAGCAATCGTTCTGTA 159 Only K5 capsule region 
MISCELLANEOUS 
rfc-f 
rfc-r 65 
ATCCATCAGGAGGGGACTGGA 
AACCATACCAACCAATGCGAG 788 
Participates in O4 LPS  
biosynthesis. O4 
serotype marker. 
ibe10 f 
ibe10 r 
76 
AGGCAGGTGTGCGCCGCGTAC 
TGGTGCTCCGGCAAACCATGC 
170 
Invasion of brain 
endothelium gene. 
ColV-C f 
ColV-C r 
67 
CACACACAAACGGGAGCTGTT 
CTTCCCGCAGCATAGTTCCAT 
680 
Colicin V. Marker for 
colV plasmids 
TraT f 
TraT r 
71 
GGTGTGGTGCGATGAGCACAG 
CACGGTTCAGCCATCCCTGAG 
290 Serum survival gene 
RPAi f 
RPAi r 
73 
GGACATCCTGTTACAGCGCGCA 
TCGCCACCAATCACAGCCGAAC 
930 
Generic marker for 
uropathogenic PAIs 
P.S (bp) = Product size (base pairs). Tm = the melting temperature of the oligonucleotide (Johnson 
and Stell, 2000) 
 Sterilisation 2.5
All equipment, media, buffers and solutions were sterilised by autoclaving at 121°C 
for 15 min, washed with 70% alcohol or filtration using 0.2 pore size µm filters. 
  Stock reagents and buffers 2.6
The chemicals in the study were obtained from either Sigma Aldrich or Fisher UK. 
All buffers were prepared in double distilled and sterilised water (dH2O) as follows: 
Chapter 2: Materials and methods 
  42 
 
 Phosphate buffered saline 2.6.1
Phosphate buffered saline (PBS) containing sodium and magnesium chloride solution 
was obtained from Sigma Aldrich, UK (D8662). The phosphate buffered saline was 
used during the work with tissue culture. 
 Saline solution 2.6.2
A 0.85% saline used as a suspension medium in bacteriological studies was prepared 
by one tablet of Oxoid Fisher Scientific, UK (BR0053G) dissolved into 500 ml of 
distilled water (dH2O). This was distributed into glass bottles in 50 ml amounts. 
 Hydrochloric acid 2.6.3
A 1 M of hydrochloric acid (HCl) was used to control the pH of solution used in 
study. This was prepared using 1 M HCl 86 ml slowly added to 914 ml of distilled 
water and mixed quietly. This was transferred into a plastic container.  
 Triton X-100 2.6.4
Triton X-100 was used during the tissue culture studies, which was obtained from 
Fisher Scientific Fluka, Canada (BPE151-100). This was prepared by adding 100 µl 
of Triton X-100 to 10 ml of sterile distilled water (dH2O). 
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  1 M Tris-HCl 2.6.5
Tris base was obtained from Fisher Scientific, UK (BP152-500) to use in the PFGE 
analysis. 121.1 g of Tris base was placed in 1 litre flask and dissolved by adding 
700 ml of (dH2O) and then placed on hot plate magnetic stirrer at 56°C. The pH was 
adjusted to pH 8.0 with concentrated HCl. The volume was brought to 1 L with 
ultra-pure water then transferred to 1 L bottle. The solution was autoclaved and 
stored at room temperature. 
  0.5 M EDTA (Ethylenediamine tetra-acetic acid, sodium hydroxide) 2.6.6
The 0.5 M EDTA was prepared during work with pulsed field gel electrophoresis. 
This was made by adding 186.1 g of EDTA (E5134) to 700 ml of distilled water. 
Sodium hydroxide (NaOH) from Sigma Aldrich, UK (S8045) was added to adjust the 
pH to 8.0 with approximately 20 g of NaOH and mixed well to dissolve. The volume 
was made up to 1 L with de-ionised water and the solution was sterilized by 
autoclaving and store at room temperature. 
 10 X TBE Buffer (Tris base, boric acid and EDTA buffer) 2.6.7
The 10 X TBE Buffer  was prepared by dissolved 108 g Tris base, 55 g boric acid 
Fisher Scientific; UK (10043-35-3) in 700 ml of (dH2O) then 80 ml 0.5 M EDTA 
pH 8.0 was added to the mixed and adjusted to 1 L with distilled water. The solution 
was autoclaved and stored at room temperature. 
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 50 X TAE buffer (50 X Tris-acetate-EDTA buffer) 2.6.8
The 50 X TAE buffer was obtained from National Diagnostics, UK (EC-872). The 
compositions of TAE buffer contain (2.0 M Tris-acetate and 100 mM sodium 
EDTA). 1 X of TAE was used in the preparation of agarose gels; Bio-Rad, UK 
(162 - 0137) and in the gel electrophoresis tanks. This was prepared by diluting 
20 ml of the concentrated buffer in 980 ml distilled water.  
 Culture media 2.7
All culture media were obtained from Oxoid Thermo-Fisher and Sigma Aldrich. 
 Tryptone Soya Agar (TSA) 2.7.1
Tryptone Soya Agar Oxoid Thermo-Fisher, UK (CM0131) was prepared in 
accordance with the manufacturer's instructions. Forty grams of TSA agar was 
dissolved onto 1 L of distilled water. It was boiled until the agar was completely 
melted. The mixture was autoclaved at 121ºC for 15 min. After it had cooled to 50ºC 
it was poured into Petri dishes 20 ml each. These were dried and then stored in the 
refrigerator at 4ºC until required. 
 Tryptone Soya Broth (TSB) 2.7.2
Tryptone Soya Broth Oxoid Thermo-Fisher, UK (CM0876) was prepared in 
accordance with the manufacturer's instructions. Thirty grams of TSB was dissolved 
into 1 L of distilled water. The mixture was dispersed in 50 ml volumes poured in 
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and to 100 ml bottles and autoclaved at 121ºC for 15 min. The media were stored at 
room temperature. 
 Luria-Bertani Agar (LBA) 2.7.3
Luria-Bertani Agar Merck KgaA, Darmstad, Germany (1102830) was prepared 
according to the manufacturer's instructions. Thirty seven grams of LBA was mixed 
in 1 L of distilled water. It was mixed until dissolved and then autoclaved at 121ºC 
for 15 min. 
 Luria-Bertani Broth (LB) 2.7.4
Luria-Bertani Sigma Aldrich, UK (L3022) was prepared in accordance with the 
manufacturer‘s instructions. Twenty five grams LB was dissolved into 1 litre of 
distilled water. The mixture was dispersed in 50 ml volumes poured in and to 100 ml 
bottles and autoclaved at 121ºC for 15 min.  
 Mueller-Hinton Agar (MHA) 2.7.5
Twenty one grams of Mueller-Hinton agar Sigma, Aldrich, UK (70191) were added 
to 1 L of distilled water and mixed to dissolve. Autoclaved at 121ºC for 15 min. 
After it had cooled to 50ºC it was poured into Petri dishes 20 ml each and then stored 
in the refrigerator at 4ºC until required. 
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 Motility medium 2.7.6
Four grams of bacteriological agar LabM agar, UK (No 2) and thirty grams of TSB 
Oxoid UK (CM0876) were dissolved into 1 L of distilled water. The mixture was 
autoclaved at 121ºC for 15 min. It was then cooled for three hours at 55ºC before 
further cooling with mixing at about 45ºC. Finally, the medium was poured into Petri 
dishes allowed to set at room temperature, and stored at 4ºC for maximum of 
8 weeks.  
 Milk agar 2.7.7
To mimic the growth conditions in infant formula, a milk agar had been designed by 
Caubilla-Barron et al. (2007). Three grams of agar Oxoid Thermo-Fisher, Ltd, 
Basingstoke, UK (LP0011) with 0.4 g of ammonium sulphate were dissolved into 
40 ml of distilled water. The medium was autoclaved at 121ºC for 15 min. Then it 
was mixed with 200 ml of warmed 55ºC sterile liquid formula (whey based). Finally, 
the mixture was poured into Petri dishes, and stored in a cooled place at 4ºC.  
 LBA - Congo red medium 2.7.8
LBA-Congo red medium was used to investigate curli fimbriae phenotype. LBA was 
prepared as given in section  2.7.3. Final concentration 40 µg/ml Congo red dye 
Sigma Aldrich, UK (C6277) was added to the media after it had cooled to ~ 50ºC. 
Then the mixture was dispensed into Petri dishes and stored in a cooled place at 4ºC. 
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 TSA - blood agar 2.7.9
TSA- blood agar was used to detect haemolysis. TSA was prepared as described in 
section  2.7.1. sheep blood final concentration 5% (v/v) from Oxoid Thermo-Fisher; 
UK (CM0854) was added to the TSA media after it had melted, sterilized and cooled 
to ~ 45ºC. Then the mixture was dispensed into Petri dishes and stored in a cooled 
place at 4ºC. 
 Pulsed Field Gel Electrophoresis 2.8
Pulsed field gel electrophoresis (PFGE) was performed to determine whether the 
strains were clonal or distinguishable. PFGE analyses of Enterobacteriaceae was as 
described by the PulseNet (USA) protocol for molecular subtyping of E. coli O157, 
non-typhodial Salmonella serotypes, and Shigella sonnei (CDC, 2004; Ribot et al., 
2006). The strains used are listed in; Table  2.1 -Table  2.5.  
 Tris EDTA buffer (TEB) 2.8.1
TE buffer was used to make the plug agarose and to wash lysed PFGE plugs. It was 
prepared as follows: 
10 mM Tris, pH 8.0 
1 mM EDTA, pH 8.0 
Dilute with sterile ultrapure water. 
Volume of TEB buffer = 15 ml (dH2O)*t*n    
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Where t = time of wash, n = number of samples 
 Cell Suspension Buffer (CSB) 2.8.2
The CSB was prepared as follows (100 mM Tris; 100 mM EDTA pH 8): 
V total = 3 ml* n   
V added of Tris pH 8.0 = 0.3 ml* n  
V added of EDTA pH 8.0 = 0.6 ml* n  
VdH2O = 3 ml* n – (V add Tris +V add EDTA)      
Where n = number of samples, V = Volume 
  Cell lysis buffer (CLB) 2.8.3
The CLB was prepared as follows (50 mM Tris; 50 mM EDTA, pH 8.0) 
(1% Sarkosyl NL (N-Dodecanoyl-N-methylglycine sodium salt) Sigma Aldrich, 
UK (L-5125) + 20 mg /mL proteinase K Sigma Aldrich, UK (P2308)): 
V total = 5 ml * n   
V added of Tris, pH 8.0 = 0.25 ml * n  
V added of EDTA, pH 8.0 = 0.5 ml * n  
Sarkosyl NL = 0.05 g *n  
V proteinase k = 25 µl * n 
Chapter 2: Materials and methods 
  49 
 
VdH2O = 5 mL * n – (V add Tris + V add EDTA + V add proteinase k) 
Where n= number of samples, V=Volume 
 DNA preparation in agarose plugs 2.8.4
Two hundred and twenty six strains of Enterobacteriaceae and Salmonella enterica 
serovar Typhimurium reference standard H9812 (732 NTU) were analysed in the 
study. The isolates and marker strains were grown overnight on TSA at 37ºC. 
Approximately a full swab of bacteria was suspended in buffer. The cell density was 
adjusted to an optical density (OD) of between 1.3 - 1.4 at 610 nm in the CSB. 
Three-hundred microliters of bacterial suspension was distributed into a 1.5 ml 
eppendorf tube. The TEB + 1% agarose + 1% SDS were boiled in a microwave oven 
until became melted and then 300 µl of the mixture were dispensed into a 1.5 ml 
eppendorf tube and placed in a thermo block at 55ºC. 
 Casting and washing 2.8.5
Casting plugs were made by mixing carefully 300 µl of bacterial suspension, 300 µl 
of TEB agarose and 15 µl of proteinase K (20 mg/ml). One hundred microliters of 
the mixture were dispensed into five well plug molds. After that the plugs were 
transferred into polypropylene tubes with 5 ml of cell lysis buffer. The mixture was 
placed in a shaking water bath at 54ºC for 1.5 - 2 h at 150 - 175 rpm. The DNA plugs 
were washed by removing the CLB and adding 15 ml of ultra-pure water, followed 
by shaking in a shaking water bath at 50ºC for 15 min. In the next step the plugs 
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were washed 4 times in 15 ml TEB in a shaking water bath at 50ºC. After washing it 
was stored in 5 ml of TEB in a fridge at 4ºC until analysis. 
 Digestion and electrophoresis 2.8.6
Two millimetres of each plug was cut and transferred to 135 µl water + 15 µl buffer, 
for 30 min at room temperature. The plugs were then digested with a restriction 
enzyme mixture 131.25 µl distilled water, 15 µl buffer and 3.75 µl XbaI enzyme, 
Promega, UK (R6181) at 37°C for 2 h [Appendix  7.1]. The fragments in the plugs 
were resolved by adding 2 litres of 0.5 X TBE buffer into the running tank. At the 
same time, 100 ml of 0.5 X TBE buffer 1% agarose was added into the plugs in the 
comb. The running parameters were as follows: the gel was run at 14°C with pulse 
times of 2.2 sec to 63.8 sec for 20 h at 6 v.  
 Staining and analysis 2.8.7
Gels were stained in ethidium bromide (1 µg /ml) for 30 to 60 min. Gels were 
viewed under Ultraviolet (UV) and photographed. Digital images were stored as 
Tagged Image File Format (TIF) and analysed by using BioNumerics software, 
version 3.5.  
 Bacterial strains for physiological experiments 2.9
Following PFGE analysis, representative strains of the pulse-types were chosen for 
further analysis. These were eight strains of E. coli, eight strains of Serratia spp. and 
four strains of E. cloacae were selected for physiological experiments see Table  2.9.  
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Table  2.9 Bacterial strains for physiological experiments 
Organism Strain  Pulsetype 
E. coli    780 EcC4 
E. coli    904 EcC3 
E. coli    923 ⸗  
E. coli    939 ⸗  
E. coli    1008 U 
E. coli    1009 EcC2 
E. coli    1047 CcE1 
E. coli    1050 ⸗  
S. marcescens  791 SC2 
S. marcescens  805 ⸗  
S. marcescens  936 SC1 
S. marcescens  942 ⸗  
S. marcescens  946 ⸗  
S. marcescens  952 ⸗  
S. liquefaciens 1030 SC3 
S. liquefaciens 1036 SC4 
E. cloacae  979 EbC5 
E. cloacae 1027 EbC1 
E. cloacae 1028 U 
E. cloacae  1074 EbC3 
⸗  = same 
It should be noted that to overcome the ambiguity of phenotypic identification of 
Enterobacter and Klebsiella, all strains were subject to PFGE. After PFGE cluster 
analysis some strains were no longer studied as they had been initially misidentified. 
Instead they were given to H. Abdalla (NTU PhD student) for her studies of 
Klebsiella and Enterobacter hormaechei. 
 Motility Test 2.10
The motility assay of the bacterial strains was performed by first inoculating a single 
colony from each strain into 3 ml of TSB at 37°C with shaking incubator at 200 rpm. 
The culture was diluted to 10
4
 CFU/ml and 3 µl from the prepared suspension was 
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stabbed in TSB supplemented with 0.4% agar as described above in section  2.7.6. 
After 10 min the inoculated plates were incubated overnight at 37°C. Strains were 
analysed twice, each time in triplicate. Data were analysed using EXCEL
Tm
 software.   
 Capsule formation test 2.11
The capsule formation of the bacterial strains was performed as follows. As 
described above in section  2.7.7, milk agar was prepared to investigate the effect of 
formula on capsule formation and determine the effect of formula components on 
capsule formation. Strains were streaked on milk agar and incubated overnight at 
37ºC and room temperature. The colony morphology was used as the main parameter 
to compare capsule production between different strains and the effect of formula 
type on capsule production. 
 Biofilm formation 2.12
The biofilm formation was performed according to the crystal violet (CV) method as 
described by Zhang et al., (2004) and Stepanović et al., (2004). A single colony of 
each twenty strains were grown in TSB with shaking at 200 rpm at 37ºC for 18 h 
after harvesting from TSA plates for 24 h at 37ºC under aerobic conditions. Two 
types of sterile infant formula (whey and casein based) from local shops were 
examined in this study. These formulas were purchased as they contain different 
protein and were sterile.  
After incubation for 18 h, the growth of bacterial was diluted by 10
-4
 in the formula. 
A 0.6 ml of cell suspension was dispensed in triplicate into plastic surfaces 24-well 
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ELISA tray for different temperatures incubation at 25ºC and 37ºC for 18 h 
incubation. After 18 h, the suspension was removed gently, and then the wells were 
washed three times by adding 1 ml of normal saline in each well, with shaking for 
10 min at 200 rpm. 0.6 ml of 0.01% (w/v) of CV was then added to stain the cells for 
15 min at room temperature and then the wells were rinsed again with normal saline 
to remove the unbound dye. One millilitre of absolute ethanol was added to each 
well, and then incubated at room temperature for 10 min. A half millilitre from each 
well was then transferred to new ELISA plates. Finally, the absorbance was 
measured at 540 nm with a spectrophotometer. Data were analysed using EXCEL
Tm
 
software.   
 Acid sensitivity 2.13
The effect of acid on Enterobacteriaceae viability was performed to determine the 
survival of bacterial strains in low level of pH according to investigation by 
Edelson-Mammel et al. (2006). A single colony from a purity TSA plate was used to 
inoculate into 5 ml of TSB and incubated overnight at 37ºC. The pH of an infant 
whey-based formula was adjusted to pH value of 3.5 units with hydrochloric acid. 
This was used to mimic the stomach. Three millilitres of overnight culture were 
inoculated into 12 ml of the acidified infant formula, and which then were distributed 
into three sterile tubes and incubated in water bath to 37ºC. Viable cells were 
enumerated after 0, 15, 30, 60, 90 and 120 min. At known time intervals of 
incubation 200 µl was transferred from each tube, diluted in normal saline and plated 
in triplicate on TSA plates using the Miles Misra technique. TSA plates were 
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incubated at 37ºC for 24 h before enumeration of cells. All experiments were 
performed in triplicate from separate overnight cultures. 
 Congo red morphotype (curli fimbriae or cellulose) 2.14
Curli fimbriae or cellulose phenotype was examined by streaking strains on 
LBA-Congo red plates as described previously in section  2.7.8 and incubated at 37ºC 
for 48 h. The colony morphology was recorded at 48 h to determine the formation of 
their Congo red phenotype. Morphology was defined according to the following 
pigmentation: red which indicate curli fimbria and pink which indicate express 
cellulose. 
 Haemolysis on blood agar 2.15
Haemolysis was examined by streaking a single colony from each strain into blood 
agar plates which prepared as described before in section 2.7.9, and then incubated 
for 24 h for at 37ºC. A response of colony morphology was recorded at 24 h to 
determine the formation of their α-haemolysis with a green-brown zone surrounding 
the colony and β-haemolysis with clear zone surrounding the colony. 
 Antimicrobial Susceptibility 2.16
Susceptibility to β-lactam antibiotics and other antimicrobials were tested by the disc 
diffusion method, as described by the National Committee for Clinical Laboratory 
Standards (NCCLS). In brief, eight strains of E. coli were streaked onto TSA and 
incubated at 37ºC overnight to obtain isolated colonies. After incubation, using a 
swab ~5 colonies were transferred into a tube containing 5 ml of a sterile saline and 
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mixed thoroughly via vortex. The suspension was then adjusted to optical equivalent 
the 0.5 McFarland standards. After adjusting the turbidity a sterile cotton swab was 
dipped into the suspension and gently the swab was used to streak Mueller Hinton 
agar which prepared as explained above in section  2.7.5. The plates were allowed to 
dry for about 3 to 5 min. β-lactamase and other antibiotic disc given in Table  2.10 
were obtained from MAST Group; UK. Single discs from each antibiotic was placed 
and pressed down to ensure complete contact with the surface of the MHA plates by 
using flame sterilized forceps. After addition of the antibiotic discs the plates were 
inverted and incubate at 37ºC for 24 h. For each antibiotic the diameter of the zone 
was measured and then compared with standard measurements in Table  2.10 to 
determine if the strains were resistant or sensitive to the antibiotic (Andrews, 2009; 
EUCAST, 2011). Control strains included were E. coli NCTC 13351 (+), E. coli  
NCTC 13352(+), E. coli  NCTC 13353 (+) and E. coli  NCTC 10418 (–). 
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Table  2.10 Zone size interpretative standards for E. coli for selected antimicrobial disks 
Antibiotic Groups Antibiotic Abbreviation Disc content (µg) 
Zone diameter breakpoint (mm) 
S ≥ R < 
Cephalosporins 
Cefpodoxime /Clavulanic Acid CPD / CLAV 30/10 Z(CPD / CLAV)-Z(CPD)≥5mm ESBL +ve 
Cefotaxime /Clavulanic Acid CTX / CLAV 30/10 Z(CTX /CLAV)-Z(CTX)≥5mm ESBL +ve 
Ceftazidime /Clavulanic Acid CAZ / CLAV 30/10 Z(CAZ /CLAV)-Z(CAZ)≥5mm ESBL +ve 
Cefpodoxime CPD 30 30 20 20 
Cefotaxime CTX 30 30 20 17 
Ceftazidime CAZ 30 30 22 19 
Penicillins 
Ampicillin AP 10C 10 14 14 
Augmentin AUG 10C 10 17 17 
Piperacillin / Tazobactam PTZ 36C 30/ 6 20 17 
Miscellaneous agents Chloramphenicol C 30C 30 17 17 
Fluoroquinolones Ciprofloxacin CIP 5C 5 22 19 
Aminoglycosides Gentamicin GM 10C 10 17 14 
Carbapenems 
Imipenem IMI 10C 10 22 17 
Meropenem MEM 10C 10 22 16 
µg = Microgram, mm = Millimeter, S = Sensitive, R = Resistance (Andrews, 2009; EUCAST, Testing 2011) 
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 Tissue culture investigations 2.17
 Attachment and invasion assays 2.17.1
Attachment and invasion assays were completed to examine the capability of 
selected bacterial strains to attach and invade mammalian cells (Caco2, rBCEC4 and 
HBMEC) as described by Townsend et al. (2007a). Attachment and invasion assays 
were performed at the same time using the same cell line passage with same 
inoculum of mammalian cell line and bacterial suspension respectively. 
 Mammalian cell lines 2.17.1.1
Bacterial attachment and invasion of eukaryotic epithelial cells was determined 
in vitro by performing adhesion and invasion assays using Caco-2 cells (Human 
colonic carcinoma epithelial cells, ECACC# 86010202), obtained from the European 
Collection of Cell Cultures, rBCEC4 cells (Rat Blood Brain Barrier cells), obtained 
from I. E. Blasig (Forschungsinstitut für Molekulare Pharmakologie, Berlin, 
Germany) and HBMEC cells (Human brain microvascular endothelial cells), 
supplied by Dr M. Rittig (University of Nottingham) and originally used by 
Lum et al., (2003). All cell lines were stored in the liquid nitrogen. 
 Culture Media 2.17.1.2
All media were obtained from Sigma Aldrich; UK. Caco-2 cells are grown in 
Minimum Essential Medium, Media Sigma Aldrich, UK (M4655) supplemented with 
10% fetal bovine serum Sigma Aldrich, UK (F7524), 1% non-essential amino acid 
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Sigma Aldrich, UK (M7145) solution and 1% Penicillin-Streptomycin Sigma 
Aldrich, UK (p4333). The infection media was minimum essential medium with 10% 
fetal bovine serum and 1% non-essential amino acid solution. Growth medium for 
rBCEC4 and HBECE was 4.5 g / l, 4 mM glutamine, 110 g/l sodium pyruvate 
(Sigma Aldrich, UK (M4655) with 10% fetal bovine serum 1% penicillin and 
streptomycin and 1% non-essential amino acid solution. The infection medium for 
rBCEC4 and HBECE was 4.5 g /l, 4 mM glutamine and 110 g /l sodium pyruvate 
Sigma Aldrich, UK (M4655) with 10% fetal bovine serum and 1% non-essential 
amino acid solution. 
 Bacterial strains 2.17.1.3
Following PFGE analysis, representative strains of the pulse-types were chosen for 
further analysis Table  2.10. These were eight strains of E. coli, eight strains of 
Serratia spp. and four strains of E. cloacae and Salmonella Entertidis strain number 
NCTC 3046 (358 NTU) as a positive control for Caco-2 cell line, Citrobacter koseri 
strain number SMT319 (NTU 48) as positive control for rBCEC4 and HMBEC cell 
lines and E. coli K12 (1230) was the negative control for all experiments of tissue 
culture. A single colony was growth in TSB after harvesting from TSA plates for 18 
h at 37ºC under aerobic conditions. Overnight cultures (120 µl) were inoculated into 
5 ml of infection media and incubated with shaking 200 rpm at 37ºC for ~ 2 h to 
obtain the OD of 0.3 - 0.5 at 600 nm, using a spectrophotometer (JENWAH, UK). 
The suspension was then diluted to obtain the number of 2 x 10
8
 cells per well to 
obtain Multiplicity of infection (MOI) of 1 - 100.   
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 Mammalian cells culture  2.17.1.4
All cell lines (Caco-2, rBCEC4 and HBMEC) were stored in liquid nitrogen until 
required. In this investigation a volume of frozen vials for each cell line were thawed 
quickly until only a small amount of ice remained in the vial. All the contain was 
transferred to a 10 ml tube containing 6 ml pre-warmed growth medium as 
mentioned above in section  2.17.1.2. The cells were harvested by centrifugation. 
After that, in a 10 ml tube the pellet was suspended gently in 6 ml of growth medium 
adding with 100 µl of gentamicin just in the first passage. The suspension then was 
transferred to 25 cm
3
 tissue culture flasks and incubated at 37ºC under 5% CO2 for 
48 h to achieve confluent monolayer cells. The cells were then harvested by 
detachment using trypsin-EDTA solution and centrifugation of the released 
suspended cells at 1300 rpm for 5 min. All cells were split routinely twice a week 
under growth continued. For attachment and invasion assays these were done to 
obtain the number of 2 x 10
4
 cells (0.5 ml/well) in 24 tissue culture plates.   
 Adhesion Assay 2.17.1.5
Mammalian cells (Caco-2, rBECE4 and HBECE) were grown as described in 
section  2.17.1.4. Cells were seeded at 2 x 104 /well. The organism was then added at 
1 x 10
8
 CFU /well. This was then incubated for 2 h at 37ºC under 5% CO2. In order 
to determine the average of adhesion, cells were washed three times with PBS before 
harvesting with Triton X-100. This assay showed the total number of bacteria that 
were attached to the surface and those that were intracellular. The overall number of 
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viable bacteria was determined using the serial dilution and Miles Misra method on 
TSA plates. 
 Gentamicin assay (Invasion Assays) 2.17.1.6
For invasion assays as per attachment studies mammalian cells (Caco-2, rBCEC4 
and HBMCE) were seeded at 2 x 10
4 
/well. The organism was then added at 
1 x 10
8
 cfu per well and this was then incubated for 3 h at 37ºC under 5% CO2. Then 
the cells were washed three times with PBS before adding gentamicin 0.1 mg/ml to 
each well followed by further incubation for 1 h to kill attached bacteria. The cells 
were washed three times before harvesting with Triton X-100. The total number of 
viable bacteria was determined using serial dilution and Miles Misra method on TSA 
plates. All strains were analysed in triplicate. 
All strains of bacteria were assayed in three independent assays.  
 Uptake and persistence into macrophage cell line U937 2.17.2
Macrophages were obtained from the American Type Culture Collection (ATCC) 
(CRL-1593.2) U937. Mammalian cell lines U937 used in this study were stored in 
the liquid nitrogen.  
  Culture media 2.17.2.1
Macrophage cells were cultivated in RPMI medium Sigma Aldrich, UK (1640) with 
2 mM L-glutamine Sigma Aldrich, UK (R8758), and modified to contain 10 mM 
HEPES, 1 mM sodium pyruvate, 4.5 g /l glucose, 1.5 g /l sodium bicarbonate, and 
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supplemented with 10% fetal bovine serum.  At least 24 h prior to infection, cells 
were treated with 0.1 g/ml of PMA (phorbol 12-myristate 13-acetate) Sigma 
Aldrich, UK (P8139), placed into 75 cm
2
 tissue culture flasks at 37ºC, under 5% CO2 
to become activated.   
 Macrophage Assays 2.17.2.2
The selected bacterial strains were investigated for their uptake and persistence in 
macrophages as described by Townsend et al. (2003). In summary, one ampoule of 
macrophage cells (U937) was collected from the liquid nitrogen and thawed quickly, 
then seeded in 10 ml of RPMI supplemented with nutrients to meet the growth 
conditions as previously described into 75 cm
2
 tissue culture flasks. Then it was 
incubated under 5% CO2 at 37ºC for cell cultivation. After activation and cultivation 
the cells were centrifuged at 1500 g for 5 min. Cells in the pellet were then counted 
low and re-suspended into maturation medium as described previously. The cells 
were seeded 500 l into 24 well plates. At 1 x 105 cells in each well and incubated 
48 h at 37ºC, 5% CO2 incubator to allow cell maturation and adherence. One day 
prior to cell infection, one bacterial colony was isolated from TSA and inoculated 
into 3 ml TSB which was then incubated aerobically overnight at 37ºC with vigorous 
shaking. Three millilitres of infection medium were inoculated using 60 µl of the 
inoculated TSB and incubated 2 hours at 37°C with vigorous shaking to obtain the 
OD between 0.3 and 0.5 at 600 nm. The bacteria were then diluted into 6 ml 
infection medium to get obtain the multiplicity of infection 1: 100. For the tissue 
culture well plates the medium was discarded from the wells and the cells were then 
washed twice with 500 µl phosphate buffer saline to remove the residual PMA. The 
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tissue culture plates were divided into 4 groups to determine macrophage uptake and 
bacterial persistence into the cell line for 72 h. Then 500 µl was dispensed into each 
well and incubated for 1 h at 37ºC in a 5% CO2 incubator to allow the matured 
macrophage cells to take-up the bacterial cells. The infection medium was then 
discarded, and the plates washed gently twice using phosphate buffer saline. Five 
hundred microliters of the concentration of gentamicin 100 µg/ ml were dispensed 
into each well and incubated for 1 h at 37ºC into CO2 incubator to eliminate untaken 
bacteria. Plates were then washed gently twice with 500 µl phosphate buffer saline. 
One group was then treated with 100 µl of 1% Triton X-100 with 10 times pipette 
flush to determine the macrophage uptake serially diluted and the number of viable 
bacterial cells was enumerated using the Miles Misra technique. For the other three 
groups, 500 µl of growth medium supplemented with 10 µg/ml gentamicin were 
added to each well. One group was taken for each 24 h washed twice and treated 
with 100 µl Triton X 100, the viable bacteria was enumerated as described above. 
The persisted bacteria was calculated by calculating the number of cells that was 
survived against the number of bacteria after 45 min or of the persistence after 24, 48 
and 72 h survived per well was expressed as a percentage of the bacterial number 
added to the well at the start of the experiment. 
All strains of bacteria were assayed in 3 independent assays.  
 Giemsa staining 2.17.3
The Giemsa stain was performed to determine the adherence pattern of selected 
strains. The assays for Caco-2 and Hep-2 cells were undertaken as described above 
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in section  2.17.1.5 except small modifications that cells monolayers were grown over 
tissue culture coverslips in six-well tissue culture plated (Rüttler et al., 2006). 
Briefly, Chamber slides were seeded with 2 x 10
4
 Caco-2 and same for Hep-2 cells 
line and then incubated at 37ºC with 5% CO2 for 48 h. After incubation period the 
coverslip monolayers were infected with 10
8
 per well overnight growth of bacteria as 
described in  2.17.1.2 and were incubated at 37ºC under 5% CO2 for 2 h. After the 
incubation period the coverslip was washed three times with sterile PBS. 
The coverslip slides were fixed with absolute methanol for 5 min and allowed to air 
dry. The cells were stained with 5% of Giemsa stain (Life Technologies™; UK 
10092 - 013) for 15 min, washed with sterile PBS and allowed to air dry. The slide 
was examined using light microscopy (X100) with oil immersion.    
 
   
 Oxidative and nitrosative stress 2.18
The investigation of oxidative and nitrosative stress of Enterobacteriaceae were 
determined by exposing strains to four using the with a disk diffusion assay approach 
on agar plates as described by Baillon et al., (1999). S-nitrosoglutathione (N4148), 
Methyl viologen (856177), cumene hydroperoxide (247502) and hydrogen peroxide 
(88597) were obtained from Sigma Aldrich; UK. From frozen stock strains were 
plated on TSA, incubated for 18 h at 37ºC. After incubation, one colony was plated 
out again in 3 ml of TSB and incubated with shaking 180 rpm for 18 h at 37ºC. 
Overnight cultures (60 µl) were inoculated into 3 ml of TSB and incubated with 
shaking 175 rpm at 37ºC for ~ 2 h to obtain the optical density of ~ 0.4 at 600 nm, 
using a spectrophotometer (JENWAH, UK). After adjusting OD, the 200 µl of 
culture was inoculated into 4 ml of soft TSA agar and poured onto TSA plates. After 
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solidification of the soft TSA agar, four sterile 6mm disks were placed on each agar 
plate. The concentrations of chemicals were prepared at 100 mM of 
S-nitrosoglutathione; 3% (w/v) of methyl viologen; 3% (w/v) of cumene 
hydrogenperoxide and 3% (w/v) hydrogen peroxide. 3 µl for each chemical were 
inculcated onto each disk. After dispensing the chemicals the agar plates were 
incubated 18 h at 37ºC. Finally for each chemical the diameter of the zone was 
measured to determine if the strains are resistant or sensitive to the chemicals. 
 Molecular biology investigations 2.19
 Bacterial strains 2.19.1
Eight strains of E. coli were chosen in this part after show interesting results in 
physiological and tissue culture studies Table  2.11.  
Table  2.11 Bacterial strains of molecular biology investigations 
Organism Strain pulsetype 
E. coli    780 EcC4 
E. coli    904 EcC3 
E. coli    923 ⸗  
E. coli    939 ⸗  
E. coli    1008 U 
E. coli    1009 EcC2 
E. coli    1047 CcE1 
E. coli    1050 ⸗  
 
⸗  = same   
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 DNA extraction  2.19.2
DNA extraction from of E. coli and references strains was performed using the 
GeneElute
TM
 kit Sigma Aldrich, UK (NA2110-1KT) according to the manufacturer‘s 
instructions. Briefly, a single colony from overnight culture TSA plate was 
inoculated into 3 ml of TSB and incubated for 24 h at 37ºC. Afterwards, 1.5 ml of 
overnight culture was centrifuged at 13,000 ×g, at 4ºC for 2 min. The pellet was 
suspended in 180 µl of lysis solution T and incubated for ~2 min at room 
temperature. A 20 µl of the proteinase K solution 20 mg/ml then were added to the 
mixture and incubate at 55ºC for 30 min. after incubation 200 µl lysis solution C was 
added to the mixture, mixed and incubated for 10 min at 55ºC. In parallel, during 
incubation time a column was prepared by adding 500 µl of column preparation 
solution and then it was centrifuged at 13,000 ×g, at 4ºC for 1 min. Subsequently, the 
mixture was transferred into the binding column after lysed cells by adding with 
200 µl of absolute ethanol and then spin for 1 min at ≥ 6500 ×g. washing the column, 
500 µL of wash Solution 1 and 2 were added 1 and 3 times and centrifuged 
at 6500 ×g, 13,000 ×g, at 4ºC for 1 min respectively with change the column each 
time. After washing DNA samples were eluted 200 µl of elution solution, centrifuged 
at 6500 ×g at 4ºC for 1 min, and DNA concentration confirmed by using 
a NanoDrop® ND-2000 UV-Vis spectrometer (Thermo Scientific; USA), and stored 
at -20ºC. 
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 Multilocus sequence typing (MLST) 2.19.3
Multilocus sequence typing (MLST) of E. coli strains was performed as described by 
Wirth et al., (2006) (http://mlst.ucc.ie/mlst/dbs/Ecoli). Seven housekeeping genes of 
E.coli were amplified by PCR using the primers, adk (adenylate kinase), fumC 
(fumarate hydratase), gyrB (DNA gyrase), icd (isocitrate/isopropylmalate 
dehydrogenase), mdh (malate dehydrogenase), purA (adenylosuccinate 
dehydrogenase), and recA (ATP/GTP binding motif). See Table  2.6 for details. 
 Polymerase chain reaction amplification 2.19.4
The total volume of PCR reaction was 30 µl, which contained 6 µl (5X PCR buffer), 
1 µl (5 µM primer pair working solution) of each primer, 0.6 µl (10 mM dNTPs) 1 µl 
(50 mM MgCl2), 0.2 µl (5 U/µl Taq polymerase), 2 µl (50 ng template DNA) and 
19 µl of ultrapure water. The PCR reactions was achieved with the PCR machine as 
follows: 1 cycle at 95ºC for 1 min followed by 95ºC for 30 sec, 54 - 60ºC (according 
to the variable for primer pairs temperature) for 30 sec, and at 72ºC for 30 sec and 
a final elongation step at 72ºC for 10 min. Successful PCR product size was 
confirmed by agarose gel electrophoresis. 
 Confirmation of PCR products by agarose gel electrophoresis 2.19.5
The PCR amplification products were visualised by gel electrophoresis on agarose 
gels (Life Science ® Company, UK, BIO-41025). Electrophoresis was performed by 
mixing a 1% (w/v) agarose gel in 1 X TAE buffer which prepared as described in 
above in section  2.6.8. The mixture was microwaved until melted and then the 
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molten gel cooled to ~50ºC. 0.001% of SYBR
®
 Safe DNA Gel Stain Life 
Technologies, Invitrogen™, UK (S33102) was added into molten gel and mixed 
before pouring into a gel tray. The gel was left to set at room temperature, and then 
placed into a Mini-Sub® Cell GT tank (Bio-Rad Laboratories Ltd., Hertford, UK) 
containing 1 X TAE buffer. Loading gel was done with 5 µl of sample and a 100 bp 
DNA ladder (Promega, Southampton, UK) to indicate product size [Appendix  7.2]. 
The run condition of the gel was 90 V for 30 min and DNA bands were visualised 
and photographed using UV InGenius® gel documentation system (Syngene, UK). 
 Purification of PCR products 2.19.6
PCR amplification products were purified using QiaQuick PCR purification kit 
(Qiagen, UK, 28106) to remove other components from the PCR reactions to use for 
DNA sequencing. Purification was completed as described in the manufacturer‘s 
protocol. Briefly, 125 µl of buffer PB was added to 25 µl of the PCR sample and 
mixed. The mixture was placed into a QIAquick spin column in a provided 2 ml 
collection tube and then centrifuged at 13,000 rpm for 1 min to binding DNA. Prior 
to washing flow-through was discarded. 750 µl Buffer PE was added to the 
QIAquick column and centrifuged at 13,000 rpm for 1 minute. The flow-through was 
discarded and the QIAquick column was placed back in the same tube and 
centrifuged at 13,000 rpm for an additional 1 min. The QIAquick column was placed 
in a clean 1.5 ml microcentrifuge tube. Elute DNA was performed by adding 50 µl 
elution buffer to the centre of the QIAquick membrane and centrifuged 
at 13,000 rpm for 1 min. The purified PCR product was stored at -20ºC 
until required. 
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 MLST DNA Sequencing 2.19.7
The reaction products and primers volumes and concentration for MLST 
sequencing were adjusted as follow: sample about 8 - 10 ng/µl and primer about 
3.5 pmol/µl. About 10 µl for each reaction, forward and reverse of the 
reaction products were then sequenced by Source Bioscience Sequencing 
http://www.lifesciences.sourcebioscience.com. 
 Phylogenetic of DNA sequence 2.19.8
After sequencing, the reaction products were imported as the FASTA files and then 
the sequences from both strands of a given locus of the same isolate  were aligned 
using the software CLC Sequence Viewer 6.6 http://www.clcbio.com. To analyse, 
trim and assign the sequences were determined via MLST E. coli database website 
http://mlst.ucc.ie/mlst/dbs/Ecoli. The trimmed sequences were compared against the 
MLST database and the sequence types (STs) were determined by submitting the 
allele number to the MLST E .coli database website http://mlst.ucc.ie/mlst/dbs/Ecoli.  
 Detection of virulence factor (VF) genes 2.20
The presence of 29 VFGs for E. coli was determined using previously published 
5 multiplex PCR–based assays (Johnson and Stell, 2000) using primers Table  2.8. 
VFGs gene classes were included adhesins (papAH, papC, papEF, papG, sfa/focDE, 
sfaS, focG, afa/draBC, bmaE, gafD, nfaE and fimH), toxins (hlyA, cnf1, cdtB), 
siderophores (fyuA, iutA), polysaccharide coatings (kpsMT II kpsMT III, kpsMT K1, 
kpsMT K5), invasins (ibeA) and others (rfc, cvaC, traT, PAI). Multiplex polymerase 
Chapter 2: Materials and methods 
  69 
 
chain reaction amplification was performed in a 25 µl reaction mixture containing 
5 µl (5X PCR buffer), 0.5 µl (30 μM) of each primer (except for those marked ―*‖, 
which were used 0.25 µl at a concentration of 30 μM), 1 µl (20 μM dNTPs) 4 µl 
(25 mM MgCl2), 0.5 µl (5 U/µl Taq polymerase), 2 µl (50 ng template DNA) and the 
volume was then made up to 25 µl with ultrapure water according to primer pools. 
The 5 primer pools Appendix  7.3, with the 29 primer pairs were listed as follows: 
pool 1: PAI (930), papA (720), fimH (508), kpsMT III (392), papEF (336), and ibeA 
(171); pool 2, fyuA (880), bmaE (507), sfa/focDE (410), iutA (302), papG allele III 
(internal; 258), and K1 (153); pool 3: hlyA (1177), rfc (788), *nfaE (498), *papG 
allele I (internal; 491), *kpsMT II (272), and *papC (200); pool 4: gafD (952), cvaC 
(680), cdtB (430), focG (360), traT (290), and papG allele II (internal; 190); and pool 
5: papG allele I (flanking; 1190), papG alleles II and III (flanking; 1070), 
*afa/draBC (559), *cnf1 (498), *sfaS (240), and K5 (159). Reactions were heated to 
95ºC in an automated thermal cycler (PTC-100-96; MJ Research, Watertown, MA) 
for 12 min to activate the AmpliTaq Gold. This was followed by 25 cycles of 
denaturation (94ºC, 30 sec), annealing (63ºC, 30 sec), and extension (68ºC, 3 min) 
and a final extension (72ºC, 10 min). Successful PCR products were confirmed by 
agarose gel electrophoresis.  
 Detection of β-lactamase genes 2.21
The presence of 4 β-lactamase genes for E. coli were determined by screen for the 
resistance genes SHV, TEM, CTX-M, and OXA (Table  2.7) by a multiplex PCR assay 
(Fang et al., 2008). PCR amplification reactions were performed in a volume of 
25 µl containing 5 µl (5 X PCR buffer), 2 µl (2.5 µM each primer), 0.25 µl (25 μM 
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dNTPs) 2.5 µl (50 mM MgCl2), 0.25 µl (5 U/µl Taq polymerase), 2 µl (50 ng 
template DNA) and 11 µl of ultrapure water. The cycling parameters were as 
follows: 1 cycle at 94ºC for 1min followed by 94ºC for 30 sec, 54ºC for 30 sec, and 
at 72ºC for 30 sec and a final elongation step at 72ºC for 10 min. The amplified PCR 
products were subjected to electrophoresis at a 2% agarose gel in 1 X TAE buffer. 
Strains with known β-lactamase types were included as references. These were 
NCTC 13351 E. coli TEM-3, NCTC 13353 E. coli CTX-M-15 (TEM, CTX-M, OXA), 
NCTC 13368 K. pneumoniae SHV-18 (TEM). 
 Statistical analysis 2.22
All experiments were repeated at least twice in triplicate. One way ANOVA was 
used to obtain the consistence of the independent experiments, the significance was 
set at p < 0.05.  
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 Introduction 3.1
The identification and characterization of bacterial isolates and their subtyping is 
increasingly important, and can be used to determine whether the strains are clonally 
related. There are a number of phenotypic and genotypic techniques which 
previously have been employed for microbial identification and classification 
(Tenover et al., 1995; Nazarowec-White and Farber, 1999). These days molecular 
typing methods of microbes have become commonplace in public and private 
laboratories. Subtyping of isolates to the strain level is an important tool, including 
studying if the bacteria are clonally related as this would help identify a common 
source in nosocomial outbreaks or potential cross-transmission events and sources of 
infection (Adamsson et al., 2000). This has been even been extended to the use of 
whole genome sequencing, which becoming central to research of human disease and 
also start to be used in routine clinical care (Bick and Dimmock, 2011). 
Numerous genotypic methods are available for the identification and characterisation 
of micro-organisms. These methods include pulsed-field gel electrophoresis (PFGE) 
for the whole genome (CDC, 2004; Tenover et al., 1995; Bick and Dimmock, 2011), 
random amplification of polymorphic DNA (RAPD) (Olive and Bean, 1999) 
amplified fragment length polymorphism (AFLP) (Goulding et al., 2000), restriction 
fragment length polymorphisms (RFLP) (Foley et al., 2009), multi-locus enzyme 
electrophoresis (MLEE) (Caugant et al., 1986),  and multi-locus sequence typing 
(MLST) (Wirth et al., 2006; Maiden et al., 1998). Molecular typing techniques can 
be additional classified into two subgroups; DNA-sequence-based and DNA 
pattern-based methods. 
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PFGE has been referred to as the gold standard of molecular typing methods. It is has 
a high discriminatory power with high resolution and reproducibility for many 
species, compared to other typing methods (Olive and Bean, 1999). The Centres for 
Disease Control and Prevention (CDC) and PulseNet have standard protocols for the 
comparison of PFGE patterns for major foodborne pathogens Salmonella, 
E. coli O157:H7, Shigella, Campylobacter jejuni, Listeria monocytogenes and 
Yersinia pestis (CDC, 2004; Cooper et al., 2006).  
PFGE involves the digestion of whole bacterial DNA by restriction enzymes. There 
are many different restriction enzymes used such as XbaI, SpeI, ApaI, SmaI, and 
NotI. These are often used to improve characterized and discrimination among 
bacteria (Tenover et al., 1995). The restriction enzymes cut the genomic DNA into 
a few fragments (8 – 25) which are separated using agarose gel electrophoresis. 
Banding patterns can be stored electronically and analysed using commercially 
available software such as BioNumerics (CDC, 2004).  
A criterion proposed by Tenover et al., (1995) for the analysis of restriction patterns 
is often used to interpret the PFGE patterns in epidemiological investigations. PFGE 
patterns showing no differences in banding pattern can be considered the same 
strains and if between 1 - 3 different bands they can be considered closely related to 
each other (i.e. clonal). Isolates showing between 4 - 6 different bands can be 
considered possibly related to each other. Strains showing 7 different bands or more 
are considered to be unrelated to each other (Ribot et al., 2006). In addition the 
comparison of patterns is possible via the internet or software such as BioNumerics , 
which were used in this study (Hunter et al., 2005). The similarity values are based 
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on the Dice coefficient, unweight pair group method with arithmetic mean band 
profile of reference standard (Vauterin and Vauterin, 2006).  
This chapter investigates further the genotypic similarities and differences between 
collections of enteral feeding tube isolates by PFGE. The bacterial genera will 
include Klebsiella, Serratia, Enterobacter and Escherichia. It is plausible that during 
the previous study by Hurrell et al. (2009a); Table  1.2 that the same strains were 
either isolated from the same neonate on more than one occasion, or even from 
different neonates. Therefore DNA fingerprinting via PFGE will be used to identify 
if the same strains were isolated on different occasions from the neonatal intensive 
care unit (NICUs). This may also reveal if certain strains were indigenous to the 
NICU, and if there are different populations between the two NICUs. The PFGE 
profiles will be compared with clinical isolates to determine if any are directly linked 
to previous neonatal infections. These organisms commonly carry 
extra-chromosomal material (encoding antibiotic resistance factors) for each strain 
will be determined. 
MLST is a highly discriminatory method for typing and detecting epidemiologically 
important strains (Urwin and Maiden, 2003). Wirth et al., (2006) constructed 
a comprehensive MLST scheme for E. coli based on the partial sequence analysis of 
7 housekeeping genes adk (adenylate kinase), fumC (fumarate hydratase), gyrB 
(DNA gyrase), icd (isocitrate/isopropylmalate dehydrogenase), mdh 
(malate dehydrogenase), purA (adenylosuccinate dehydrogenase) and recA 
(ATP/GTP binding motif). Therefore, we investigated whether the frequency 
of isolation by E. coli is associated with particular genotype by compiling patient 
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details and isolation site, for clinical E. coli isolates and comparing these with the 
isolates ST profile. 
 Materials and methods 3.2
The key methods, culture media and culturing conditions for this part were described 
previously in chapter 2 of materials and methods. 
 Results  3.3
 Pulsed Field Gel Electrophoresis 3.3.1
A dendrogram and band assignment of all strains was achieved using BioNumerics 
software, version 3.5. Dice coefficient, unweight pair group method with arithmetic 
mean (UPGMA) were used for cluster analysis. Less than 95% of band similarity 
value was used to consider the isolates to be non-clonal (Tenover et al., 1995). The 
tolerance and optimization of the bands was 1.5%. Two-hundred and sixty-two 
strains of Enterobacteriaceae which had been isolated from neonatal enteral feeding 
tubes, different patients and date were analysed. The PFGE analysis of these isolated 
were based on the analysis criteria that strains differing in their restriction fragment 
patterns belonged to different clonal clusters. PFGE patterns were compared of 
between 9 - 18 bands, with an average of 13 bands per gel. Salmonella enterica 
serovar Typhimurium reference standard H9812 (NTU strain 732) was used as the 
reference strain and gave distinct bands in the XbaI-digested PFGE profile; 
[Appendix  7.1]. 
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 PFGE profile analysis Enterobacteriaceae strains from enteral feeding 3.3.2
tubes 
As shown in Figure  3.1, the typing of thirty of E. coli isolates from neonatal enteral 
feeding tubes from City Hospital (NCH) and Queen‘s Medical Centre (QMC), 
Nottingham, showed the strains clustered into four pulsetypes, and one unique strain. 
Figure  3.2 shows PFGE typing of sixty PFGE banding patterns for Serratia isolated 
from neonatal enteral feeding tubes from two local hospitals were formed four 
distinguishable pulsetypes. Fifty PFGE patterns for Enterobacter which were 
isolated from neonatal enteral feeding tubes from neonatal enteral feeding tubes also 
from Nottingham are shown in Figure  3.3 which was formed eight distinguishable 
pulsetypes and six unique strains. Figure  3.4 shows forty eight PFGE patterns of 
Klebsiella isolates from neonatal enteral feeding tubes from QMC and NCH. These 
strains were formed 13 distinguishable pulsetypes. Figure  3.5 shows the PFGE 
typing of thirty eight of E. coli isolated from Jordan were formed three 
distinguishable pulsetypes and one unique strain. It should be noted that all strains 
were isolated from neonatal enteral feeding-tubes. Unfortunately no clinical data 
were provided for the patients.  
To overcome the ambiguity of phenotypic identification of Enterobacter and 
Klebsiella, all strains were subject to PFGE. After PFGE cluster analysis, a number 
of E. coli strains were selected for MLST profiling. It should be noted that Figure  3.1 
- Figure  3.4 are the bacterial species identification as according to phenotyping, 
however some strains were later renamed following PFGE analysis and MLST 
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sequence analysis. Some strains were re-identified as different species, and were 
given to H. Abdalla for her studies of Klebsiella and Enterobacter hormaechei. 
 E. coli strains from QMC and NCH  3.3.2.1
 
Figure  3.1 PFGE profiles of thirty E. coli strains isolated from neonatal enteral 
feeding tubes 
Dendrogram obtained from cluster analysis by Bionumerics software, version 3.5, Dice coefficient 
and unweight pair group method with arithmetic mean (UPGMA) for cluster analysis. The tolerance 
and optimization in the band was 1.5%. The first column from right to left, PFGE cluster group, U = 
unique, the hospital identifier, NCH = Nottingham City Hospital (n = 27), QMC = Queen‘s Medical 
Centre (n = 3), DOI = Date of isolation, S.No = Strain number.   
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Table  3.1 Cluster analysis of E. coli isolates 
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E. coli 
NCH 
1009, 1010, 1015, 1016 EcC2 4 Same day 3 BMF, BM 
904, 905, 910, 912,  913, 917, 923, 
924, 926, 927, 929, 933, 934, 937, 
939,  943, 944, 947, 949 
EcC3 19 Two weeks 11 
BMF, BM, PIF, 
IF, Th, RTF 
780, 786, 796 EcC4 3 One month 2 
BM, BMF, PIF, 
Th 
1008 U 1 One day 1 BMF, PIF,  Th 
QMC 1047, 1050, 0151 EcC1 3 One  day 1 RTF 
NCH = Nottingham City Hospital. QMC = Queen‘s Medical Centre. U = Unique. EcC = E. coli 
cluster BM = Breast milk, BMF = Breast milk fortified, PIF = Reconstituted powdered infant formula, 
IF = Infant formula, RTF = Ready to feed formula, Th = Thickener added to feed 
Table  3.1 summarises the results of Figure  3.1. The thirty isolates of E. coli were 
from two local hospital NCH (n = 27, 90%) and the remaining 3 were from QMC. 
These strains were isolated from enteral feeding tubes as a biofilm. The strains were 
clustered into four pulsetypes; EcC1, EcC2, EcC3 and EcC4 and are described 
briefly below.  
Table  3.1 shows that a number of neonates were described as receiving a ‗mixed 
feeding regime‘. For example, pulsetype EcC3 contain 19 strains were isolated from 
11 neonates; those neonates received breast milk and fortified breast milk, whereas 
others received breast milk and reconstituted PIF. A thickener was added to feeds to 
reduce reflux for neonates receiving fortified breast milk, ready to feed formula, 
reconstituted PIF, and mixed feed [Appendix  7.8]. 
 Three strains belonged to pulsetype EcC1, which were isolated on the same 
day (22 October 2007), and from the same patient.  
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 Four strains formed pulsetype EcC2 which were isolated on same day 
(12 June 2007) from 3 different patients.  
 A total of nineteen strains were isolated over a two week period (24 April, 
3 May, and 8 May 2007). These strains were belonged to pulsetype EcC3, 
and were isolated from 11 different patients.  
 Three strains belonged to pulsetype EcC4 and were isolated over a one month 
period (16 January, 30 January and 16 February 2007). They were isolated 
from 2 different patients. 
  In addition there was one unique strain.   
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 Serratia spp.  3.3.2.2
 
Figure  3.2 PFGE profiles of sixty Serratia spp. isolated from neonatal enteral feeding 
tubes 
Dendrogram obtained from cluster analysis by Bionumerics software, version 3.5, dice coefficient and 
unweight pair group method with arithmetic mean (UPGMA) for cluster analysis. The tolerance and 
optimization in the band was 1.5%. The first column from right to left, PFGE cluster group, the 
hospital identifier NCH: Nottingham City Hospital (n = 53), QMC: Queen‘s Medical Centre (n = 7), 
DOI = Date of isolation, S.No = Strain number.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dice (Opt  1.5 ) (Tol  1.5 ) (H 0.0  S 0.0 ) (0.0  -100 ) 
Similarity                                                                                                  PFGE—  Xba1 
 
 
SPP.         S.No    D.O.I   Source  P.G  
 
Dice (Opt:1.50%) (Tol 1.5%-1.5%) (H>0.0% S>0.0%) [0.0%-100.0%] 
PFGE 
100 
95 90 85 80 75 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
. 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia  
Serratia  
Serratia  
Serratia 
Serratia  
Serratia  
Serratia 
Serratia  
Serratia  
Serratia 
Serratia  
Serratia  
Serratia  
Serratia  
Serratia  
Serratia  
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia  
Serratia  
Serratia  
Serratia  
Serratia  
Serratia  
Serratia  
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
Serratia 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
marcescens 
liquefaciens 
liquefaciens 
liquefaciens 
liquefaciens 
liquefaciens 
liquefaciens 
liquefaciens 
854 
936 
925 
964 
965 
967 
970 
973 
974 
940 
942 
945 
946 
951 
958 
975 
919 
920 
921 
935 
952 
953 
954 
955 
959 
961 
962 
963 
853 
898 
899 
911 
918 
941 
791 
804 
823 
837 
844 
849 
852 
903 
812 
813 
821 
822 
838 
840 
846 
793 
805 
809 
811 
1036 
1041 
1045 
1076 
1080 
1030 
1055 
17/04/2007 
08/05/2007 
01/05/2007 
22/05/2007 
22/05/2007 
22/05/2007 
22/05/2007 
22/05/2007 
22/05/2007 
08/05/2007 
08/05/2007 
08/05/2007 
08/05/2007 
09/05/2007 
22/05/2007 
22/05/2007 
08/05/2007 
08/05/2007 
08/05/2007 
01/05/2007 
22/05/2007 
22/05/2007 
22/05/2007 
22/05/2007 
22/05/2007 
22/05/2007 
22/05/2007 
22/05/2007 
17/04/2007 
15/05/2007 
15/05/2007 
03/05/2007 
08/05/2007 
08/05/2007 
23/01/2007 
30/01/2007 
17/02/2007 
28/02/2007 
02/04/2007 
10/04/2007 
10/04/2007 
24/04/2007 
06/02/2007 
06/02/2007 
17/02/2007 
17/02/2007 
28/02/2007 
28/02/2007 
02/04/2007 
23/01/2007 
06/02/2007 
07/02/2007 
06/02/2007 
22/10/2007 
22/10/2007 
16/10/2007 
16/10/2007 
12/11/2007 
16/10/2007 
22/10/2007 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
NCH 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
QMC 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC1 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC2 
SC3 
SC3 
SC3 
SC3 
SC3 
SC4 
SC4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
Chapter 3: Genotyping profiles 
  81 
 
Table  3.2 Cluster analysis of Serratia spp. 
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S. marcescens NCH 
853, 854, 898, 899, 911, 918, 919, 920, 
921, 925, 935, 936, 940, 941, 942, 945, 
946, 951, 952, 953, 954, 955, 958, 959, 
961, 962, 963, 964, 965, 967, 970, 973, 
974, 975 
SC1 34 Over one month 20 
791, 793, 804, 805, 809, 811, 812, 813, 
821, 822, 823, 837, 838, 840, 844, 846, 
849, 852, 903 
SC2 19 Over three months 12 
S. liquifaciens QMC 
1036, 1041, 1076, 1045, 1080 SC3 5 About one month 5 
1030, 1055 SC4 2 One week 2 
NCH = Nottingham City Hospital. QMC = Queen‘s Medical Centre. SC = Serratia cluster 
Figure  3.2 shows the dendrogram of sixty isolates of Serratia species from NCH 
(n = 53, 88.3%) and QMC (n = 7, 11.7%). Table  3.2 summarises these results. These 
isolates were grouped into four distinguishable pulsetypes SC1, SC2, SC3 and SC4. 
Strains of each pulsetypes SC2, SC3 and SC4 showed 100% of similarity coefficient 
(SC). Whereas pulsetype SC1 is composed of two sub-clusters: 3 and 31. These were 
composed of identical strains (SC 100%) and the similarity coefficient of 854, 936 
and 925 with others was SC 95%. Pulsetypes SC1 and SC2 were S. marcescens. 
These were isolated from Nottingham, City Hospital, while pulsetypes SC3 and SC4 
were S. liquifaciens which were isolated from Queen‘s Medical Centre. Overall, the 
Serratia pulsetypes were isolated from a large number of patients over a wide time 
period. 
 A total of 34 S. marcescens strains belonged to pulsetype SC1. These were 
isolated over a prolonged period of over one month (17 April, 1, 3, 8, 9, 
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15 May and 22 May 2007), and furthermore were isolated from 20 different 
patients.  
 Nineteen strains belonged to pulsetype SC2. This pulsetype was isolated over 
a prolonged period of four months (23, 30 January, 6, 7, 17, 28 February, 2, 
10 April and 24 April 2007), and were from 12 different patients.  
 Five strains belonged to cluster SC3. These were isolated over extended 
periods of about one month (16, 22 October and 12 November 2007).They 
were also isolated from 5 different patients.  
 There were two strains in pulsetype SC4, which were isolated at one week 
period (16 and 22 October 2007), and were from different patients. 
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 Enterobacter spp.  3.3.2.3
 
Figure  3.3 PFGE profiles of fifty Enterobacter spp. isolated from neonatal enteral 
feeding tubes 
Dendrogram obtained from cluster analysis by Bionumerics software, version 3.5, Dice coefficient 
and unweight pair group method with arithmetic mean (UPGMA) for cluster analysis. The tolerance 
and optimization in the band were 1.5%. The first column from right to left: PFGE cluster group, U = 
unique, the hospital identifier NCH = Nottingham City Hospital (n = 25), QMC = Queen‘s Medical 
Centre (n = 25), DOI = Date of isolation, S.No= Strain number.  
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Table  3.3 Summary of cluster analysis for Enterobacter spp. 
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E. hormaechei 
NCH 
795, 797, 798, 799, 800, 801, 802, 803 EbC2 8 Same day 6 
E. cloacae 979, 980, 981, 983, 986, 987, 993, 997 EbC5 8 Same day 1 
E. hormaechei 856, 859, 860, 861,862, 863 EbC6 6 Same day 3 
E. cloacae 
QMC 
1027,1066, 1067, 1068, 1069, 1081, 1084, 1089 EbC1 8 One month 3 
1033, 1034, 1035, 1052, 1074 EbC3 5 Same day 2 
1032, 1053, 1075 EbC4 3 Same day 2 
1037 ,1088 EbC7 2 Three days 2 
1039, 1044, 1038, 1040 EbC8 4 One week 2 
1028 
U 
1 One day 1 
1094 1 One day 1 
E. cancerogenus 1077 1 One day 1 
E. cancerogenus 
NCH 
806 1 One day 1 
E. hormaechei 
960 1 One day 1 
790 1 One day 1 
Strains, study neonate, date of isolation and hospital, NCH = Nottingham City Hospital. QMC = 
Queen‘s Medical Centre.  U = Unique. EbC = Enterobacter cluster 
The result of Figure  3.3 are summarised in Table  3.3. Fifty isolates of Enterobacter 
species from NCH (n=25, 50%) and QMC (n=25, 50%). These isolates were 
clustered into eight distinguishable pulsetypes (EbC1 – EbC8) and six unique strains 
as shown in the dendrogram. All strains of each pulsetypes showed 100% of 
similarity coefficient (SC). The strains were isolated from neonatal enteral 
feeding-tubes but no further clinical data were provided. The Enterobacter spp. 
pulsetypes were isolated from a number of patients, and over a considerable time 
period: 
 Over more than one month (16 October, 12 November and 19 November 
2007) eight strains of E. cloacae were isolated which belonged to pulsetype 
EhC1. These strains were isolated from 3 different patients.  
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 Eight strains of E. hormaechei in pulsetype EhC2, were isolated on the same 
day (30 January 2007), nonetheless were isolated from 6 different patients.  
 Five strains of E. cloacae formed pulsetype EhC3 were isolated on the same 
day (16 October 2007), and isolated from 2 different patients.  
 Three strains of E. cloacae were formed pulsetype EhC4, which were isolated 
on the same day (16 October 2007). There were isolated from 2 different 
patients.  
 Eight strains of E. cloacae formed pulsetype EhC5 were isolated on the same 
day (16 February 2007), and were isolated from same patient.  
 Six strains of E. hormaechei formed pulsetype EhC6 were isolated on the 
same day (17 April 2007), from 3 different patients.  
 Two strains of E. cloacae belonged to pulsetype EhC7, which were isolated 
over a one month (16 October and 19 November 2007). There were isolated 
from 3 different patients.  
 Four strains of E. cloacae were belonged to pulsetype Eh8, which were 
isolated at one week period (16 and 22 October 2007), also were isolated 
from 2 different patients.  
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  Klebsiella spp.  3.3.2.4
 
Figure  3.4 PFGE profiles of forty-eight Klebsiella spp. isolated from neonatal enteral 
feeding tubes 
Dendrogram obtained from cluster analysis by Bionumerics software, version 3.5, Dice coefficient 
and unweight pair group method with arithmetic mean (UPGMA) for cluster analysis. The tolerance 
and optimization in the band were 1.5%. The first column from right to left, PFGE cluster group, U = 
unique, the hospital identifier NCH = Nottingham City Hospital (n = 69) QMC = Queen‘s Medical 
Centre (n = 15), DOI = Date of isolation, S.No = Strain number. 
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Table  3.4 Cluster analysis of Klebsiella spp. 
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K. pneumoniae 
NCH 
778, 785, 787, 788, 792, 794 KC2 6 Over five months 6 
K. oxytoca 
781,782,783,784, 807, 808, 810, 814, 
815, 816, 817, 818, 824, 825, 826, 827, 
828, 829, 831, 834, 842 
KC4 21 Over two months 12 
839, 841 KC6 2 One day 1 
779, 789 KC7 2 One day 1 
830,832,833 KC8 3 One week 2 
845, 847, 848, 850, 851 KC10 5 One week 2 
907, 908, 909, 982, 985, 988, 989, 990, 
991, 992, 994, 996, 998 
KC11 13 Over two months 3 
957, 966, 969, 972 KC12 4 Same day 3 
K. pneumoniae 
976, 977, 999, 1000, 1001, 1002, 1003, 
1004, 1005, 1006, 1012, 1013, 1014 
KC13 13 Over two weeks 5 
QMC 
1046,1048, 1049, 1090, 1091, 1092 KC1 6 One month 2 
K. oxytoca 
1078, 1079 KC3 2 One day 1 
1042, 1054, 1059, 1071 KC5 4 One week 3 
1056, 1058 KC9 2 One week 1 
K. pneumoniae 1093 U 1 One day 1 
NCH = Nottingham City Hospital. QMC = Queen‘s Medical Centre. U = Unique. KC = Klebsiella 
cluster 
Table  3.4 above is a summary of the results in Figure  3.4. The forty-eight isolates of 
Klebsiella spp. were from NCH (n = 69, 82.3%) and QMC (n = 15, 17.7%). These 
were clustered together into 13 pulsetypes KC1 – KC13 and one unique strain. 
In addition, all strains in each pulsetypes showed 100% of similarity coefficient 
(SC). All strains were isolated from neonatal enteral feeding-tubes and no clinical 
data was provided for the patients. These pulsetypes were clustered of strains isolated 
over a wide time period. 
 Six strains of K. pneumoniae were belonged into pulsetype KC1. These 
strains were isolated from 2 different patients during one month (22 October 
and 19 November 2007).  
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 Pulsetype KC2 was composed of 4 strains of K. pneumoniae. These strains 
were isolated over a prolonged period of more than five months (23 January, 
23 February and 16 May 2007), and were isolated from 3 different patients.  
 Two strains of K. oxytoca belonged to pulsetype KC3, which were isolated on 
the same day (31 October 2007) and from same patient.  
 Twenty-one strains of K. oxytoca were formed pulsetype KC4, which were 
isolated over more than two months (16, 17 January, 6, 11, 13, 16, 17, 20, 23 
February and 20 March 2007). These were from 12 different patients.  
 At one week period (16 and 22 October 2007) four strains of K. oxytoca were 
isolated which belonged to pulsetype KC5. These were isolated from 
2 different patients.  
 Pulsetype KC6 was composed of two strains of K. pneumoniae. These strains 
were isolated on the same day (28 February 2007), and similarly were 
isolated from 1 patient.   
 Pulsetype KC7 was composed of two strains of K. oxytoca were isolated 
during one week (16 and 23 January 2007), and were isolated from 2 patients.  
 Three strains of K. oxytoca belonged to pulsetype KC8, which were isolated 
on one week (16 and 20 February 2007), and isolated from 2 different 
patients.  
 Two strains of K. oxytoca were belonged to pulsetype KC9, which were 
isolated over a one week period (16 and 22 October 2007). These strains were 
isolated from 1 patient.  
 Five strains of K. oxytoca formed pulsetype KC10, which were isolated over 
a one week period (2 and10 April 2007), and were from 2 different patients.  
Chapter 3: Genotyping profiles 
  89 
 
 From 3 different patients 13 isolates of K. oxytoca were recovered which 
belonged to pulsetype KC11. They were isolated over more than two months 
(16, 17 February and 26 April 2007).  
 Four strains of K. oxytoca belonged in pulsetype KC12, which were isolated 
same day (22 May 2007), and were from 3 different patients.  
 A total of 13 strains of K. pneumoniae belonged to pulsetype KC13, which 
were isolated over a two week period (30 May, 5 and 12 June 2007), and 
from 5 different patients. 
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 E. coli isolated from neonatal enteral feeding tubes in Jordan 3.3.2.5
 
Figure  3.5 PFGE profiles of thirty eight strains of E. coli 
Dendrogram obtained from cluster analysis by Bionumerics software, version 3.5, Dice coefficient 
and unweight pair group method with arithmetic mean (UPGMA) for cluster analysis. The tolerance 
and optimization in the band were 1.5%. The first column from right to left, PFGE cluster group, U = 
unique, the hospital identifier, DOI = Date of isolation, S. No. = Strain number. 
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Table  3.5 Cluster analysis of E. coli from neonatal enteral feeding tubes in Jordan 
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E. coli 
1651, 1653 EC1 2 Same day 1 
 
1645, 1646,1647,1648, 1649, 1650, 1652, 1654, 
1655, 1656, 1657, 1658, 1659, 1660, 1661, 1662, 
1663, 1664, 1665, 1666, 1667, 1668, 1669, 1670, 
1671, 1672, 1673, 1674, 1675, 1676, 1677, 1679, 
1680 
EC2 33 Ten days 12 
1643, 1644 EC3 2 Same day 1 
1678 U 1  1 
U = Unique. EC = E. coli cluster        
Table  3.5 above summarises the cluster analysis shown in Figure  3.5. Thirty-eight 
strains of E. coli isolated from neonatal enteral feeding tubes from a hospital in 
Jordan were grouped into three pulsetypes; EC1, EC2 and EC3 and one unique 
strain.  
 Two strains belonged to pulsetype (EC1), which were isolated on same day 
(16 and 22 October 2007), and were from the same patient.  
 Total of 33 strains were formed pulsetype (EC2) which isolated over one 
week period (16 and 22 October 2007). These were isolated from 12 different 
patients.  
 Two strains belonged to pulsetype (EC3) were isolated on ten days; in 
addition they were isolated from the same patients.  
Chapter 3: Genotyping profiles 
  92 
 
 Multi-locus sequence typing (MLST) of E. coli isolates from Nottingham 3.3.3
neonatal intensive care units 
Eight strains of E. coli were selected for MLST; 780, 904, 923, 939, 1008, 1009, 
1047 and 1050. These were selected according to pulsotype grouping and 
represented thirty strains of E. coli isolated from neonatal enteral feeding tubes used 
in Nottingham City Hospital and Queen‘s Medical Centre, UK.  
The sequence types (ST) obtained for eight strains are given in Table  3.6 . Five STs 
were identified across the pulsotype groups, and were internally consistent within the 
clonal group. EcC1, EcC2, EcC3, EcC4, and unique isolates corresponded with 
sequence types ST2076, ST73, ST95, ST127 and ST394, respectively. According to 
the MLST database at the ERI, University College Cork 
(http://mlst.ucc.ie/mlst/dbs/Ecoli/GetTableInfo_html) all strains were belonged to the 
E. coli pathogenic group B2. 
Table  3.6 MLST profile of selected E.  coli strains 
EcC = E. coli cluster, ST sequence type, PG = pathogenic group, ⸗  = same 
 
 
E .coli strain 
PFGE  
pulsotype 
Housekeeping gene  
adk fumC gyrB icd mdh purA recA ST PG 
780 EcC4 21 35 61 52 5 5 4 394 B2 
904 EcC3 37 38 19 37 17 11 26 95 ⸗  
923 ⸗  37 38 19 37 17 11 26 95 ⸗  
939 ⸗  37 38 19 37 17 11 26 95 ⸗  
1008 U 13 14 19 36 23 11 10 127 ⸗  
1009 EcC2 36 24 9 13 17 11 25 73 ⸗  
1047 EcC1 21 35 61 52 5 77 4 2076 ⸗  
1050 ⸗  21 35 61 52 5 77 4 2076 ⸗  
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 DISCUSSION 3.4
To control and reduce outbreaks, it is very important to rapidly and accurately 
discriminate and identify sources and routes of transmission of bacterial pathogens. 
Molecular subtyping methods is an important tool in epidemiological studies and if 
the strains are clonally related then this will assist in determining a common source 
of infection causing nosocomial outbreaks or potential cross-transmission events and 
sources of infection (Adamsson et al., 2000).  
In this study a collection two hundred fifty six Enterobacteriaceae strains isolated 
from the enteral feeding tubes of neonates on intensive care units from two local 
hospitals in Nottingham UK were analysed as the primary research focus. However 
later an additional collection of thirty-eight E. coli strains from Jordan were obtained 
for preliminary profiling. Unfortunately, because of the long time between the 
collection and this study, clinical details (ie. infection) were not available to us. 
Therefore, this study is not an epidemiological outbreak investigation. Instead, it has 
focused on the discrimination and identification of the isolates. Nevertheless, 
neonatal information regarding, strain, study neonate, date of isolation are shown in 
the tables above. This project describes the use of DNA fingerprinting of these 
Enterobacteriaceae strains via PFGE, to determine if the same strains were isolated 
on different occasions from the NICUs. Therefore indicating whether certain strains 
have colonised the neonatal enteral feeding tubes could be led to colonise the NICUs 
leading to increased exposure and risk to the neonates. 
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This study shows that over the period from 17
th
 January to 19
th
 November 2007, 
neonatal enteral feeding tubes were colonised by four pulsetypes of E. coli, four 
pulsetypes of Serratia spp., eight pulsetypes of Enterobacter spp. and thirteen 
pulsetypes of Klebsiella spp. for which no definitive sources were identified. The 
pulsetypes of E. coli and Serratia spp. were less diverse than the other species. This 
indicates that a narrower range of strains was colonising the enteral feeding tubes.  
The PFGE profiles of strains indicated the existence of clones and were designated as 
genetically indistinguishable; for example E. coli isolates exhibited three small 
pulsetype groups EcC1, EcC2 and EcC4 which containing 3, 4 and 3 strains 
respectively and a large group (EcC3) which comprising 19 strains. The EcC3 
pulsetype was isolated during two week period from 26 April to 9 May. It was 
isolated from eleven patients. Serratia spp. isolates encompassed two species 
S. marcescens and S. liquifaciens. S. marcescens formed two large pulsetype groups 
SC1 and SC2, which included 34 and 19 strains respectively. These pulsetypes were 
isolated over a prolonged period from 19 April to 23 May and from 24 January to 26 
April respectively. In addition, SC1 and SC2 were isolated from twenty and twelve 
patients respectively. This indicates the existence of a clone for each group, which 
were showed 100% of similarity coefficient (SC).  
Interestingly the clonally related strains of E. coli EcC3 could be confirmed that the 
same clone were cross contamination to different feeding tube and prevalence of the 
same clone among those recovered from different patients for short term. In addition 
this could be confirm that, with rustle of collection of E. coli from Jordan, these 
collection shown large pulsetype group EC2 comprised 33 strains out of 38 strains 
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E. coli Table  3.5. While SC1 and SC2 of S. marcescens were demonstrated analysis 
indicates that the S. marcescens more prevalence indistinguishable clone were 
contaminated different feeding tube. This in addition provided cross-transmission 
indistinguishable clone were recovered from different patients for long period. 
Our findings also indicate that the neonates were fed by shows that a number of 
Patients were described as receiving a ‗mixed feeding regime‘. For example, 
pulsetype EcC3 contain 19 strains were isolated from 11 neonates; those neonates 
received breast milk and fortified breast milk, whereas others received breast milk 
and reconstituted PIF. A thickener was added to feeds to reduce reflux for neonates 
receiving fortified breast milk, ready to feed formula, reconstituted PIF, and mixed 
feed that may possibly originate from the same sources, especially for substances 
such as environment or carer see Table  3.1 and for more information see 
[Appendix  7.8]. 
In contrast with E. coli and Serratia spp., the Enterobacter species and Klebsiella 
species pulsotypes showed a large diversity (Figure  3.3 and Figure  3.4), showing that 
wider ranges of strains were isolated from the enteral feeding tubes. Enterobacter 
species and Klebsiella spp. exhibited multiple pulsetypes KC 8 and KC 13 
respectively. This diversity in PFGE profiles indicates the contamination of feeding 
tube could be from different sources. Nonetheless pulsetype KC4 of K. oxytoca were 
recovered from twelve patients and also were isolated over more than two months.   
Eight strains of E. coli, representing the various pulsetypes were selected for MLST 
analysis of E. coli. These were from two neonatal intensive care units. As shown in 
Table  3.6, the concatenated MLST sequences showed clear discrimination between 
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the 8 strains of E. coli ST2076, ST73, ST95, ST394 and ST127. All the STs 
comprised a varying number of isolates. Interestingly, included in the current study, 
remarkable genetic similarity among  the PFGE profiles observed among isolates of 
STs, for example E. coli strains 904, 923 and 939 exhibited indistinguishable PFGE 
profiles and were the same ST. E. coli ST95 was isolated over a two week period 
from three neonates, and therefore of concern due to the continued exposure. 
Reviewing the MLST database at the ERI, University College Cork 
(http://mlst.ucc.ie/mlst/dbs/Ecoli/GetTableInfo_html) revealed that the prevalent 
ST95 in this study has been associated with various infections, including meningitis, 
diarrhoea, septicaemia and invasion. According to the database three strains out of 
one-hundred sixty-four strains of ST95 had caused meningitis. These strains are 
reference named as ISUNMEC48, ISUNMEC36 and ISUNMEC70; two from 
Europe and one from North America respectively.   
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 Physiological and virulence related Chapter 4
traits of Enterobacteriaceae isolated from 
neonatal enteral feeding tubes. 
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 Introduction 4.1
Newborns baby are at increased risk of bacterial infection and currently our 
understanding of the fundamental mechanisms of the immune system in neonates is 
incomplete. In addition, bacterial infections of newborn babies are associated with 
higher morbidity and mortality than older children (Levy et al., 2004). Many 
neonates are not feed breast milk when they are born, but reconstituted powdered 
infant formula. Despite the common mis-conception that such products are sterile, 
the Codex Alimentarius Commission reported that powdered infant formula does 
contain a variety of bacteria, including opportunistic pathogens (CAC, 2007). The 
FAO/WHO, (2004 and 2006) reviewed the microbiological status of powdered infant 
formula and reported that Enterobacteriaceae present were 'causality plausible, but 
not yet demonstrated' with respect to neonatal infections and their occurrence in 
powdered infant formula and follow-on formula. Previous studies by Gastmeier et al. 
(2007) and Kaufman and Fairchild (2004) showed the rate of neonatal infections by 
Enterobacteriaceae has increased and are one of the most predominant pathogen in 
intensive care units outbreaks. Gastmeier et al. (2007) reported that the most 
common bacterial pathogen causative infections are Klebsiella, staphylococci and 
Serratia spp. The study by Stoll et al. (2005) proposed that pathogenic E. coli are 
one of the causative neonatal infections such as meningitis and sepsis. Hurrell et al. 
(2009b) found that the neonatal enteral feeding tube acts as loci for in the attachment 
and colonisation by Enterobacteriaceae. Consequently, enteral feeding tubes are an 
important risk factor with respective to neonatal infections. 
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Hurrell et al., (2009b) investigated Enterobacteriaceae isolated from the enteral 
feeding tubes which had been collected from two NICUs in Nottingham. The 
organisms had attached inside the feeding tubes and formed biofilms Figure  1.1 and 
Table  1.2. In addition, they found that the Enterobacteriaceae biofilms formed in 
tube which had been used to feed babies in both infant formula and breast milk. 
Another study by Hurrell et al. (2009a) used laboratory-based experiments to 
investigate the effect of acidity on bacteria in reconstituted powdered infant formula 
and breast milk. They found that bacteria can survive at acid pH values in the range 
2.5 to 4.3.  
The bacterial capsule is a layer on the outside of bacterial cells. It is composed of 
a polymeric material consisting of polysaccharides, polypeptides or polynucleotides 
(Forsythe, 2010). The capsule formation as a stress protection factor by bacteria and 
is considered a virulence factor which can protect the organisms from macrophages 
(Daffe and Etienne, 1999). Capsule formation by Enterobacteriaceae is linked to 
pathogenicity (Pluschke et al., 1983). In addition capsulated bacteria are more 
resistant to stress conditions (Caubilla-Barron et al., 2007; Beuchat et al., 2009). 
Investigations by Iversen et al., (2004) found that the capsulated strains of 
Cronobacter sakazakii were able to form more biofilms than non-capsulated strains.  
Curli fimbriae also have a role in biofilm formation (Barnhart and Chapman, 2006). 
E. coli, Salmonella serovars and other Enterobacteriaceae produce curli fimbriae 
and/or cellulose (Zogaj et al., 2003). Austin et al., (1998) found Salmonella 
Enteritidis expressed curli fimbriae that were able to form biofilm on abiotic 
surfaces. Most pathogenic strains of E. coli are able to produce curli fimbriae 
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(Bian et al., 2000). Type 1 fimbriae are a feature of E. coli strains and have a role in 
adherence and invasion of intestinal epithelial cells (Boudeau et al., 2001). 
In the immune system, the phagocytic cells such as macrophages produce reactive 
oxygen species (ROS) and nitric oxide species (NOS) to kill invading microbes 
(Burmester and Pezzutto, 2003; Urban et al., 2006; Kehrer, 2000). ROS comprise 
two major groups: free radicals, O2 or hydroxyl moiety (OH) and non-radical of O2 
like hydrogen peroxide (H2O2) or peroxynitrite (ONOO
-
) (Paravicini and Touyz, 
2008) the effect of oxidative stress on cells leads to oxidation, DNA damage, 
methylation of DNA, deamination and depurination (Ames et al., 1993). Nitric oxide 
synthase (NOS) produces NO. Three different NOS are produced by endothelial: 
NOS (eNOS), neuronal NOS (nNOS) and inducible NOS (iNOS) (Kone et al., 2003). 
Bogdan et al., (2000) reported that the killing of microbes was dependent upon 
iNOS-derived NO. 
In this chapter the experimental work was focussed on comparing enteral feeding 
tube isolates of E. coli, Serratia spp. and Enterobacter cloacae. These strains were 
subjected to a range of physiological and virulence related tests. The physiological 
studies included determining biofilm formation, as neonatal exposure to the bacteria 
may in part be due to the extent of biofilm formation on the enteral feeding tube. 
This will be determined by biofilm formation on polymeric substances. Capsule 
production will be determined by colony morphology on milk formula agar plates. 
To mimic ingestion, bacteria will be exposed to the acidity of the neonate stomach. 
Hence survival curves for the strains will be determined at 37°C in infant formula 
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adjusted with HCl to pH3, as representative of the neonate stomach (Hurrell et al., 
2009b).    
Virulence traits determined were those considered relevant to an enteroinvasive 
bacterial pathogen. These included motility, curli fimbriae, haemolysis on blood agar 
and oxidative stress. Many of these have been previously used at NTU to study the 
related Enterobacteriaceae C. sakazakii and E. hormaechei. The susceptibilities of 
E. coli isolates to antimicrobial agents will be determined by the breakpoint method 
on antibiotic supplemented Iso-Sensitest agar according to the British Society for 
Antimicrobial Chemotherapy protocol. Extended spectrum β-lactamases (ESBL) 
production will be detected using the combination disc method and presence of 
ESBL for E. coli. These experiments will assess the potential susceptibility of 
neonates to infections and efficacy of first choice antibiotics in subsequent treatment.  
 Materials and methods 4.2
The methods section, culture media and culturing conditions for this part were as 
previously described in Chapter 2 Materials and Methods. 
 Result 4.2.1
 Biofilm formation 4.2.2
Biofilm formation was studied in twenty strains of Enterobacteriaceae. These were 
eight strains of E. coli (780, 904, 923, 939, 1008, 1009, 1047 and 1050), eight strains 
of Serratia species (792, 805, 936, 942, 946, 952, 1030 and 1036) and four strains of 
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E. cloacae (979, 1027, 1028 and 1074) Table  2.9. Strains were selected as 
representatives of the PFGE pulsotypes. In this study pulsotypes group were used to 
represent groups of Enterobacteriaceae strains, which were isolated from enteral 
feeding tubes. 
The ability of Enterobacteriaceae strains, isolated from enteral feeding tubes at two 
local hospitals in Nottingham during 2007, to form biofilms on plastic surfaces is 
shown in Figure  4.1 and Figure  4.2. Two factors influenced biofilm formation: 
incubation temperature (25°C and 37°C) and type of formula (casein and whey).  
Figure  4.1 shows the biofilm formation of eight strains of E. coli, six strains of 
S. marcescens, two strains of S. liquifaciens and four strains of E. cloacae. All strains 
showed the ability of form biofilm compared with the control, and there was 
variation between strains.  The highest values were by S. liquifaciens in both formula 
types.  The average of the absorbance at 540 nm was between 1.5 to 1.75 absorbance 
units (AU). All E. coli strains showed the lowest amount of biofilm formation with 
whey formula, the average of the absorbance at 540 nm was between 0.75 to 1 AU, 
and were higher when grown in casein formula. S. marcescens and E. cloacae 
showed the same values in both formula types. Their average absorbance values 
at 540nm was between 1 - 1.5 AU. 
Figure  4.1 and Figure  4.2 compared the production of biofilm according to the 
incubation temperature and type of formula. The effect of temperature was apparent. 
All selected strains of Enterobacteriaceae were able to form biofilm at 37ºC 
compared with the control sample; Figure  4.1. While at 25ºC all strains only 
produced a small amount of biofilm which was close to the control value; Figure  4.2. 
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One way ANOVA test was performed to compare the effect of temperatures. This 
showed significantly higher biofilm formation at 37ºC (p < 0.05) compared to 25ºC.  
There was no influence due to the type of formula on biofilm formation at 25ºC, with 
all strains showing same rate of biofilm formation, whereas the effect of the formula 
type was apparent at 37ºC for some strains. All E. coli strains, two strains of 
S. marcescens (791 and 805) and S. liquifaciens (1036) in casein based formula was 
significantly higher compared to biofilm formation in whey based formula 
(p < 0.05). While the others strains did not shown any variation attributable to 
formula types.  
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Figure  4.1 Biofilm formation at 37ºC temperatures in two different formula types (whey and casein) 
Biofilms were stained with 0.01% (w/v) crystal violet, which was analysed at 540 nm; control was inoculated formula. Experiments were assayed in three independent assays. 
Error bars represented using standard error.  
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Figure  4.2 Biofilm formation at 25ºC temperatures in two different formula types 
Data presented in this figure are the same of the presented data in figure one. Biofilms were stained with 0.01% (w/v) crystal violet which was analysed at 540 nm; control 
was taken as formula without inoculation. Experiments were assayed in three independent assays. Error bars represented using standard error. 
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 Motility  4.2.3
The motility of the Enterobacteriaceae, E. coli, Serratia species and E. cloacae 
strains were demonstrated by growth on TSB supplemented with 0.4% agar by 
measuring the diameter of growth after 24 h the results and are shown in Figure  4.3. 
Strains showed a wide-range of motility zone diameter. S. liquifaciens strain 1030 
showed highest amount of motility, approximately 40mm diameter. On the other 
hand, five E. coli strains 780, 904, 923, 939 and 1009, S. marcesens strain 936, 
S. liquifaciens 1036 and E. cloacae 979 were non-motile. While the remaining strains 
were showed different swarm zone diameters between 15 to 35 mm. For example the 
motility zone for E. cloacae strain 1028, S. marcesens strain 946 and E. coli strain 
1047 were 20 mm, 30 mm and 35 mm respectively.  
There was a variation range in motility between strains in the same pulsetype; 
Figure  4.3. Two strains of E. coli 1047 and 1050 from same pulsetype EcC3 showed 
different swarm zone diameters. These were 8 mm and 18 mm, respectively. Three 
strains 942, 946 and 952 of S. marcescens, which belong to pulsetype SC1, 
demonstrated high motility. The diameter of their swarm zone was nearly 30 mm, 
whereas a fourth SC1 strain; 939 was non-motile. The motility diameters for strains 
791 and 805 both pulsetype SC2 were 25.5 and 16.5 mm, respectively. In general, for 
comparison data of all strains, E. coli was less motile than Serratia spp. and 
E. cloacae strains. 
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Figure  4.3 Motility of E. coli, Serratia spp. and E. cloacae strains at 37ºC for incubated 18 h  
The diameter for the motility zone was measured in millimetres. Standard deviation represents the error bars, Experiments were assayed in three independent assays. U= 
unique. EcC, SC and EbC= cluster group of  Pulsed Field Gel Electrophoresis. 
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 Acid sensitivity   4.2.4
Twenty strains of Enterobacteriaceae, including eight strains of E. coli, Serratia spp. 
and E. cloacae were investigated for their tolerance to pH 3. This was used to mimic 
the neonatal stomach. They were exposed to pre-adjusted infant formula at pH 3 for 
two hours at body temperature.  Figure  4.4, Figure  4.5 and Figure  4.6 show the 
results for the different species. 
In general, the initial viable count for all strains was between 5.25 log10 CFU/ml to 
5.75 log10 CFU/ml. The duration of the experiment was two hours, and all strains 
Serratia spp. and Enterobacter cloacae were resistant to pH 3; Figure  4.5 and 
Figure  4.6.  
E. coli strains showed a variation in resistant to pH 3 over the two hour period. Three 
different groups are shown in Figure  4.4. The viability of Group 1 of E. coli 
representative of pulsetypes; EcC4 strain (780), EcC3 strains (904, 923 and 939) and 
unique strains (1008) remained stable. Group 2 containing E. coli strain 1009 
representative of pulsetype EcC2 was able resistant to pH 3 and started to multiply 
after 90 min. Group 3 pulsetype EcC1 included E. coli strains 1047 and 1050, both of 
which belonged to EcC1, showed resistant initially, and then the viable count 
decreased from 5.30 log10 CFU/ ml after 1 hour to 4.80 log10 CFU/ ml after 2 hours. 
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Figure  4.4 Survival of E. coli after the exposure to pH 3 
The survival was measured for up to 2 h at 0, 15, 30, 60, 90 and 120 minutes. The number of recovered cells was obtained from two independent experiments in triplicate. 
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Figure  4.5 Survival of Serratia spp. after the exposure to pH 3 
The survival was measured for 2 h at 0, 15, 30, 60, 90 and 120 minutes. The number of recovered cells was obtained from two independent experiments in triplicate. 
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Figure  4.6 Survival of E. cloacae after the exposure to pH 3 
The survival was measured for 2 hours at 0, 15, 30, 60, 90 and 120 minutes. The number of recovered cells was obtained from two independent experiments in triplicate.
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 Capsule production 4.2.5
Table  4.1 below shows the results of an investigation into capsule production on 
whey-based formula milk agars for twenty strains of Enterobacteriaceae including 
E. coli, Serratia spp. and E. cloacae strains. All strains formed creamy white 
colonies on the agar. There was a notable variation between strains in their ability to 
produce capsules and Table  4.1 shows the relative results. There were three groups 
according to the relative scale of high, medium and low capsule production are 
represented by +++, ++ and + respectively. Strains of E. cloacae 1047 and 
S. marcescens 791 & 805 were able to form high levels of capsular materials. 
E. coli strains 780, 1008 & 1009 and 904, 923, 939, 1047 & 1050 produced medium 
and lower levels of capsule production, respectively. In contrast, all other strains of 
Serratia spp. and E. cloacae strains formed medium levels of capsule, except 
E. cloacae 979, which was only able to form a small amount of capsular material. 
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Table  4.1 Capsule formation on milk agar 
Organism Strain Pulsetype Capsule formation 
E. coli 780 EcC4 ++ 
E. coli 904 EcC3 + 
E. coli 923 ⸗  + 
E. coli 939 ⸗  + 
E. coli 1008 U ++ 
E. coli 1009 EcC2 ++ 
E. coli 1047 CcE1 + 
E. coli 1050 ⸗  + 
S. marcescens 791 SC2 +++ 
S. marcescens 805 ⸗  +++ 
S. marcescens 936 SC1 ++ 
S. marcescens 942 ⸗  ++ 
S. marcescens 946 ⸗  ++ 
S. marcescens 952 ⸗  ++ 
S. liquifaciens 1030 SC3 ++ 
S. liquifaciens 1036 SC4 ++ 
E. cloacae 979 EbC5 + 
E. cloacae 1027 EbC1 ++ 
E. cloacae 1028 U ++ 
E. cloacae 1074 EbC3 +++ 
Capsule production; +++ high, ++ medium, and + low. U= unique. EcC, SC and EbC= cluster group 
according to PFGE, ⸗  = same  
 Congo red morphotype (curli fimbriae or cellulose) 4.2.6
Table  4.2 shows the pigment production on Congo red agar for each strain of 
Enterobacteriaceae including E. coli, Serratia spp. and E. cloacae strains. 
Morphology was defined according to the following pigmentation: red, pink or 
white. The expression red morphotype on Congo red agar indicates the ability of the 
bacterium to express curli fimbria. Whereas the expression pink morphotype on 
Congo red agar; that means it is able to express cellulose. The morphology of E. coli 
strains and Serratia species colonies were pink. All but one strain of E. cloacae were 
pigmented pink, except 1028 which was pigmented red. 
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Table  4.2 Congo red morphotype (curli fimbriae or cellulose) 
U= unique. EcC, SC and EbC= cluster group of PFGE, ⸗  = same 
 Haemolysis on blood agar 4.2.7
Haemolysis on blood agar for twenty strains of Enterobacteriaceae including eight 
strains of E. coli, eight strains of Serratia spp. and four strains of E. cloacae are 
shown in Table  4.3. All strains, with the exception of E. coli strain 1008 were 
produced -haemolysis, while strain 1008 was produced β-haemolysis. All strains of 
Serratia spp. and E. cloacae were produced -haemolysis. 
 
Organism Strain  Pulsetype Congo red phenotype 
E. coli 780 EC4 Pink 
E. coli 904 EC3 Pink 
E. coli 923 ⸗  Pink 
E. coli 939 ⸗  Pink 
E. coli 1008 U Pink 
E. coli 1009 EC2 Pink 
E. coli 1047 CE1 Pink 
E. coli 1050 ⸗  Pink 
S. marcescens 791 SC2 Pink 
S. marcescens 805 ⸗  Pink 
S. marcescens 936 SC1 Pink 
S. marcescens 942 ⸗  Pink 
S. marcescens 946 ⸗  Pink 
S. marcescens 952 ⸗  Pink 
S. liquifaciens 1030 SC3 Pink 
S. liquifaciens 1036 SC4 Pink 
E. cloacae 979 EbC5 Pink 
E. cloacae 1027 EbC1 Pink 
E. cloacae 1028 U Red 
E. cloacae 1074 EbC3 Pink 
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Table  4.3 Bacterial Haemolysis on blood agar 
Organism Strain  Pulsetype Types of haemolysis 
E. coli 780 EcC4  
E. coli 904 EcC3  
E. coli 923 ⸗   
E. coli 939 ⸗   
E. coli 1008 U  
E. coli 1009 EcC2  
E. coli 1047 CcE1  
E. coli 1050 ⸗   
S. marcescens 791 SC2  
S. marcescens 805 
  
S. marcescens 936 SC1  
S. marcescens 942 ⸗   
S. marcescens 946 ⸗   
S. marcescens 952 ⸗   
S. liquifaciens 1030 SC3  
S. liquifaciens 1036 SC4  
E. cloacae 979 EbC5  
E. cloacae 1027 EbC1  
E. cloacae 1028 U  
E. cloacae 1074 EbC3  
= -haemolysis, β= β-haemolysis. U= unique. EcC, SC and EbC= cluster group based on PFGE, 
⸗  = same. 
 Enterobacteriaceae oxidative and nitrosative stress response  4.2.8
The results of Table  4.4 show the sensitivity of E. coli, Serratia species and 
E. cloacae to oxidative and nitrosative stress. There was no significant variation 
between E. coli, Serratia spp. and E. cloacae (p > 0.05). While there was significant 
variation between E. coli, Serratia species and E. cloacae compared to the control 
strains E. coli K12 and C. koseri (p < 0.001) in their sensitivity to oxidative and 
nitrosative agents.  
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The sensitivity to methyl viologen was produced zones of inhibition with diameter in 
the range between 9 mm and 12 mm for E. coli strain 939 and S. marcescens strain 
791. The zone of E. coli K12 and C. koseri were 18 and 23 mm respectively. For 
sensitivity to cumene hydroperoxide E. coli were inhibition zone was between 
28 mm and 31 mm, whereas Serratia species and E. cloacae had zones between 
20 mm and 23 mm and 18 mm and 19 mm respectively.  
Hydrogen peroxide sensitivity was investigated. The inhibition zone was 10 mm and 
13 mm for E. coli. There was no influence of hydrogen peroxide on S. marcescens. 
Two strains of S. liquifaciens and E. cloacae showed no significant variation 
(p < 0.01) and their inhibition zones were between 12 mm - 14 mm. The sensitivity 
of E. coli, Serratia species and E. cloacae strains to S-nitrosoglutathione was in the 
same range, as E. coli K12 and C. koseri. 
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Table  4.4 Sensitivity for E. coli, Serratia spp. and E. cloacae to agents of oxidative and nitrosative stress 
Organism Strain Pulsetype Methyl viologen (mm) Cumenehydroperoxide (mm) Hydrogen peroxide (mm) S-Nitrosoglutathione (mm) 
E. coli 780 EcC4 10.33 ± 2.52 29.33 ± 1.15 10.67 ± 1.15 5.00 ± 0.00 
E. coli 904 ⸗  10.00 ± 1.00 28.67 ± 1.15 11.33 ± 0.58 5.00 ± 0.00 
E. coli 923 ⸗  9.67 ± 0.58 28.67 ± 1.15 11.00 ± 0.00 5.00 ± 0.00 
E. coli 939 ⸗  10.33 ± 1.15 30.67 ± 0.58 10.33 ± 0.58 5.00 ± 0.00 
E. coli 1008 U 11.67 ± 1.53 31.33 ± 1.53 13.00 ± 1.00 5.00 ± 0.00 
E. coli 1009 EcC2 10.33 ± 0.58 30.00 ± 2.65 11.00 ± 0.00 6.00 ± 0.00 
E. coli 1047 CcE1 10.67 ± 0.58 28.33 ± 0.58 11.33 ± 0.58 5.00 ± 0.00 
E. coli 1050 ⸗  11.33 ± 2.08 28.67 ± 2.08 12.00 ± 1.00 5.00 ± 0.00 
S. marcescens 791 SC2 12.33 ± 0.58 20.67 ± 1.53 5.00 ± 0.00 6.33 ± 0.58 
S. marcescens 805 ⸗  10.33 ± 0.58 20.33 ± 1.15 5.00 ± 0.00 5.00 ± 0.00 
S. marcescens 936 SC1 11.67 ± 2.89 22.00 ± 1.00 6.00 ± 0.00 5.00 ± 0.00 
S. marcescens 942 ⸗  10.33 ± 1.15 20.67 ± 1.53 6.00 ± 0.00 6.33 ± 0.58 
S. marcescens 946 ⸗  12.00 ± 1.00 20.00 ± 1.73 5.00 ± 0.00 5.00± 0.00 
S. marcescens 952 ⸗  8.67 ± 0.58 20.00 ± 1.00 5.00 ± 0.00 5.00 ± 0.00 
S. liquifaciens 1030 SC3 10.00 ± 0.00 23.00 ± 1.00 12.67 ± 0.58 5.00 ± 0.00 
S. liquifaciens 1036 SC4 10.67 ± 1.15 22.33 ± 0.58 13.33 ± 0.58 5.00 ± 0.00 
E. cloacae 979 EbC5 11.00 ± 1.00 18.33 ± 0.58 12.33 ± 0.58 5.00 ± 0.00 
E. cloacae 1027 EbC1 10.00 ± 1.00 18.33 ± 0.58 13.00 ± 1.00 5.00 ± 0.00 
E. cloacae 1028 U 9.00 ± 1.00 19.67 ± 0.58 14.67 ± 0.58 7.67 ± 0.58 
E. cloacae 1074 EbC3 11.33 ± 2.08 19.67 ± 0.58 13.67 ± 0.58 5.00 ± 0.00 
C. koseri 48 - 18.33 ± 0.58 35.33 ± 1.73 12.33± 0.58 5.00 ± 0.00 
E. coli K12 1230 - 23.33 ± 0.58 34.00 ± 1.53 13.33 ± 0.58 5.00 ± 0.00 
Results represent the diameter of the zone of inhibition. Experiments were assayed in three independent assays. Standard deviation (±) represents the error between diameters 
of the zones of inhibition. U= unique. EcC, SC and EbC= cluster group of  PFGE, ⸗  = same. 
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 Antimicrobial Susceptibility of E. coli 4.2.9
Antimicrobial susceptibility of the E. coli strains was examined. This included 
screening sensitivity to six antibiotic groups; cephalosporins (Cefpodoxime, 
Cefotaxime and Ceftazidime), penicillins (Ampicillin, Augmentin and Piperacillin / 
Tazobactam), miscellaneous (Chloramphenicol), fluoroquinolones (Ciprofloxacin), 
aminoglycosides (Gentamicin) and carbapenems (Imipenem and Meropenem). In 
addition, three antibiotics were tested to determine ESBL phenotype; Cephalosporins 
(Cefpodoxime /Clavulanic Acid, Cefotaxime /Clavulanic Acid and Ceftazidime 
/Clavulanic Acid), Table  4.5. The analysis of the E. coli strains in antibiotic 
susceptible and antibiotic resistant strains used representative strains based on MLST 
and pulsetypes groups.  
As shown in Table  4.5, strains 1008 and 1009 which belonged to STs 127 and 73 and 
pulsotypes U and EcC2 respectively were susceptible to all antibiotics. The sequence 
type ST2076 including E.coli strains 1047 and 1050, which belonged to EcC1, 
showed resistance to the penicillin‘s antibiotic group and susceptible to all others.  
The sequence type ST95, including three E. coli strains 904, 923 and 939 from 
pulsotype EcC3, displayed susceptibility to all the antibiotics with the exceptional 
resistance towards ampicillin. E. coli strain 780 ST394 belonged to EcC4 and 
displayed resistance towards three antibiotics (Ampicillin and Augmentin) and 
Meropenem which not expected. While strain 780 was susceptible to the other tested 
antibiotics. In addition analyses for phenotypic of an ESBL detection of ESBL-
producing strains was performed. As presented in Table  4.6 , all strains were shown 
to be ESBL negative.  
Chapter 4: Physiological and virulence traits  
  119 
 
Table  4.5 Sensitivity for E. coli to agents of Antibiotic 
Antibiotic Antibiotic 
Zone diameter (mm) 
D.C (µg) 
EcC4 EcC3 EcC3 EcC3 U EcC2 EcC1 EcC1 
ST 394 ST 95 ST 95 ST 95 ST127 ST73 ST2076 ST2076 
S ≥ R < 780 904 923 939 1008 
100
9 
1047 1050 
Cephalosporins 
Cefpodoxime /Clavulanic Acid Z (CPD/CLAV) - Z (CPD) ≥ 5mm ESBL +ve 30/10 -ve -ve -ve -ve -ve -ve -ve -ve 
Cefotaxime /Clavulanic Acid Z (CTX/CLAV) - Z (CTX) ≥ 5mm ESBL +ve 30/10 -ve -ve -ve -ve -ve -ve -ve -ve 
Ceftazidime /Clavulanic Acid Z (CAZ/CLAV) - Z (CAZ) ≥ 5mm ESBL  +ve 30/10 -ve -ve -ve -ve -ve -ve -ve -ve 
Cefpodoxime 20 20 30 S S S S S S S S 
Cefotaxime 20 17 30 S S S S S S S S 
Ceftazidime 22 19 30 S S S S S S S S 
Penicillins 
Ampicillin 14 14 10 R R R R S S R R 
Augmentin 17 17 10 R S S S S S R R 
Piperacillin / Tazobactam 20 17 30/ 6 S S S S S S R R 
Miscellaneous Chloramphenicol 17 17 30 S S S S S S S S 
Fluoroquinolones Ciprofloxacin 22 19 5 S S S S S S S S 
Aminoglycosides Gentamicin 17 14 10 S S S S S S S S 
Carbapenems 
Imipenem 22 17 10 S S S S S S S S 
Meropenem 22 16 10 R S S S S S S S 
U= unique, EcC = E. coli cluster group of Pulsed Field Gel Electrophoresis and ST = sequence typing. 
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 Detection of β-lactamase genes of E. coli 4.2.10
The presence of the β-lactamase genes in E. coli strains was also screened for in the 
study; Table  4.6. The blatem gene was found in E. coli ST95, ST394 and ST2076 of 
isolates and none harboured blaSHV, blaCTX-M and blaOXA. ST127 and ST73 did not 
carry any of these genes. 
Table  4.6 Genotypic traits for ESBL E. coli isolates 
 
E. coli   strain 
 
Pulsetype 
 
ST 
ESBL genotype Phenotypic 
blashv blatem blactxm blaoxa ESBL-producing 
780 EcC4 394 - + - - - 
904 EcC3 95 - + - - - 
923 ⸗  ⸗  - + - - - 
939 ⸗  ⸗  - + - - - 
1008 U 127 - - - - - 
1009 EcC2 73 - - - - - 
1047 
EcC1 2076 
- + - - - 
1050 ⸗  ⸗  - + - - - 
U= unique, EcC= cluster group of Pulsed Field Gel Electrophoresis, STs= sequence typing, ⸗  = same
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 DISCUSSION 4.1
In recent years there has been a rise in incidence of neonatal infections due to 
Enterobacteriaceae, especially E. coli, Serratia spp. and Enterobacter spp. These are 
major causative agents in neonatal intensive care unit (NICU) infections. Despite 
recent concerns over the microbiological safety of infant feeds, there has been no 
consideration that the nasogastric enteral feeding tube may act as a site for bacterial 
colonisation as a biofilm. Consequently microbial analysis of feeding tubes could 
add further information on factors related to enteral feeding (Hurrell et al., 2009b).  
This chapter investigated whether neonatal nasogastric enteral feeding tubes were 
colonised by opportunistic pathogenic strains of E. coli, S. marcescens, 
S. liquifaciens and E. cloacae, and whether their presence was influenced by the 
feeding regime.  
In this research a collection of Enterobacteriaceae strains were used, which had been 
isolated from the enteral feeding tubes of neonates on intensive care units. PFGE was 
used to cluster strains before studying their physiological and virulence related traits. 
Selected strains were chosen to represented pulsotype group. These strains included 
eight strains of E. coli, 6 strains of S. marcescens, two strains of S. liquifaciens and 
four strains of E. cloacae. 
Bacterial pathogens can form biofilms on food and food contact surfaces, 
consequently enhancing the capability of these bacteria to survive under harsh 
environments and resist antimicrobial treatments (Annous et al., 2009). Numerous 
opportunistic pathogens within the Enterobacteriaceae family are known to be able 
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to attachment, multiplication and colonize nasogastric enteral feeding tubes 
(Hurrell et al., 2009a). The comparison of E. coli, S. marcescens, S. liquifaciens and 
E. cloacae in Figure  4.1 and Figure  4.2 generally reflects common knowledge of 
their ability to form biofilms. In this investigation only 2 variables (incubation 
temperature and formula composition) were used. 
These investigations showed the ability of strains to form biofilms; Figure  4.1 and 
Figure  4.2. The effect of temperature on biofilm formation was evident. Biofilm 
formation was significantly higher (p < 0.05) at 37ºC for all strains compared 25ºC. 
Biofilm formation may be affected by the formula composition. Two different types 
of formulas were used for biofilm investigations. The results did not show any 
correlation of formula type on biofilm production by S. marcescens, S. liquifaciens or 
E. cloacae; Figure  4.1 and Figure  4.2. However, formula composition affected 
E. coli biofilm production. For example strains of E. coli 939 and 1047 grown in 
whey-based formula showed absorbance units approximately 0.57 AU while biofilm 
formation in casein-based formula was about 1.5 AU; Figure  4.1.  
Previous studies have shown that conditions, which affect biofilm formation, are 
temperature, pH, O2, hydrodynamics, and osmolarity. These conditions affect 
enzymatic and structural elements which are important for biofilm formation 
(Romeo, 2008).  Proliferation of bacteria is a significant effect only in some cases 
during the first steps of form biofilm (Chavant et al., 2002). In study by Else et al., 
(2003) the lowest and highest of humidity values led to the best biofilm 
development. Temperature may also affect he production of extracellular polymeric 
substances, which is known to increase the biofilm formation. Another study 
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indicated that curli fimbriae in members of Enterobacteriaceae play a role in 
adherence and biofilm formation (Romeo, 2008; Olsén et al., 1993; Römling et al., 
1998; Zogaj et al., 2003; Lee et al., 2011). E. coli could be affected by the formula 
composition to form biofilm; Figure  4.1. The study by Kucerova et al., (2011) found 
that the whey and casein based formulae, commonly used in infants feeding, and 
affected the growth rate and death of Enterobacteriaceae. Finally, the study by 
Hurrell et al., (2009b) showed that biofilm formation by bacteria on neonatal feeding 
tubes increases the risk of baby infection at NICUs. 
In this study, the motility test of the selected strains was investigated to determine 
any correlation of motility with biofilm. There was a different range in motility 
shown by strains of E. coli, S. marcescens, S. liquifaciens and E. cloacae; Figure  4.3. 
In general, most strains of E. coli were less motile compared to Serratia species and 
Enterobacter cloacae strains. Investigation showed no correlation between motility 
and biofilm formation. In addition, the study showed a variation range in motility 
between strains belonged to same pulsetypes. For example, strain 939 of 
S. marcescens, which belong to pulsetype SC1 was non-motile, whereas the other 
strains of the same pulsetype SC1 group were motile, with the same swarm diameter 
of ~ 30 mm. However, further analyses is necessary in order to confirm the isolates 
are related or not by used another restriction enzyme then those strains could be 
confirmed as the same. There is biofilm data showed can be relationship between 
motility Figure  4.3 and biofilm formation Figure  4.1. Previous studies of E. coli and 
Salmonella reported that motility was not required for initial attachment and biofilm 
formation (Pratt and Kolter, 1998; Prigent-Combaret et al., 2000). This contrasts 
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with a study of E. coli K-12 which showed correlation between motility and biofilm 
formation (Wood et al., 2006). 
The ingestion of microbes during feeding exposed them to acidity stress in the 
stomach. The infants‘ stomach pH of infant‘s fed milk formula is between 2.5 and 
4.3 (Hurrell et al., 2009a) in this study the role of biofilm in the resistance of cells to 
pH 3 was investigated. The same selected strains for biofilm studies were screened 
for pH 3 tolerance. Serratia species and E. cloacae strains showed persistence at pH3 
for up to 2 hours; Figure  4.5 and Figure  4.6. As well as in Figure  4.4, E. coli strains 
shown to resist pH 3 for 2 hours with the exception of strains 1047 and 1050 which 
were only resistant for up to 1 h and then their viable count slightly decreased. The 
survival of these strains at low pH may increase the risk of exposure to bacterial 
pathogens by neonates. In addition, the persistence of strains in low pH may be 
because of their ability to form a biofilm inside the feeding tube. Previous study of 
acid tolerance by biofilm cells of Streptococcus mutans (McNeill and Hamilton, 
2006) showed the cells in the biofilm are highly resistant to low pH.  
Capsule morphology was also assessed. E. coli, S. marcescens, S. liquifaciens and 
E. cloacae showed different capsule morphology; Table  4.1. Study observed there 
was no correlation between capsule formation and biofilm on milk agar for 20 strains 
studied as shown in Table  4.1 and Figure  4.1. For instance, S. marcescens 791 and 
805 produce more capsules, nevertheless those strains were produced less biofilm. E. 
coli pulsotype EcC3 produced more biofilm than the most capsulated S. marcescens 
strains 791 and 805. Hurrell et al., (2009b) found that strains, which did not produce 
any capsule on milk agar plates, produced more biofilm. Capsules may have played 
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roles in resistance to desiccation, serum activity and contribute to the survival of the 
organism after uptake by phagocytic cells (Guerry and Szymanski, 2008). 
In addition to capsule production, there is another production by cell wall, which is 
the expression of cellulose and / or curli fimbriae. The role of curli fimbriae in 
adherence and invasion has been described in members of Enterobacteriaceae 
(Olsén et al., 1993; Zogaj et al.; 2003; Boudeau et al., 2001; Lee et al., 2011; 
Römling et al., 2003). In this study, 20 Enterobacteriaceae isolates were 
characterised on media characterising the cell wall expression of cellulose and/or 
curli fimbriae. The morphotypes are shown in Table  4.2.  All isolates belonging to 
the dominant morphotypes produced pink colonies on Congo red indicating that 
these isolates are able to produce cellulose and not curli fimbriae. However, one 
strain E. cloacae 1028 produced red colonies on Congo red showing the expression 
of curli fimbriae. Pink morphotype on Congo red agar indicate that the cells are 
producing cellulose (Bokranz et al., 2005). The same authors also reported the 
capability of E. coli strains to form biofilms was correlated with expression of 
fimbriae and cellulose. In E. coli and Salmonella, cellulose is one of the major 
components of the biofilm matrix (Da Re and Ghigo, 2006). 
A number of supposed virulence factors play a role in the pathogenesis of bacteria. 
Toxins production by bacteria are major important virulence factors in bacterial 
disease. Haemolysin is one of the toxins producted by bacteria. There are three 
different of haemolysins; α-haemolysin, β-haemolysin and γ-haemolysin. Secreted 
haemolysin are found in clinical isolates, such as E. coli and Serratia species 
(König et al., 1987; Welch, 1987; Schmidt et al., 1995). 
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In this current study, E. coli, S. marcescens, S. liquifaciens and E. cloacae were 
investigated for their capability to lyse sheep erythrocytes. All showed α-haemolytic 
activity on sheep blood, except E. coli 1008 which was ß-haemolytic; Table  4.3. The 
α-haemolysin is an important virulence factor generally expressed by extraintestinal 
pathogenic E. coli (Balsalobre et al., 2006). All E. coli in this study belonged to the 
E. coli pathogenic group B2, extraintestinal pathogenic E. coli. Gianotti, (1999) 
found that most clinical isolates of S. marcescens, S. liquifaciens and other 
Serratia species were β-haemolytic. 
During infection, pathogenic bacteria are engulfed by phagocytic cells, such as 
macrophages. The engulfed bacteria are then exposed to high concentrations of ROS 
and NOS, which often leads to killing (Burmester and Pezzutto, 2003; Urban et al., 
2006; Kehrer, 2000). However, some of pathogenic bacteria are able to adapt to 
oxidative and nitrosative stress (Soares et al., 2010). NrfA enzymes and cytoplasmic 
Fdp proteins, which are produced by Wolinella succinogenes, E. coli, C. jejuni and 
other bacteria contribute to the conversion of nitric oxide to ammonium and then to 
nitrous oxide (Kern et al., 2011). The sensitivity of E. coli, S. marcescens, 
S. liquifaciens and E. cloacae to a range of oxidative and nitrosative were studied. As 
shown in Table  4.4, strains of E. coli, S. marcescens, S. liquifaciens and E. cloacae 
did slightly vary in their response to methyl viologen, cumene hydroperoxide, and 
hydrogen peroxide between strains. Nonetheless, strains were less sensite to these 
compounds compared to control strains, for example S. marcescens which was not 
affected by hydrogen peroxide, whereas other strains and were effaced Table  4.4. 
Strains were not affected by S-nitrosoglutathione Table  4.4. These traits could be 
links between oxidative stress resistance and tissue culture results.   
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Antimicrobial resistance and ESBL were determined for eight strains of the E. coli 
isolated; Table  4.5 and Table  4.6. The E. coli strains were highly sensitive to 
miscellaneous, cephalosporins, fluoroquinolones, and aminoglycosides. However 
E. coli strains showed low sensitivity to penicillin‘s, for example ST2076 of E. coli 
strains 1047 and 1050 were resistances to Penicillin‘s. Although strains were not 
demonstrated phenotypic ESBL activity, nonetheless all strains note according to 
Table  4.6 of E. coli carried blatem gene of ESBL. Strains of E. coli not detected of 
phenotypic ESBL activity, whereas ST394, ST95 and ST2076 of E. coli strains were 
harboured blatem gene of β-lactamase Table  4.6. Strains of E. coli did not expression 
of phenotypic ESBL that could be β-lactamase genes are locked or may be it need 
change the concentration of the antimicrobial agent.   
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 Virulence determination of Chapter 5
Enterobacteriaceae isolated from neonatal 
enteral feeding tubes. 
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 Introduction 5.1
Numerous enteric pathogens require surface molecules such as adhesins for their 
adherence to host cells, leading to colonization and infection. Recently, important 
evidence has shown that markedly diverse microbial pathogens use common 
strategies to cause infection and disease. For example, several pathogenic bacteria 
share a common strategy to adhere, invade, and subvert host cells and tissues, as well 
as to survive within host cells and causes infection (Wilson et al., 2002; Miller, 
1995).  
Enterobacteriaceae infections start after the bacteria adhere to the host cell surface 
(Shoaf‐Sweeney and Hutkins, 2008). Many bacterial pathogens including E. coli, 
Salmonella, Shigella and Yersinia have evolved specific pathogen: host interactions 
e.g. actively enter eukaryotic cells (Finlay and Falkow, 1988). Additionally, 
microbes such as Salmonella spp., Streptococcus pneumoniae, E. coli, Shigella are 
able to invade and survive within host cells, causing a number of infectious diseases 
(Horwitz, 1983; Formal et al., 1983; Isberg and Falkow, 1985; Ernst et al., 1999). 
Caco-2 as a model of small intestine is the main epithelial cell line used in vitro to 
study the mechanisms of bacterial adhesion and invasion of human pathogens 
(Grajek and Olejnik, 2004; Cenciĉ and Langerholc, 2010). The Caco-2 cell line was 
proposed by Szymanski et al. (1995) as a model to investigate the invasion of 
Campylobacter jejuni and Campylobacter coli of intestinal epithelia. The ability of 
E. coli isolated from children to invade Caco-2 cells was shown to be significantly 
more than controls (p ≤ 0.001) (Geyid et al., 1998). The cell line has previously used 
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at NTU to study that E. hormaechei strains vary in their ability to invade intestinal 
and brain cells, and persistence in macrophages (Townsend et al., 2008). 
In contrast, HEp-2 or Hela epithelial cell lines are the most common cell line for 
differentiating between enteropathogenic E. coli (EPEC), Diffuse Adherence E. coli 
(DAEC) and enteroaggregative E. coli (EAEC). In earlier studies adherence tests had 
been used to detect distinct the adherence patterns; localized adherence (LA), diffuse 
adherence (DA) and aggregative adherence (AA) (Janda and Abbott, 2006; 
Rüttler et al., 2006). 
Phagocytic cells are the first defence in the body against microbes‘ infection. 
However many pathogenic microbes are able to survive and even replicate within 
phagocytic cells (Lindgren et al., 1996). Fields et al. (1986) investigated Salmonella 
Typhimurium in vitro for its ability to survive and replicate within macrophages. An 
investigation by Townsend et al. (2003) used the human macrophages U937 to 
determine the virulence of C. koseri. The study detected the ability of C. koseri to 
survive and replicate within macrophages which could be contributing to chronic 
central nervous system infection including brain abscesses. Previous studies showed 
that Citrobacter causes meningitis and brain abscess formation in babies (Kline et 
al., 1988b). Lucchini et al. (2005) found that S. flexneri are able to persist within 
macrophages (U937) cell line. 
In spite of the advances of increased health care, there remains a significant amount 
of mortality and morbidity associated with bacterial meningitis (Lucchini et al., 
2005). Studies of bacteria translocation in brain endothelial cells to the central 
nervous system (CNS) can be studied in vitro because of the availability of human 
Chapter 5: Virulence determination  
  131 
 
brain microvascular endothelial cells HBMEC (Huang et al., 1995; Stins et al., 
2001). Kim et al. (2003) investigated the ability of E. coli K1 to invade human brain 
microvascular endothelial cells HBMEC, although it remains unclear how E. coli K1 
crosses HBMEC. Khan et al. (2007) demonstrated that type 1 fimbriae, specifically 
FimH attached to brain endothelial cells and triggers signalling events that promote 
E. coli K1 to invade in HBMEC.  Townsend et al. (2008) investigated the virulence 
of E. hormaechei using the invasion of rat brain capillary endothelial cell line 
rBCEC4 cell line as a model to investigate the bacterial invasion of brain cells. 
A number of virulence factors have been identified in E. coli, although many others 
are probably not yet totally elucidated (Sussman, 1997; Manges and Johnson, 2012). 
E. coli are responsible for extraintestinal infections such as neonatal meningitis 
(Manges and Johnson, 2012). The virulence potential of extraintestinal pathogenic E. 
coli (ExPEC) is determined largely by the presence of particular virulence factors 
(VFs), such as adhesins, invasins, capsule, toxins and siderophores (Johnson and 
Stell, 2000).  
In this chapter a range of virulence determinants in E. coli, Serratia species and 
E. cloacae strains have been investigated, which are relevant to an enteroinvasive 
bacterial pathogen. These will include attachment and invasion of Caco-2, HBMEC, 
rBCEC4, and macrophage cell line U937. A selection of virulence factor genes for 
E. coli was considered and any observed differences would be compared to the 
pulsetypes group; Table  2.8. 
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 Materials and methods 5.2
The methods section, culture media and culturing conditions for this part were 
previously described in Chapter 2 Materials and Methods. 
 RESULTS 5.3
 Attachment and invasion assays (Caco-2, rBECE4 and HBECE) 5.3.1
The virulence determination of Enterobacteriaceae strains has been studied in vitro 
by investigating their attachment and invasion of three different cell lines, Caco-2, 
rBCEC4 and HBMEC. The bacterial attachments to epithelial and endothelial cells 
were determined after two hours of the exposure of the mammalian cells and 
compared to the initial inoculum size. The invasion experiment was performed by 
using a gentamicin protection method after three hours exposure epithelial and 
endothelial cells with strains compared to the viable count of the initial inoculum 
[Appendix  7.5 -Appendix  7.7]. Salmonella Enteritidis strain number NCTC 3046 
(NTU strain 358) was used as positive control for the Caco-2 cell line. While 
C. koseri strain number SMT319 (NTU strain 48) was used as positive control for 
rBCEC4 and HBMEC. Both were used in this investigated as standard enteric 
pathogens capable of attachment and invasion. While E. coli K12 (NTU 1230) was 
used as a negative control for all cell lines used in this study, which was 
non-pathogenic and incapable of attachment to Caco-2 cell line (Townsend et al., 
2008).  
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 Caco-2 attachment 5.3.1.1
Figure  5.1 below shows the attachment to the mammalian epithelial cell line Caco-2 
by E. coli, Serratia species and E. cloacae. In addition, E.coli K12 and Salmonella 
Enteritidis 358 were also used as reference strains for comparative data. As shown in 
Figure  5.1, all strains attached to Caco-2 cells when inoculated (T = 0) and later both 
the initial bacterial count and the count after 3 hours (T = 3). Statistically one-way 
ANOVA all strains showed significantly more attachment than E. coli K12 
(p < 0.001).  
Most strains were able to attach to the Caco-2 cell line readily and the number of 
recovered cells was in the range 5.5 log10 - 6 log10 CFU/ml. Two strains of E. coli 
type (strain 1008 and 1009), strain 1030 of S. liquefaciens and E. cloacae showed a 
lower attachment rate than the other bacterial strains. 
 Caco-2 invasion 5.3.1.2
The gentamicin protection assay was performed to investigate the ability of 
Escherichia coli, Serratia species and Enterobacter cloacae to invade the Caco-2 
cell line. Salmonella Enteritidis 358 and E. coli K12 were used as positive and 
negative controls, respectively for comparative data. All strains invaded Caco-2 cells 
at a significantly (p ≤ 0.001) greater value than E. coli K12. 
Figure  5.2 below shows a range of invasion abilities of E. coli, Serratia spp. and 
E. cloacae to Caco-2. The number of recovered cells was in the range between 
1.5 log10 to 4 log10 CFU/ml.  
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The E. coli strain 1050 showed the highest level of invasion. As given above, this 
strain also had the highest attachment value. E. coli and E. cloacae showed the 
higher levels of invasion than Serratia spp. One strain of E. coli 1008, five strains of 
Serratia spp. (type strain 791, 805, 942, 1030, and 1036) and one strain of E. cloacae 
(1047) were shown to be unable to invade Caco-2 cells. Three Serratia strains (type 
strain 936, 946 and 952), which previously had the highest attachment rates, showed 
low invasion rates of about 1 log10 CFU/ml. In addition, E. coli 1009 showed low 
invasion value of about one log10 CFU/ml and had low attachment rates. 
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Figure  5.1 Attachment of CaCo-2 cells by E. coli, Serratia spp. and E. cloacae 
 S. Enteritidis 358 and E. coli K12 were used as positive and negative controls respectively 
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Figure  5.2 Invasion of Caco-2 cells by E. coli, Serratia spp. and E. cloacae 
S. Enteritidis 358 and E. coli K12 were used as positive and negative controls, respectively. U= unique. EcC, SC and EbC= cluster group of Pulsed Field Gel Electrophoresis. 
0
1
2
3
4
5
V
ia
b
le
 C
o
u
n
t 
(l
o
g
1
0
 C
F
U
/m
l)
 
 
Strains 
EbC3 
U EbC1 EbC5 
SC4 SC3 
SC1 
SC2 
EcC1 
EcC2 
U 
EcC3 
EcC4 
Chapter 5: Virulence determination  
  137 
 
 rBCEC4 Attachment 5.3.1.3
Figure  5.3 below displays the level of the attachment of the selected 
Enterobacteriaceae strains to the mammalian endothelial cell line rBCEC4 by the 
same strains as used previously with Caco-2 cells. C. koseri 48 and E. coli K12 were 
used as positive and negative controls, respectively for comparative data. 
The selected strains were varied in their attachment to rBCEC4cells, that there was 
a three-log variation in invasion values between strains. The number of recovered 
cells was in the range between 2.5 log10 – 6 log10 CFU/ml. All strains showed 
significantly more attachment than E. coli K12 (p ≤ 0.001).  
Strains of E. coli with the exception of 1009 showed the attachment to rBCEC4 cells 
at higher values approximately 6 log10 CFU/ml. Three Serratia strains (805, 857 and 
936) had an attachment rate higher than C. koseri 48, which were recovered in the 
range approximately 5.5 log10 CFU/ml. These were significantly greater than 
C. koseri 48 (p ≤ 0.001). All strains of E. cloacae and six strains of Serratia species 
(type strain 791, 942, 952, 968, 1030, and 1036) had similar values and the lowest 
attachment, which was lower than C. koseri 48, although significantly greater than 
E. coli K12 (p ≤ 0.001) 
 rBCEC4 Invasion  5.3.1.4
The ability of E. coli, Serratia species and E. cloacae strains to invade into the 
rBCEC4 cells are shown in Figure  5.4 below. The rBCEC4 cell line was used to 
investigate the ability and interaction of strains to invade brain capillary endothelial 
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cells in vitro. The gentamicin protection assay used C. koseri 48 as the positive 
control as it very able to invade this cell line and E. coli K12 as a negative control as 
it is unable to invade this cell line whereas the number of recovered cells was in the 
range between 2.5 log10 to 3.5 log10 CFU/ml. Four strains of E. coli (780, 904, 923 
and 939) and one strain of Serratia spp. 936 showed the ability to invade rBCEC4, 
which had an attachment rate higher, while all other strains were unable to invade 
endothelial cell line rBCEC4. 
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Figure  5.3 Attachment of rBCEC4 cells by E. coli, Serratia spp. and E. cloacae 
C. koseri 48 and E. coli K12 were used as positive and negative controls, respectively.  
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Figure  5.4 Invasion of rBCEC4 cells by E. coli, Serratia species and E. cloacae 
C. koseri 48 and E. coli K12 were used as positive and negative controls, respectively. U= unique. EcC, SC and EbC= cluster group of pulsed field gel electrophoresis 
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 HBMCE Attachment 5.3.1.5
Figure  5.5 summarizes the attachment to HBMEC by E. coli, Serratia species and 
E. cloacae. C. koseri 48 and E. coli K12 were included for comparison data as 
positive and negative controls. 
All strains were able to attach to the HBMCE cell line and the number of recovered 
cells was in the range between 4 log10 to 6 log10 CFU/ml. In addition all strains 
showed significantly more attachment than E. coli K12 (p ≤ 0.001). 
Based on data presented in Figure  5.5, the four strains of E. coli (780, 904, 923, 939) 
and three strains of Serratia marcescens showed the greatest attachment and there 
was significantly more attachment than E. coli K12 (p ≤ 0.001) and higher than 
C. koseri 48. Two strains of E. coli (type strain 1008 and 1009) showed low 
attachment values, about 4.5 log10 CFU/ml. These strains also showed low values for 
attachment and invasion of Caco-2 cells. Three strains of E. cloacae showed the 
lowest rate of attachment of ~ 3.5 log10 CFU/ml 
 HBMCE Invasion 5.3.1.6
Figure  5.6 below displays the abilities of E. coli, Serratia spp. and E. cloacae strains 
to invade the human blood brain barrier endothelial cell line HBMCE. The 
gentamicin protection assay used C. koseri 48 as a positive control and E. coli K12 as 
a negative control that was unable to invade this cell line and the number of 
recovered cells was in the range between approximately 2.5 log10 to 3 log10 CFU/ml. 
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All E. coli strains except strain number 1008, Serratia spp. (strains 857, 936, 946 and 
952) and E. cloacae strains 979 and 1028 were significantly higher invaders 
compared with E. coli K12 (p ≤ 0.001). These strains were not different from 
C. koseri 48, which were recovered in the range 2.5 log10 to 3 log10 CFU/ml. 
However all other strains were unable to invade this cell line. E. coli strains were 
more invasive than Serratia spp. and E. cloacae. 
 
Chapter 5: Virulence determination  
  143 
 
 
Figure  5.5 Attachment to HBMCE cells by E. coli, Serratia spp. and E. cloacae 
 C. koseri 48 and E. coli K12 were used as positive and negative controls, respectively 
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Figure  5.6 Invasion to HBMCE cells by E. coli, Serratia spp. and E. cloacae 
C. koseri 48 and E. coli K12 were used as positive and negative controls, respectively. U= unique. EcC, SC and EbC= cluster group based on PFGE. 
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 Uptake and Persistence into Macrophage Cell Line (U937) 5.3.2
Macrophages are immune cells, which engulf invading microbes and kill them to 
protect the host body. This is known as an innate immune process that plays a role in 
human antimicrobial defence mechanisms. The capabilities of some bacteria to 
persist or even grow within these long-lived immune cells provide them with 
protection and evasion from the immune response. 
Figure  5.7 shows the results for twenty strains of Enterobacteriaceae which were 
investigated for their ability to persist in human macrophages after phagocytosis. 
This was performed using the U937 macrophage cell line. The same strains of 
E. coli, Serratia spp. and E. cloacae strains as used with previous cell lines were 
used to infect the U937 macrophage cell line. Strains of C. koseri SMT319 (NTU 48) 
and E. coli K12 (NTU strain 1230) were used as positive and negative controls 
respectively. The same strains of Enterobacteriaceae tested were able to persist in 
macrophages for up to 72 h. 
All bacterial strains were shown to be taken up by the macrophages following the 
initial 45 min incubation. However, different levels were taken up by the 
macrophage after inoculation in the initial 45 min period, and there were between 
2.5 log10 to 4.5 log10 CFU/ml. 
Despite all bacterial strains were taken up by the macrophages following the initial 
45 min incubation, only E. coli strains 780, 904, 923, 939, 1009, 1047, and 1050 
were shown to persist and replicate inside macrophages; Figure  5.7. In contrast, E. 
cloacae strains showed decrease levels of persistence after the initial 45 min period.  
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E. coli strain 1008 and Serratia, strains 952, 1030, and 1036 showed the least 
resistance to macrophage engulfment, and were killed during the initial time 
(45 min). Whereas Serratia strains 971, 805, 942, and 1036 persisted and were 
recovered from macrophages at detectable levels after 48 h.  Strains 939 and 946 of 
Serratia and E. cloacae 1074 did not show any persistence in the macrophages 
after 24 h. 
 Summary of virulence factors for Enterobacteriaceae 5.3.3
When assessing opportunistic pathogen virulence potential, macrophage survival and 
invasion of CaCo-2, rBCEC4 and HBMCE cells are an important consideration. 
Using the data summarised in Table  5.1, twenty strains of Enterobacteriaceae used 
in study can be compared with respect to virulence potential. Their comparison 
showed that strains could be grouped as follow; high, moderate and low in their 
virulence potential. Group 1 high in their potential risk, which includes EcC3 and 
EcC4 of E. coli persisted or replicated in macrophages, showed high attachment and 
invasion of CaCo-2, rBCEC4 and HBMCE cells. These were followed by group 
2 with moderate potential hazards. Group 2 involved E.coli strains 1009, 1047 and 
1050; S. marcescens strains 936 and E. cloacae strains 979 and 1028. Third group of 
strains low in their potential risk such as E. coli 1008, Serratia strains 791, 805, 946, 
952 and 1052 and E. cloacae 1074 and 1027. These strains were differed from group 
1, with respect to lower CaCo-2, rBCEC4 and HBMCE invasion and killed by 
macrophage cells. 
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Figure  5.7 E. coli, Serratia spp. and E. cloacae survival in U937 macrophage cells after 45 min, 24h, 48h and 72h incubation 
C.  koseri 48 and E. coli K12 were used as positive and negative controls, respectively. U= unique. EcC, SC and EbC= cluster group of PFGE. 
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 Table  5.1 Summary of virulence factors for E.  coli, Serratia spp. and E. cloacae 
U = unique, EcC, SC and EbC= cluster group of PFGE, ⸗  = same  
 
Species 
 
Strain 
 
Pulsetype 
Caco-2 
Macrophage response 
rBCEC4 HBMCE  
Potential risk Attachment Invasion Attachment Invasion Attachment Invasion 
E. coli 780 EcC4 Very High High Replicates- Persist Very High Moderate Very High High High 
E. coli 904 EcC3 Very High High Replicates- Persist Very High High Very High High High 
E. coli 923 ⸗  Very High High Replicates- Persist Very High Moderate Very High High High 
E. coli 939 ⸗  Very High High Replicates- Persist Very High High Very High High High 
E. coli 1008 U Very High Not able Killed Very High Not able High Not able Low 
E. coli 1009 EcC2 Very High Moderate Replicates- Persist Very High Not able High High Moderate 
E. coli 1047 EcE1 Very High High Replicates- Persist Very High Not able Very High High Moderate 
E. coli 1050 ⸗  Very High Very High Replicates- Persist Very High Not able Very High High Moderate 
S. marcescens 791 SC2 Very High Not able Persist -Killed High Not able Very High Not able Low 
S. marcescens 805 ⸗  Very High Not able Persist -Killed Very High Not able Very High Not able Low 
S. marcescens 936 SC1 Very High Moderate Persist -Killed Very High High Very High High Moderate 
S. marcescens 942 ⸗  Very High Not able Persist -Killed High Not able Very High Not able Low 
S. marcescens 946 ⸗  Very High Moderate Persist -Killed Very High Not able Very High High Low 
S. marcescens 952 ⸗  Very High Moderate Killed High Not able Very High High Low 
S. liquefaciens 1030 SC3 Very High Not able Killed High Not able Very High High Low 
S. liquefaciens 1036 SC4 Very High Not able Killed High Not able Very High Not able Low 
E. cloacae 979 EbC5 Very High High Persist High Not able Very High High Moderate 
E. cloacae 1027 EbC1 Very High High Persist High Not able High Not able Low 
E. cloacae 1028 U Very High High Persist High Not able High High Moderate 
E. cloacae 1074 EbC3 Very High Not able Persist -Killed High Not able High Not able Low 
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 Giemsa staining 5.3.4
Based on the adhesion to Caco-2 and HEp-2 cells, E. coli, Serratia spp. and 
E. cloacae strains were investigated by staining with Giemsa stain to visualise their 
patterns of adherence. Enterobacteriaceae were distinctly in two patterns: Diffuse 
Adherence (DA), in which attach pattern of strains was dispersed to the whole cell 
surface and aggregative adherence (AA), in which attach pattern were appearance 
strains attach to the cell aggregated and stacked. 
Table  5.2 show the attachment pattern of E. coli Hep-2 cell line and Table  5.3 shows 
adherence patterns of E. coli, Serratia spp. and E. cloacae to Caco-2 cell line. All 
strains of E. coli with the exception of strain 1008 showed aggregative attachment 
(AA), while strain 1008 showed diffuse attachment. These attachment patterns were 
the same with Caco-2 and Hep-2. Two strains of Serratia 952 and 1030 showed 
aggregative attachment (AA), whereas the others showed diffuse attachment (DA). 
An E. cloacae 979 was diffusely attachment (DA). Whereas the other E. cloacae 
strains aggregatively attached (AA) [Appendix  7.4]. 
Table  5.2 Adherence patterns of E. coli to Hep-2 cell line 
Organism Strain Pulsetype Adherence pattern 
E. coli    780 EcC4 AA 
E. coli    904 EcC3 AA 
E. coli    923 EcC3 AA 
E. coli    939 EcC3 AA 
E. coli    1008 U DA 
E. coli    1009 EcC2 AA 
E. coli    1047 CcE1 AA 
E. coli    1050 CcE1 AA 
AA = aggregative adherence, DA = diffuse adherence, U = unique. 
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Table  5.3 Adherence patterns of E. coli, Serratia spp. and E. cloacae to Caco-2 cell 
line 
Organism Strain Pulsetype Adherence pattern 
E. coli    780 EcC4 AA 
E. coli    904 EcC3 AA 
E. coli    923 ⸗  AA 
E. coli    939 ⸗  AA 
E. coli    1008 U DA 
E. coli    1009 EcC2 AA 
E. coli    1047 CcE1 AA 
E. coli    1050 ⸗  AA 
S. marcescens  791 SC2 DA 
S. marcescens  805 ⸗  DA 
S. marcescens  936 SC1 DA 
S. marcescens  942 ⸗  DA 
S. marcescens  946 ⸗  DA 
S. marcescens  952 ⸗  AA 
S. liquefaciens 1030 SC3 AA 
S. liquefaciens 1036 SC4 DA 
E. cloacae  979 EbC5 DA 
E. cloacae 1027 EbC1 AA 
E. cloacae 1028 U AA 
E. cloacae  1074 EbC3 AA 
AA = aggregative adherence, AD = diffuse adherence, U = unique, ⸗  = same 
 Detection of virulence factor genes (VFGs) 5.3.5
Eight strains of E. coli isolates were selected from the 30 E. coli feeding tube isolates 
for virulence factor genes based on their pulsetypes groups and virulence related 
traits. Virulence genotyping of E. coli strains were from the two local hospitals; 
QMC and NCH. The 30 virulence genes investigated, included a range of traits 
including genes encoding for adhesins, invasins, capsule, toxins, siderophores and 
others.  
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The virulence factor genes were detected between 0 to 75% of the strains and their 
incidence differed depending on the strain pulsotype; Figure  5.8. Adhesin genes 
afa/draBC, bmaE, focG, fimH, gafD, papEF, papA, papC, nfaE, sfa/focDE, papG 
allele II, papG I, papG II III, papG allele, sfaS and papG allele I. Figure  5.8 and 
Table  5.4 were present in 37.5%, 50%, 50% and 6.25% of EcC3, U, EcC2 and EcC1 
strains, respectively, while adhesion genes were not found in EcC4. No strains 
carried the invasion gene ibeA therefore either false negative or other mechanisms 
involved in invasion. For capsular genes, kpsMT III, kpsMT II, k1 and k5 were found 
in 75.5%, 50%, 75.5%, 50% and 75% of EcC4, EcC3, unique strain 1008, EcC2 and 
EcC1 strains, respectively. The unique strain (1008) and EcC2 encoded the genes for 
toxins hlyA, cnf1 and cdtB and were present in 66.7% of these pulsotypes whereas no 
toxins genes were detected in other pulsotypes. Additionally, siderophore genes fyuA, 
iutA and pathogenic isolated gene PAI were found in 6.25%, 12.5%, 12.5% and 
18.75% of EcC4, EcC3, unique strain of E. coli 1008 and EcC2 respectively and not 
found in EcC1. The other genes rfc, cvaC and traT occurred in only 6.25% of EcC4, 
EcC3, U and EcC1, while not detected in EcC2. 
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Figure  5.8 Virulence factor genes prevalence in E. coli isolates from feeding tube of two local hospitals in Nottingham 
U = unique. EcC, SC and EbC = cluster group of Pulsed Field Gel Electrophoresis and STs = sequence typing. 
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Table  5.4 Distribution virulence factors among of E. coli isolates selected based on pulsotype 
  Adhesions Invasion Capsule Toxins Siderophores Others 
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780 EcC4 394 - - - - - - - - - - - - - - - - - + + - + - - - + - - - - + 
904 EcC3 95 - - - + - + + + - - + + - - - - - - + + - - - - + - + - - + 
923 ⸗  ⸗  - - - + - + + + - - + + - - - - - - + + - - - - + - + - - + 
939 ⸗  ⸗  - - - + - + + + - - + + - - - - - - + + - - - - + - + - - + 
1008 U 127 - - - + - + + + - + - + - + + - - + + - + + + - + - + - - + 
1009 EcC2 73 - - + + - + + + - + - + - + - - - - + - + + + - + + + - - - 
1047 EcC1 2076 - - - + - - - - - - - - - - - - - + + - + - - - - - - - - + 
1050 ⸗  ⸗  - - - + - - - - - - - - - - - - - + + - + - - - - - - - - + 
U = unique,  EcC, SC and EbC = cluster group of Pulsed Field Gel Electrophoresis and STs = sequence typing, ⸗  = same 
 154 
 
 Discussion  5.4
The ability of different strains of Enterobacteriaceae to cause different clinical 
diseases are attributable to one or more virulence factors such as, attachment, 
invasion and survival with mammalian cells (Wilson et al., 2002; Miller, 1995). The 
genera of E. coli (most common), Enterobacter, Serratia, and other 
Enterobacteriaceae are opportunistic pathogens responsible for a wide range of 
infections. Many of these genera are members of the normal intestinal flora 
(Baron and Guentzel, 1996; Logue et al., 2012). 
This part of the study assessed the potential virulence of strains from neonatal enteral 
feeding tubes and whether they pose an infection risk to cause neonates was 
investigated. Twenty Enterobacteriaceae composed of E. coli, Serratia spp. and 
E. cloacae, isolated from feeding tubes were chosen that represented species from 
the major genera isolated. The virulence potential of these 20 strains to mammalian 
cells was assessed using attachment and invasion studies of Caco-2, rBCEC4 and 
HBMEC tissue culture cells. Macrophage survival was studied using the U937 cell 
line of human monocyte cells.  
The ability of E. coli, Serratia spp. and E. cloacae to attachment and invade Caco2, 
HBMCE and rBCEC4 mammalian cell lines are shown in Figure  5.1 - Figure  5.6. All 
strains were able to attach to epithelial and endothelial cell lines. The viable counts 
showed that Enterobacteriaceae strains were able to attach to Caco2, HBMCE and 
rBCEC4 cells. The viable counts showed that Enterobacteriaceae strains were able 
to attach to Caco2 cells, whereas E. cloacae strains were at relatively low numbers 
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compared to E. coli, Serratia Figure  5.1, Figure  5.3 and Figure  5.5. However all 
strains were able to attach to epithelia and endothelial cell line. Attachment to host 
cells may be a key of causes infection, where this step of interaction of pathogen to 
host surfaces, then microbes able by specific biochemical developments to result in 
disease including outbreak, toxin secretion, host cell invasion (Wilson et al., 2002).  
Following attachment to the host surface, some bacterial pathogens are able to invade 
mammalian cells. It is believed that bacterial infection is the ability of microbes to 
invade host epithelial and endothelial cells (Townsend et al., 2008). Certainly, the 
capability for invasion of epithelial cells and brain endothelial cells is a concern 
(Kim, 2002), especially if E. coli, Serratia spp. and E. cloacae are found to colonise 
enteral feeding tubes. Consequently, their virulence potential was investigated to 
better understand the pathogenic potential of E. coli, Serratia and E. cloacae. 
Comparable invasion values had obtained using Caco-2, HBMCE and rBCEC4 
culture cells. The gentamicin protection assay demonstrated differing capacity of 
E. coli, Serratia spp. and E. cloacae to invade the intestinal epithelium (Caco-2). In 
detail, E. coli, and E. cloacae were more able to invade the intestinal epithelium than 
S. marcescens. Additionally, S. liquifaciens was not able to invade the intestinal 
epithelium Caco-2 and brain endothelial HBMCE and rBCEC4; Figure  5.2, 
Figure  5.4 and Figure  5.6.  Further invasion studies investigated the potential of E. 
coli, Serratia and E. cloacae to invade the HBMCE and rBCEC4. This investigation 
suggests that E. coli showed more ability to invade HBMCE than S. marcescens and 
E. cloacae. As for rBCEC4, just four strains of E. coli pulsetypes EcC4, EcC3, and 
one of S. marcescens 936 showed the ability to invade rBCEC4 while others were 
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not able to invade; Figure  5.4 and Figure  5.6. This tendency was also observed in 
macrophage persistence experiments, which showed that the E. coli strains, except 
strain 1008, were capable of persistence and replicate within human macrophages, 
whereas E. cloacae strains only persisted at lower levels within the macrophages 
after 24 h. S. marcescens persisted at lower levels within the macrophages up to 48 
then were killed. Whereas E. coli 1008 and S. liquefaciens were killed by 
macrophages, furthermore they were not able to invade the epithelial cells and brain 
endothelial cells. 
Each assay determined the presence of virulence factors of selected strains, and 
demonstrated which virulence traits might be used by individual strains during 
infection. In addition when assessing opportunistic pathogen virulence potential of 
strains, to survive and replicate within epithelial, endothelial or macrophages cells 
are an important consideration. So according to summary of Table  5.1 E. coli 1008, 
S. marcescens, S. liquefaciens and E. cloacae 1074 isolated from an enteral feeding 
tube are not recognized as pathogens, this may be due in part to an inability to invade 
cells and showing less level to persist in human macrophage cells. Extra-intestinal 
pathogenic E. coli are commonly implicated in neonatal meningitis, urinary tract 
infections and septicemia in humans. Therefore, the ability of E. coli to invade the 
epithelial cells, persist and replicate in human macrophage cells and brain endothelial 
cells, and it is isolated from neonatal enteral feeding tubes at NICU may be a cause 
for concern. 
Selected strains of E. coli, Serratia spp. and E. cloacae exhibited two characteristic 
adherence patterns diffuse adherence (DA) and aggregative adherence (AA), which 
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could be distinguished. Furthermore, in a number of strains a mixture of those two 
patterns could be observed. In several studies, strains of opportunistic pathogens such 
as entero-pathogenic E. coli has been categorised based on their adherence pattern to 
tissue culture cells: aggregative patterns, diffuse adhesion and localized (Janda and 
Abbott, 2006; Rüttler et al., 2006).  
The results of the study showed that E. coli strains exhibited aggregative adhesion in 
both of cell line Caco-2 and Hep-2; except E. coli strain 1008 which showed was 
diffuse adhesion Table  5.2 and Table  5.3. In addition, E. cloacae strains exhibited 
aggregative adhesion except E. cloacae strain 979, which showed a diffuse pattern. 
While most strains of Serratia spp. showed diffuse adhesion, two strains had 
aggregative adhesion. These results indicate there could be a relationship between 
the adhesion patterns and invasion the epithelial cells, persist and replicate in human 
macrophage cells and brain endothelial cells, for example strains of E. coli that 
showed aggregative adhesion, invaded endothelial cells and persist and replicated in 
macrophages, in contrast to E. coli strain 1008. The aggregative, diffuse and 
localized pattern of adhesion were previously recognized in Klebsiella, Enterobacter, 
and Serratia strains associated with neonatal colitis and was found to be most 
prevalent phenotype in nosocomial strains (Livrelli et al., 1996). Nevertheless, for 
other bacteria such as E. coli, the association of adhesion patterns with different 
clinical cases is still contentious (Levine et al., 1988; Gomes et al., 1989). Although 
E. coli strains with localized adherence have been recognized enteric pathogens in 
several parts of the world, while the role of diffuse and aggregative adherence 
patterns are still unclear (Gomes et al., 1989).  
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A major focus in bacterial pathogenesis in recent years is the identification and 
characterization of the molecular virulence factors of genes that allow pathogens to 
cause infection in the hospital (Wilson et al., 2002). The capability of E. coli to cause 
diverse clinical infection is attributable to the cumulative impact of one or several 
virulence factors traits or virulence factor genes carried by these strains (Gibreel, 
2011). For example, the carriage of genes for the K1 capsule contributes avoidance 
of neonatal host immunity (Johnson, 1991). Previous study reported that carriage of 
hly operon and the sfa / foc operon were often harboured by group B2 of E. coli 
meningitis strains (Bingen et al., 1998). 
In this study, the prevalence of virulence factors was investigated. With regard to 
VFGs possession, it was found that fimH, papEF, papA, papC, papG1, fyuA, kpsMT 
II, traT and PAI were present in high levels across the most strains. Figure  5.8 and 
Table  5.4. For individual VFGs profile, ST95 strains harboured the K1 capsular 
antigen, papG allele II adhesions gene and type 1 ﬁmbriae FimH adhesions gene. 
However, the K1 capsule is compatible an essential meningeal virulence determinant 
and strongly linked it to neonatal meningitis E. coli strains and pathogenicity 
(Saukkonen et al., 1988; Peigne et al., 2009). This study shows that ST73 and ST127 
of E. coli were not possessed the K1 capsular antigen, papG allele II adhesions gene 
and type 1 ﬁmbriae FimH adhesions gene. Those STs were show Low levels of 
invasion of epithelial cells, persist and replicate in human macrophage cells and brain 
endothelial cells. This could suggest that the key to ST95 elevated virulence potential 
cannot be attributed to specific VFGs set or increased carriage of VFGs in general. 
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 General discussion 6.1
Neonates are at high risk of nosocomial infection in neonatal intensive care units 
(NICUs). Nosocomial infections are a most important problem in neonatal intensive 
care units (NICUs), and the estimated rates of infection at NICUs can be 10 – 20%; 
these are higher than in most paediatric and many adult wards. In addition, many 
outbreaks at NICUs have been reported (McGuire et al., 2004; Vergnano et al., 2005; 
Brady, 2005; Phillips et al., 2008). Nosocomial infection via Enterobacteriaceae is 
commonly caused by commensal bacterial strains that already colonise the infants 
(Al muneef et al., 2001). Klebsiella spp., E. coli, Serratia spp., and Enterobacter spp. 
are opportunistic pathogens that colonize the gut and sometimes causes invasive, 
meningitis, pneumonia and are responsible for considerable morbidity and mortality 
(Friedland et al., 2003; Adamson et al., 2012). Hurrell et al. (2009a) found that the 
neonatal enteral feeding tubes act as loci for in the attachment and colonisation by 
numerous opportunistic pathogens within the Enterobacteriaceae family. 
Subsequently, these organisms will enter the stomach as a bolus with each feed. So, 
enteral feeding tubes are an important risk factor with respective of neonatal 
infections. 
Molecular subtyping methods are an important tool in determining a common source 
of infection causing nosocomial outbreaks or potential cross vertical transmission or 
horizontal transmission events and sources of infection (Adamsson et al., 2000; 
Almuneef et al., 2001). Molecular typing techniques such PFGE are commonly used 
in outbreak investigations. In this study, PFGE was used to track the spread of 
Enterobacteriaceae in two NICUs with the absence of an outbreak.  
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For improve health care and avoid outbreaks and nosocomial infections there are 
debates how to investigate avoided infection by microbes. Where a previous study 
suggested that directed investigation of outbreaks and nosocomial infections rather 
than study colonization and environments microbes (White et al., 1981). While 
others, considering that studying the colonisation by microbes is a more important 
for avoided infection (Goldmann, 1988). In this study a collection of two-hundred 
and twenty-four Enterobacteriaceae strains isolated from the lumen and the inner 
wall as biofilm of neonatal enteral feeding tubes of 2 NICUs in Nottingham UK were 
investigated. Tubes received from infants that were 'nil by mouth'. In addition, the 
neonates were fed by diversity of feeds including breast milk and sterile feed formula 
Table  1.2 and for more information see Appendix  7.8. These are described as 
receiving a 'mixed feeding regime'. The enteral feeding tubes were in place between 
< 6 h to > 48 h and the neonates was received fresh fed of milk at every 2 - 3 h. The 
ages of the neonates were from 1 week, to 4 weeks.  
Later additional collections of thirty-eight strains of E. coli from Jordan were 
obtained for preliminary profiling. Unfortunately, because of the long time between 
the collection and this study, less information is currently available on the clinical 
details. This could be useful for detecting reservoirs of potentially pathogenic 
microbes. Consequently that can be leading to increased exposure and risk to the 
neonates at NICUs. 
This study shows that over the period from January to November 2007, neonatal 
enteral feeding tubes were contaminated by twenty-nine pulsetypes of 
Enterobacteriaceae. Which was distribute as follow four, four, eight and thirteen 
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pulsetypes of E. coli, Serratia spp., Enterobacter spp. and Klebsiella spp. for which 
no sources were identified. These has been established by others and is considered to 
be the most infants were colonized with Enterobacteriaceae, primarily E. coli, 
Klebsiella, Enterobacter, Serratia and Citrobacter spp. (Adamson et al., 2012; 
Almuneef et al., 2001; Goldmann, 1988; Tullus et al., 1988; Parm et al., 2011). 
Although multiple Enterobacteriaceae pulsetypes were isolated, this study 
demonstrated that the presence of the prevalent strains. The indistinguishable; 
pulsetypes of E. coli and Serratia spp. were less diverse than the other species. This 
indicates a narrower range of strains were colonising the enteral feeding tubes. For 
example, pulsetype group EcC3 of E. coli comprised 19 strains, isolated during the 
two-week period from 26 April to 9 May and isolated from eleven patients. 
Similarly, for two large pulsetype groups SC1 and SC2 of S. marcescens, each group 
had including 34 and 19 strains and was isolated over a prolonged period for one 
month and four months, respectively. In addition may be provided cross-transmission 
clone was recovered from different patients for long periods. Our findings in this 
study indicate that indistinguishable clone of EcC3 strain of E. coli was colonising 
feeding tube from 11 different patients. Where those patients were fed by different 
kind of milk Table  3.1 and for more information see [Appendix  7.8]. So that 
indicates the contamination not from the milk, may possibly originated from the 
same sources, especially for substances such as environment or carer. In addition this 
study indicated that E. coli could be more of a prevalent and cross-transmission 
clone, whereas the later collection of E. coli strains from Jordan were shown large 
pulsetype group EC2 comprised 33 strains out of 38 strains; Figure  3.5. In contrast, 
the Enterobacter spp. and Klebsiella spp. showed a large diversity of PFGE profiles 
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(Figure  3.3 and Figure  3.4), reflecting a wider range of strains was isolated from the 
enteral feeding tubes. This diversity in PFGE profiles indicates the contamination of 
feeding tubes could be from different sources. 
An important finding in this investigation was the same pulsetypes spread among 
enteral feeding tubes of infants in the same NICUs. The result of specific strains 
belonged to same pulsetypes EcC3 and EcC2 of E. coli and SC1 and SC2 of 
S. marcescens associated with enteral feeding tubes or NICUs could be there is no 
doubt that there was a common source of contamination, such as the feed or carers 
(i.e. nurse). Enterobacteriaceae was isolated from PIF include E. cloacae, 
K. pneumoniae, K. oxytoca, E. hormaechei, and E. coli (Muytjens et al., 1988). The 
FAO/WHO, (2004 and 2006) considered these organisms as 'causality plausible, but 
not yet demonstrated' with respect to their potential source to cause neonatal 
infection via ingestion of reconstituted PIF. 
On the other hand, it was clear that certain strains of pulsetypes EcC3 and EcC2 of 
E. coli and SC1 and SC2 of S. marcescens were isolated from different patients and 
isolated over a prolonged period in which medical care could be provided by a single 
medical team. Transmission of Enterobacteriaceae is commonly from patient to 
patient by way of the hands of the health care team (Brady, 2005). Previous study 
indicated that a potentially higher probability of cross-transmission with certain 
Gram-negative such as S. marcescens by the hands of the health care team 
(Waters et al., 2004).  
Eight strains of E. coli, from two NICUs in Nottingham, UK, representing the 
various pulsetypes were selected for MLST analysis. As shown in clear 
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discrimination between the eight strains of E. coli ST2076, ST73, ST95, ST394 and 
ST127. According to UCC database, these STs belonged to the E. coli pathogenic 
group B2, extraintestinal pathogenic E. coli (ExPEC). Based on the type of infection 
ExPEC were subtypes into: uropathogenic E. coli (UPEC); neonatal meningitis 
associated E. coli (NMEC) and sepsis-associated E. coli (Köhler and Dobrindt, 
2011). In this study MLST profile were confirmed the result of PFGE, where 
STs group strains of E. coli isolated showed as well as similar PFGE patterns, which 
suggest that these isolates could be related. For example E. coli strains 904, 923 and 
939 were indistinguishable by their PFGE profiles as well as being the same ST. 
E. coli ST95 was isolated over a two week period from three neonates, and therefore 
of concern due to the continued exposure. The study by Manges et al. (2008) 
indicated that E. coli members isolated from both study locations showed similar 
PFGE patterns and MLST patterns, which indicated that, they are likely related. 
Reviewing the MLST database at the ERI, University College Cork 
(http://mlst.ucc.ie/mlst/dbs/Ecoli/GetTableInfo_html) revealed that the prevalence 
ST95 in this study has been associated with various infections, including meningitis, 
diarrhoea, septicaemia and invasion. According to Achtman database three strains 
out of 146 strains of E. coli ST95 had caused meningitis. These strains were 
reference numbers ISUNMEC48, ISUNMEC36 and ISUNMEC; two were from 
Europe and one North America respectively. The study by Gibreel et al., (2012) 
found that uropathogenic E. coli strains UTI89, NU14 and RS218 were causes of 
neonatal meningitis. These strains were also ST95. Additionally more information 
from database shows that there are 34 strains out of 146 also ST95 which caused 
septicaemia.  
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Following subgroup Enterobacteriaceae collection, data generated in this study 
using 20 isolates were chosen for the represented pulsetype group. These strains 
included eight strains of E. coli, six strains of S. marcescens, two strains of 
S. liquefaciens and four strains of E. cloacae. 
The work included in this thesis, focuses on studying biofilm formation and 
composition, which related factors with relevance for enteral feeding tubes. E. coli, 
S. marcescens, S. liquifaciens and E. cloacae, were abundant bacteria in the enteral 
feeding tubes biofilm. It was previously known that opportunistic pathogens within 
the Enterobacteriaceae family are known to be able to attach, multiply and colonize 
nasogastric enteral feeding tubes (Hurrell et al., 2009a). In NICUs, low birth weight 
infants are fed via enteral feeding tubes, and these may be left in-place over 
prolonged periods (> 24 h). Consequently, this will enhance bacterial attachment and 
multiplication as biofilm (Hurrell et al., 2009b). As shown in this study 
Enterobacteriaceae, such as E. coli, S. marcescens, S. liquifaciens and E. cloacae are 
able to form biofilm. The biofilm detected by crystal violet staining allows 
quantifying the production of biofilm and comparing different strains or different 
conditions (Stepanović et al., 2004). Average OD of producing biofilm by 20 
Enterobacteriaceae strains was 1.35 AU; Figure  4.1 and Figure  4.2. 
In a NICU the tubes will be between ambient body temperature, and receive fresh 
nutrients from the infant feed at every 2 – 3 h, which may have an additional affected 
formation as well as biofilm is temperature. In this study the effect of temperature 
was evident an in biofilm formation. This was significantly higher (p < 0.05) at 37ºC 
for all strains compared 25ºC. According to Else et al. (2003) temperature may also 
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affect the production of extracellular polymeric substances, which is known to 
increase the biofilm formation of bacteria. Another factor which may have an effect 
on biofilm formation is the type of formulas. The results show that formula 
composition may effect of biofilm production, where all pulsetypes group of E. coli 
and SC2 of S. marcescens were shown form value of biofilm with casein-based more 
than whey-based formula, for example strains 939 and 1047 grown in whey-based 
formula showed absorbance units approximately 0.57 (AU) while biofilm formation 
in casein-based formula was about 1.5 (AU); Figure  4.1.   
In addition the study has shown a variation range in motility between strains 
belonged to same pulsetypes. For example strains 939 and 942 of S. marcescens, 
belong to pulsetype SC1 were one non-motile and the other swarm diameter 
of ~ 30 mm respectively; Figure  4.3. So, further analyses are necessary in order to 
confirm the isolates are related or not by used another restriction enzyme then those 
strains could be confirmed as the same or not. According to the results shown in 
Figure  4.1 and Figure  4.3 there was no relationship between motility and biofilm 
formation. Previous studies of E. coli and Salmonella reported that motility was not 
required for initial attachment and biofilm formation (Pratt and Kolter, 1998; 
Prigent-Combaret et al., 2000).  
As the biofilm ages the Enterobacteriaceae become detached and break off as 
clumps. These detached cells with fresh feed, will subsequently enter the neonate 
stomach. The ingestion of microbes during feeding will expose them to acidity stress 
in the stomach. Although the pH of stomach is ~ 2.5, which kills the common of 
swallowed bacteria, however this is not true for the neonate. While the infants‘ 
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stomach pH of the infant fed milk formula is remaining ~ 3.5 to 4.3 during the 
feeding regimes (Hurrell et al., 2009a). In this study the selected strains were 
screened for pH 3 tolerance to mimic infant's stomach pH of the infant fed milk 
formula. E. coli strains, Serratia spp. and E. cloacae strains showed persistence at 
pH 3 for up to 2 h; Figure  4.4 to Figure  4.6. The protection of these strains from the 
low pH acidity could be because of the detached cells being in clumps. In addition, 
the persistence of strains in low pH may be because of their ability to form a biofilm 
inside the feeding tube. A previous study of acid tolerance by biofilm cells of 
Streptococcus (McNeill and Hamilton, 2006) showed the cells in the biofilm are 
highly resistant to low pH. The survival of these strains at low acid may increase the 
risk of exposure bacterial pathogens in neonates. Furthermore, capsule formation 
may have role in protecting strains from the low pH.  
In this study the production of capsule was investigated for E. coli, S. marcescens, 
S. liquifaciens and E. cloacae. All strains were showed different capsule 
morphology; Table  4.1. There was no correlation between capsule formation and 
biofilm on milk agar for 20 strains studied. For example, S. marcescens 791 and 805 
produce more capsules, nevertheless those strains produced less biofilm. E. coli 
pulsotype EcC3 produced more biofilm than the most capsulated S. marcescens 
strains 791 and 805. Capsules may have a role in resistance to desiccation, serum 
activity and contribute survival of the organism after uptake by phagocyte cells 
(Guerry and Szymanski, 2008). The reason for the difference is incretion between 
microbes and cell surface structure. Also it may be linked to attachment factors such 
as curli fimbriae and cellulose production. The role of curli fimbriae in adherence 
and invasion has been described in members of Enterobacteriaceae (Olsén et al., 
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1993; Römling et al., 1998; Zogaj et al., 2003; Boudeau et al., 2001; Lee et al., 
2011).  
Through this study the morphotypes are shown in Table  4.2. All isolates belonging to 
the dominant morphotypes produced pink colony on Congo red agar formation, so 
that indicates that strains are producing cellulose, with exception strain 1028 of 
E. cloacae which expressed red colony which mean showing the expression of curli 
fimbriae Bokranz et al. (2005). The author also reported the capability of E. coli 
which formed biofilms and correlated with expression fimbriae and cellulose. In E. 
coli and Salmonella, cellulose is one of the major components of the biofilm matrix 
(Da Re and Ghigo, 2006). 
This study demonstrates that 20 strains of E. coli, Serratia spp. and E. cloacae are 
able to form bioﬁlms. In addition the strains surviving in low acidity produce 
capsules and express cellulose. These factors is associated with these organisms 
could be constitute a risk factor to neonatal health.  
Survival strains of E. coli, S. marcescens, S. liquifaciens and E. cloacae up to 2h in 
the neonate‘s stomach due to protection from the low acidity. This will enhance cells 
to pass through from neonate‘s stomach to the neonate's intestine. These could result 
to increased risk subsequently greater potential to colonise and infect the neonate via 
toxins productions by bacteria such as α-haemolysis, which may damage the host cell 
membrane or invasion cell line. Alpha-haemolytic activity was detected in E. coli, 
S. marcescens, S. liquifaciens and E. cloacae, except E. coli 1008 which was 
ß-haemolytic; Table  4.3. The α- haemolysin is an important virulence factor 
generally expressed by extraintestinal pathogenic E. coli (Balsalobre et al., 2006). 
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This part of the study assessed the potential virulence of 20 strains composed of 
E. coli, Serratia spp. and E. cloacae strains from neonatal enteral feeding tubes and 
whether they pose an infection risk to cause neonates. The virulence potential was 
assessed using standard using attachment and invasion studies of Caco-2, rBCEC4 
and HBMEC tissue culture cells. Macrophage survival was studied using the U937 
cell line of human monocyte cells. The ability of organisms to attachment, invasion 
and survival within mammalian cells, that would be cause different clinical diseases 
and in some cases, may be responsible for considerable morbidity and mortality at 
NICU (Wilson et al., 2002; Miller, 1995). 
Comparable attachment and invasion values were obtained using Caco2, HBMCE 
and rBCEC4 mammalian cell lines and are shown in Figure  5.1- Figure  5.6. All 
strains were able to attach to epithelial and endothelial cell lines. This demonstrated 
that CaCo-2, HBMCE and rBCEC4 cells did not lack attachment factors required for 
E. coli, Serratia species and E. cloacae strains that may support the robustness of the 
epithelial cell invasion assay. The viable counts showed that Enterobacteriaceae 
strains were able to attach to Caco2, HBMCE and rBCEC4 cells. The viable counts 
showed that Enterobacteriaceae strains were able to attach to Caco2 cells, whereas 
E. cloacae strains were at relatively low numbers compared to E. coli, and 
Serratia spp.; Figure  5.1, Figure  5.3 and Figure  5.5. However all strains were able to 
attach to epithelia and endothelial cell line. Attachment to host cells may be a key of 
causes infection, where this step of interaction of pathogen to host surfaces, then 
microbes able by specific biochemical developments to result in disease including 
toxin secretion and host cell invasion (Wilson et al., 2002).  
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Following attachment to the host surface, some bacterial pathogens are able to invade 
mammalian cells. The gentamicin protection assay demonstrated differing capacity 
of E. coli, Serratia spp. and E. cloacae to invade the intestinal epithelium Caco-2. It 
was noted that E. coli and E. cloacae showed higher attachment and invasion values 
of Caco-2 than S. marcescens; Figure  5.2. This investigation detected that E. coli 
pulsetypes EcC4, EcC3 showed more ability to invade HBMCE than S. marcescens 
and E. cloacae. As for rBCEC4, just four strains of E. coli pulsetypes EcC4, EcC3, 
and one of S. marcescens 936 showed the ability to invade rBCEC4, while others 
were not able to invade; Figure  5.4 and Figure  5.6. 
When assessing bacterial strains for virulence potential, macrophage survival is an 
important consideration in Figure  5.7. For example all pulsetypes groups of E. coli, 
EcC1, EcC2, EcC3 and EcC4 (except strain 1008), persisted and replicated within 
human macrophages. E. cloacae strains only persisted at lower levels within the 
macrophages after 24 h. S. marcescens were persisted at lower levels within the 
macrophages up to 48 than were killed. Whereas E. coli 1008 and S. liquefaciens 
were killed by macrophages, furthermore they were not able to invade the epithelial 
cells and brain endothelial cells. In this work there was not relationship between 
sensitivity of E. coli, Serratia species and E. cloacae strains to oxygen radicals and 
persistence of these strains within macrophages.  
Using the details summarised in Table  5.1 the five pulsetypes groups of E. coli EC4, 
EC3, EC2, CE1 and U; four pulsetypes Serratia species SC2, SC1, SC3, SC4 and 
four pulsetypes E. cloacae EbC5, EbC1, U, EbC3 can be compared with respect to 
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virulence potential. Such comparison confirms that the four pulsetypes groups of 
Enterobacteriaceae vary in their virulence potential, which was distributed as follow:  
 Cluster 1 organisms considered high potential risk EcC3 and EcC4 of E. coli 
showed high attachment and invasion of Caco-2, HBMCE and rBCEC4 cells 
persisted and replicated in macrophages.  
 Cluster 2 organisms considered moderate potential risk EcC1and EcC2 of 
E. coli, EbC5 and strains 936 and 1028 of S. marcescens with respect ability 
Caco-2 and HBMCE attachment and invasion and persist up to 48 then killed 
in macrophages.  
 Cluster 3 organisms considered low potential risk all other pulsetypes were 
killed by macrophage cells and not able to invade Caco-2, HBMCE and 
rBCEC4.  
Therefore, the ability of E. coli to invade the epithelial cells, persist and replicate in 
human macrophage cells and brain endothelial cells, and it is isolation from neonatal 
enteral feeding tubes at NICU may be a cause for concern. It is believed to be that 
bacterial infection would be capable of invasion of host epithelial and endothelial 
cells (Townsend et al., 2008). Certainly, the capability for invasion of epithelial cells 
and brain endothelial cells is a concern (Kim, 2002). 
The ability of E. coli strains to invade to mammalian cell lines could be linked with 
adherence patterns. Strains showing aggregative adhesion pattern showed high 
invasion rates. For example, results in this study showed that E. coli collations, EcC3 
and EcC4 strains exhibited with Caco-2 and Hep-2 aggregative adhesion Table  5.2 
and Table  5.3. Those pulsetypes showed high invasion. E. coli strain 1008 of E. coli 
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showed diffuse adhesion and was not able to invade to Caco-2, HBMCE or rBCEC4. 
In addition, E. cloacae strains exhibited aggregative adhesion except E. cloacae 
strain 979, showed a diffuse pattern and were more invasive. Whereas most of strains 
Serratia spp., showed diffuse adhesion and shows lees invasive. E. coli strains with 
localized adherence have been recognized enteric pathogens in several parts of the 
world (Gomes et al., 1989).  
This study was aimed at investigating the prevalence of virulence factor genes of 
E. coli. The ability of different strains of E. coli to cause nosocomial infections in 
NICUs could be attributed to virulence factors harboured by these strains. For 
example K1 capsule is compatible an essential meningeal virulence determinant and 
strongly linked it to neonatal meningitis E. coli strains and pathogenicity (Saukkonen 
et al., 1988; Peigne et al., 2009). A carriage gene of K1 capsule allows evasion of 
neonatal host humoral immunity (Johnson, 1991). Kim et al. (2003) investigated the 
ability of E. coli K1 to invade human brain microvascular endothelial cells HBMEC, 
although it remains unclear how E. coli K1 crosses HBMEC. Khan et al. (2007) 
demonstrated that type 1 fimbriae, specifically FimH attached to brain endothelial 
cells and also triggers signalling events that promote E. coli K1 to invade in 
HBMEC. Type 1 ﬁmbriae, speciﬁcally FimH adhesion, which   was harboured by 
our strains of Table  5.4; is not only an adhesive organelle that provides bacteria with 
a foothold on brain endothelial cells but also triggers signalling events that promote 
E. coli K1 invasion in HBMEC (Khan et al., 2007) . Furthermore, E. coli K1 binding 
to and invasion of HBMEC. Taken together, these ﬁndings indicate that FimH 
induces host cell signalling cascades that are involved in E. coli K1 invasion of 
HBMEC and CD48 is a putative HBMEC receptor for FimH. With regard to VFGs 
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possession, it was found that K1 capsular, papG allele II adhesions gene and type 1 
ﬁmbriae FimH adhesions gene were harboured by ST95 isolates Table  4.6. This 
group shows more invasions to Caco-2, HBMCE and rBCEC4 and in addition were 
persist and replicate in human macrophage cells Table  5.1. ST95 belonged to 
pulsetype group EcC3 of E. coli which comprised 19 strains, and shows more the 
prevalence of period and between 11 patients.  
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 Conclusion 7.1
Finally, the first part of the this study considered possible reasons why certain 
Enterobacteriaceae are more frequently associated with enteral feeding tubes and 
possible links with neonatal infections at NICUs and determining a common source 
of infection, based on DNA fingerprinting via PFGE. The conclusions of this part 
can be summarised as follows: 
  The findings some strains were genotypecally related or differing by 
restriction fragments belonged to different PFGE groups.   
 Genotyping using PFGE would be an appropriate strategy for studying 
relationship between isolates e.g. for enteral feeding tubes pathogens.  
 An important finding in this investigation was the same pulsetypes were 
spread across enteral feeding tubes of different infants in the same NICUs. A 
consistent profile of E. coli EcC3 and S. marcescens SC1, SC2 repeatedly 
appeared in patients were over an extended time period. 
 All pulsetype EcC3 strains were ST95. 
 E. coli strains studied (n= 30) belonged to the pathogenic group B2, 
extraintestinal pathogenic E. coli (ExPEC).  
The second part of the study focused on comparative physiological and virulence 
related tests of 20 strains E. coli, Serratia spp. and E. cloacae.  
 Incubation temperature affected biofilm formation on plastic materials by 
E. coli, Serratia spp. and E. cloacae. 
 Type of formula has an influence on biofilm formation by E. coli. 
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 Strains belonging to the same pulsetype, differed in their motility one non 
motile and the other motile. It would be of use to use another restriction 
enzyme to confirm these as indistinguishable strains or otherwise. 
 Strains in this study were able to survive at low acidity (pH 3) for up to 2h 
and may increase the risk of exposure to bacterial pathogens by neonates. 
 The detected of haemolytic activity (α and β) by most of strains in study 
could indicate an increased risk to neonates. 
The third part of the study concentrated on virulence traits which are relevant to an 
enteroinvasive bacterial pathogen.   
 All strains used in study were able to attach to Caco-2, rBCEC4 and 
HBMCE cell line. 
 Many stains were able to invade human intestinal epithelial cells Caco-2 
and brain endothelial cells HBMCE and rBCEC4. These can be used to 
find mechanisms of invasion and spreading in the infected host. 
 The average invasion rate of the E. coli strains was greater than Serratia 
spp. and E. cloacae. 
 Most of the E. coli strains show macrophage survival values whereas 
strains of Serratia spp. and E. cloacae not persist after 24 hours.  
 This study revealed that strains showing the aggregative adhesion pattern 
also showed more invasions. 
 In this study found K1 capsular gene was only harboured by E. coli ST95 
strains, which considered high potential risk, also showing high 
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attachment and invasion of Caco-2, HBMCE and rBCEC4 cells. In 
addition were show persisted and replicated within macrophages. 
 Future work 7.2
 Visualisation of bacterial adherence patterns and engulfment by Caco-2 
intestinal cells using GFP labelled bacterial cells.  
 Rearrangement of host cell cytoskeleton on exposure to bacterial cells. 
Any re-arrangement will be visualised using fluorescent microscopy 
using such anti-actin antibody labelled with dyes. 
 Measuring pro-inflammatory and anti-inflammatory cytokines, and 
NF-KB production by host cells on bacterial exposure. Caco-2 colonic 
cells invasion, inflammation of the human and rat brain endothelial cells 
will be determined to demonstrate the cause of meningitis. 
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Appendix 
 
Appendix  7.1 approximate band sizes in Kbp of the Salmonella, restricted with XbaI 
and run under the PulseNet standardized electrophoresis conditions. 
 
Appendix  7.2 100 bp PCR sizer ladder run at 90v. 
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Appendix  7.3 Agarose gel showing polymerase chain reaction (PCR) products from 
multiplex virulence factor 
primer pools 1–5. M, 100 bp PCR sizer ladder; + = positive control; - = negative control.  
Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to 
phylogeny and host compromise (JOHNSON, 2000). 
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A  
B   
C   
Appendix  7.4 Adherence patterns (A) control, (b) Aggregative Adherence (AA) and 
(c) Diffuse adherence (DA) 
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Appendix  7.5 Initial inoculum of E. coli, Serratia spp., E. cloacae, positive control and negative control to CaCo-2 cells  
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Appendix  7.6 Initial inoculum of E. coli, Serratia spp., E. cloacae, positive control and negative control to rBCEC4 cells  
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Appendix  7.7 Initial inoculum of E. coli, Serratia spp., E. cloacae, positive control and negative control to HBMCE cells  
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Species Pulsetype cluster Strain number 
Location 
recovered from 
NGT 
Source Date of isolation Neonate Feeding source Duration (h) Age (wk) 
Frequency of 
feeding 
  
  
  
  
  
  
  
  
  
E. coli 
  
  
  
  
  
  
  
  
  
  
  
  
EcC4 
780 
Biofilm 
NCH 
16/01/2007 4 BM 18-24 >4 Every 2h 
796 30/01/2007 17 BM, PIF 6-12 >4 Every 2h 
786 17/02/2007 37 BMF,PIF, Th 18-24 >4 Every 3h 
EcC3  K1 
904 
NCH 
24/04/2007 55 BM,IF 24-48 3-4 Every 3h  
905 Lumen 
926 Biofilm 
01/05/2007 
61 BMF, RTF 6-12 >4 Cont. 
927 Lumen 
929 Biofilm 
62 PIF >48 >4 Cont. 
933 Lumen 
934 
Biofilm 
63 RTF 18-24 3-4 Every 3h 
910 
03/05/2007 
64 BMF, RTF >48 1-2 Every 2h 
912 Lumen 
913 Biofilm 
65 RTF 24-28 >4 
Cont 
  917 Lumen 
923 Biofilm 
08/05/2007  
67 BMF 12-18 1-2 
Every 2h 
  924 
Lumen 
937 68 BMF, RTF 18-24 3-4 Every 2h 
939 
Biofilm 
69 BMF <6 1-2 Every 2h 
943 
70 RTF, Th 24-48 >4 Every 2h  
944 
Lumen 
947 
71 PIF, Th  <6h >4 Every 4h  
949 Biofilm 
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E. coli 
U 1008 Lumen NCH 06/06/2007 99 BMF, RTF, Th >48 2-3 Every 3h 
EcC2 
1009 
Biofilm 
NCH 
05/06/2007 101 
BMF 
>48 >4 Every 2h 
1010 
12/06/2007  
102 12-18 >4 Every 2h 
1015 
104 BM 24-48  3-4 Every 2h 
1016 Lumen 
EcC1 
1047 Biofilm 
QMC 22/10/2007 116 RTF 12-18  2-3  Every 2h  1050 
Lumen 
1051 
Appendix  7.8 Summary of neonates‘ age and feeding regimes 
BM = Breast milk, BMF = Breast milk fortified, PIF = Reconstituted powdered infant formula, IF = Infant formula, no further description given, RTF = Ready to feed 
formula, Cont = Continuous feed, Th = Thickener added to feed, NCH = Nottingham City Hospital and QMC = Queens medical Centre 
 
